[{"source":"Twitter for Windows Phone","text":"@EMA_News","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-25T11:13:00.000Z","conversation_id":"448400855700873216","possibly_sensitive":false,"lang":"und","referenced_tweets":[{"type":"replied_to","id":"448400855700873216"}],"id":"448417257522495488","author_id":"2301781832","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: Meeting highlights from the #CHMP 17-20 March 2014 http://t.co/L9CN9pMayU #pharmacovigilance #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":62,"end":84,"url":"http://t.co/L9CN9pMayU","expanded_url":"http://j.mp/1oWq9vf","display_url":"j.mp/1oWq9vf"}],"hashtags":[{"start":39,"end":44,"tag":"CHMP"},{"start":85,"end":103,"tag":"pharmacovigilance"},{"start":104,"end":115,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-25T09:01:25.000Z","conversation_id":"448384143504990208","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"448384143504990208","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends cond. mkting auth. for Vintafolide for treatmt of Platinum-resistant Ovarian Cancer sub-type http://t.co/vRbnvtvZhM","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/vRbnvtvZhM","expanded_url":"http://ow.ly/uTKpk","display_url":"ow.ly/uTKpk"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-24T13:28:51.000Z","conversation_id":"448089060746473472","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"448089060746473472","author_id":"69232855","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"iOS","text":"@EMA_News talks about what we have done to help combat multi-drug resistant strains of #tuberculosis. http://t.co/ww1y93ehAs","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/ww1y93ehAs","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/03/news_detail_002052.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":87,"end":100,"tag":"tuberculosis"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-24T12:55:42.000Z","conversation_id":"448080715767619585","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"448080715767619585","author_id":"113148426","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News: We've issued recommendations for the composition of #flu #vaccines for 2014/2015: http://t.co/Csi7rTwmwb","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/Csi7rTwmwb","expanded_url":"http://bit.ly/1g7Z5qu","display_url":"bit.ly/1g7Z5qu"}],"hashtags":[{"start":63,"end":67,"tag":"flu"},{"start":68,"end":77,"tag":"vaccines"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-23T09:53:13.000Z","conversation_id":"447672407067983872","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"447672407067983872","author_id":"308356449","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News had to share this on my site. Thank you! http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":51,"end":73,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-22T15:08:03.000Z","conversation_id":"446990865974968321","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"446990865974968321"}],"id":"447389247637831680","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Check out Lee Majors’ mission against the flu http://t.co/QBOkyETlYH share this with your loved ones, especially people 65+","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/QBOkyETlYH","expanded_url":"http://bit.ly/GJwWI6","display_url":"bit.ly/GJwWI6","status":200,"unwound_url":"https://www.youtube.com/watch?v=a4dpeKzqECQ"}],"hashtags":{},"annotations":[{"start":20,"end":29,"probability":0.4371,"type":"Person","normalized_text":"Lee Majors"}],"cashtags":{}},"created_at":"2014-03-21T14:30:22.000Z","conversation_id":"446987512662466560","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"446987512662466560"}],"id":"447017375448432640","author_id":"67413545","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News EMA launches adaptive licensing pilot project http://t.co/shnFI6Vw4D #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/shnFI6Vw4D","expanded_url":"http://ow.ly/uOx9g","display_url":"ow.ly/uOx9g"}],"hashtags":[{"start":79,"end":86,"tag":"pharma"},{"start":87,"end":95,"tag":"biotech"}],"annotations":[{"start":10,"end":12,"probability":0.4409,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"created_at":"2014-03-21T09:40:30.000Z","conversation_id":"446944430936035328","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"446944430936035328","author_id":"964487156","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News EMA launches adaptive licensing pilot project http://t.co/M3lHXZEbjI #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/M3lHXZEbjI","expanded_url":"http://ow.ly/uOwA2","display_url":"ow.ly/uOwA2"}],"hashtags":[{"start":79,"end":86,"tag":"pharma"},{"start":87,"end":95,"tag":"biotech"}],"annotations":[{"start":10,"end":12,"probability":0.4409,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"created_at":"2014-03-21T09:35:28.000Z","conversation_id":"446943160879841280","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"446943160879841280","author_id":"469324230","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News EMA launches adaptive licensing pilot project http://t.co/21f1MEduGY #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/21f1MEduGY","expanded_url":"http://ow.ly/uOx9e","display_url":"ow.ly/uOx9e"}],"hashtags":[{"start":79,"end":86,"tag":"pharma"},{"start":87,"end":95,"tag":"biotech"}],"annotations":[{"start":10,"end":12,"probability":0.4409,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"created_at":"2014-03-21T09:35:27.000Z","conversation_id":"446943156878471168","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"446943156878471168","author_id":"45537659","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Your tweet is now featured on my @RebelMouse http://t.co/zmglX5FBmp *bump it* http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":43,"end":54,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":88,"end":110,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"},{"start":55,"end":77,"url":"http://t.co/zmglX5FBmp","expanded_url":"https://twitter.com/RebelMouse/status/443829838369918976/photo/1","display_url":"pic.twitter.com/zmglX5FBmp"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-21T08:04:03.000Z","conversation_id":"446594917490769920","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"446594917490769920"}],"id":"446920157911605248","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":["3_443829838378307584"]},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News launches adaptive licensing pilot project http://t.co/Nm077TEKt4 #AccessToMedicine #health #EU #HTA #HealthRisks #PatientSafety","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":52,"end":74,"url":"http://t.co/Nm077TEKt4","expanded_url":"http://goo.gl/LnIZJU","display_url":"goo.gl/LnIZJU"}],"hashtags":[{"start":75,"end":92,"tag":"AccessToMedicine"},{"start":93,"end":100,"tag":"health"},{"start":101,"end":104,"tag":"EU"},{"start":105,"end":109,"tag":"HTA"},{"start":110,"end":122,"tag":"HealthRisks"},{"start":123,"end":137,"tag":"PatientSafety"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-20T10:08:32.000Z","conversation_id":"446589095784247296","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"446589095784247296","author_id":"376804644","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Exciting move on #adaptivelicensing; been long time in pipeline. Key debate will be how much is allowable under existing framework","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":27,"end":45,"tag":"adaptivelicensing"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-19T20:38:30.000Z","conversation_id":"446328001979248641","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"446328001979248641"}],"id":"446385246989062144","author_id":"552617924","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"V interesting, esp given recent Chinerix. MT @EMA_News: inviting companies to a pilot project on #adaptivelicensing: http://t.co/l3XbeX76dT","entities":{"mentions":[{"start":45,"end":54,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/l3XbeX76dT","expanded_url":"http://bit.ly/1fHHbWC","display_url":"bit.ly/1fHHbWC"}],"hashtags":[{"start":97,"end":115,"tag":"adaptivelicensing"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-19T17:30:51.000Z","conversation_id":"446328001979248641","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"446328001979248641"}],"id":"446338022070435841","author_id":"31353538","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @Aifa_ufficiale Screw your drugs! We're going old school!\nhttp://t.co/REY3Gda50i","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":68,"end":90,"url":"http://t.co/REY3Gda50i","expanded_url":"http://lordsofthedrinks.com/2014/03/18/10-alcoholic-drinks-to-replace-the-pills-in-your-medicine-cabinet/","display_url":"lordsofthedrinks.com/2014/03/18/10-…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-18T19:54:51.000Z","conversation_id":"445871824807940096","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"445871824807940096"}],"id":"446011872740118528","author_id":"962947430","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Great update - see it live here: http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":43,"end":65,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-18T14:29:02.000Z","conversation_id":"445904925856636929","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"445904925856636929"}],"id":"445929879520157696","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @EU_Health @animalpharm Presentations from #EMAIFAHEuropeInfoDay are available here: http://t.co/wpaU1XBr2C","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":21,"end":33,"username":"animalpharm","id":"15904344"}],"urls":[{"start":95,"end":117,"url":"http://t.co/wpaU1XBr2C","expanded_url":"http://bit.ly/1fr65LR","display_url":"bit.ly/1fr65LR"}],"hashtags":[{"start":53,"end":74,"tag":"EMAIFAHEuropeInfoDay"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-18T09:18:38.000Z","conversation_id":"445851761543503872","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"445851761543503872","author_id":"1017044760","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Help make it happen for Support #Expat Medics in the Dominican Republic on @indiegogo http://t.co/JmG7b6d14E … … …","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":95,"username":"Indiegogo","id":"34732474"}],"urls":[{"start":96,"end":118,"url":"http://t.co/JmG7b6d14E","expanded_url":"http://igg.me/at/supportexpatmedicsinthedr/x/4452112","display_url":"igg.me/at/supportexpa…"}],"hashtags":[{"start":42,"end":48,"tag":"Expat"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-18T05:53:35.000Z","conversation_id":"445800160094715905","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"445800160094715905","author_id":"156892827","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: 2 weeks to comment on paediatric clinical investigation of meds for #hypertension guidelines addendum: http://t.co/953sSF49oM”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/953sSF49oM","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"hashtags":[{"start":80,"end":93,"tag":"hypertension"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-17T11:04:50.000Z","conversation_id":"445509567720747008","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"445509567720747008"}],"id":"445516099975921664","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: 2 weeks left to comment on draft clinical development of medicines of #HIV infection guideline: http://t.co/GQeitOXxiB” #biotech","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/GQeitOXxiB","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"hashtags":[{"start":82,"end":86,"tag":"HIV"},{"start":132,"end":140,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-17T10:42:40.000Z","conversation_id":"445508802352525312","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"445508802352525312"}],"id":"445510523535515649","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: 2 weeks left to comment on draft clinical development of medicines of #HIV infection guideline: http://t.co/GQeitOXxiB” #pharma","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/GQeitOXxiB","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"hashtags":[{"start":82,"end":86,"tag":"HIV"},{"start":132,"end":139,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-17T10:42:14.000Z","conversation_id":"445508802352525312","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"445508802352525312"}],"id":"445510415251173376","author_id":"243228907","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News Excellent. Also consider publishing your reference info and other docs as structured data via open APIs as http://t.co/iNLoGFyYaC","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/iNLoGFyYaC","expanded_url":"http://5stardata.info/","display_url":"5stardata.info"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-17T10:38:17.000Z","conversation_id":"444583515603365888","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"445501083923021824"}],"id":"445509420848807937","author_id":"144624330","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News calls for scientific data for use in assessment of medicinal herbs  http://t.co/PtPLgY1X1T  #herbal #medicine","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":78,"end":100,"url":"http://t.co/PtPLgY1X1T","expanded_url":"http://bit.ly/1cFIryJ","display_url":"bit.ly/1cFIryJ"}],"hashtags":[{"start":102,"end":109,"tag":"herbal"},{"start":110,"end":119,"tag":"medicine"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-15T22:13:43.000Z","conversation_id":"444959653840314368","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"444959653840314368","author_id":"140344419","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @EU_Health http://t.co/eSIuVL2uYA","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"urls":[{"start":21,"end":43,"url":"http://t.co/eSIuVL2uYA","expanded_url":"https://twitter.com/English_Woman/status/444509618824171521/photo/1","display_url":"pic.twitter.com/eSIuVL2uYA"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-14T16:25:26.000Z","conversation_id":"444506469728522240","possibly_sensitive":false,"lang":"und","referenced_tweets":[{"type":"replied_to","id":"444506469728522240"}],"id":"444509618824171521","author_id":"18474984","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":["3_444509618828365824"]},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News English version: http://t.co/c2Af1I6JmE","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":27,"end":49,"url":"http://t.co/c2Af1I6JmE","expanded_url":"http://en.urpl.gov.pl/general-information/%3Cspan-style=-colol-red-information-of-the-office-from-14-march-2014-regarding-the-move-to-new-premises-of-the-office-for-registration-of-medicinal-pro","display_url":"en.urpl.gov.pl/general-inform…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-14T15:29:20.000Z","conversation_id":"444494960516403200","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"444494960516403200"}],"id":"444495499933286401","author_id":"556679074","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News just featured you on my @RebelMouse http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":34,"end":45,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":46,"end":68,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-14T15:27:03.000Z","conversation_id":"444493110996115456","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"444493110996115456"}],"id":"444494926727114753","author_id":"134450541","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @GCessak Great. Really appreciate the reply.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"GCessak","id":"556859372"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-14T15:19:07.000Z","conversation_id":"444445442563383296","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"444491978269810688"}],"id":"444492928732631041","author_id":"203357203","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News to move HQ this year... but will remain in Canary Wharf, London #EMAIFAHEuropeInfoDay","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":74,"end":95,"tag":"EMAIFAHEuropeInfoDay"}],"annotations":[{"start":53,"end":64,"probability":0.9422,"type":"Place","normalized_text":"Canary Wharf"},{"start":67,"end":72,"probability":0.6099,"type":"Place","normalized_text":"London"}],"cashtags":{}},"created_at":"2014-03-14T12:48:33.000Z","conversation_id":"444455040015929344","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"444455040015929344","author_id":"2382044864","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Mackay: New legislation to be published in 2014 should create true single market for #veterinarymedicines #EMAIFAHEuropeInfoDay","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":95,"end":115,"tag":"veterinarymedicines"},{"start":116,"end":137,"tag":"EMAIFAHEuropeInfoDay"}],"annotations":[{"start":10,"end":15,"probability":0.4187,"type":"Person","normalized_text":"Mackay"}],"cashtags":{}},"created_at":"2014-03-14T12:28:41.000Z","conversation_id":"444450039889690624","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"444450039889690624","author_id":"1017044760","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Mackay: #VICH Outreach Forum 4 globally harmonised regulation important in developing regions #EMAIFAHEuropeInfoDay","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":18,"end":23,"tag":"VICH"},{"start":104,"end":125,"tag":"EMAIFAHEuropeInfoDay"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-14T10:46:19.000Z","conversation_id":"444424279632146432","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"444424279632146432","author_id":"1017044760","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Mackay on trends: Healthy pipeline 4 #veterinarymedicines development. Increased access 2 new technologies #EMAIFAHEuropeInfoDay","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":47,"end":67,"tag":"veterinarymedicines"},{"start":117,"end":138,"tag":"EMAIFAHEuropeInfoDay"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-14T10:42:00.000Z","conversation_id":"444423189712887808","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"444423189712887808","author_id":"1017044760","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Saving that tweet! It's now featured on http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":50,"end":72,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-12T12:59:03.000Z","conversation_id":"443716401317314561","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"443716401317314561"}],"id":"443732904708145152","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"RT @EMA_News: Yesterday we started publishing summaries of risk-management plans for authorised human medicines: http://t.co/F70w56NnDY","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/F70w56NnDY","expanded_url":"http://bit.ly/1cR952c","display_url":"bit.ly/1cR952c"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-12T10:00:49.000Z","conversation_id":"443686090189570048","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"443686090189570048"}],"id":"443688050523389952","author_id":"35511598","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Donate a tweet to @worldkidneyday via Thunderclap. Join our mission to increase awareness http://t.co/dPUMw0s0mH  Thank you!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":28,"end":43,"username":"worldkidneyday","id":"64681292"}],"urls":[{"start":100,"end":122,"url":"http://t.co/dPUMw0s0mH","expanded_url":"http://bit.ly/1mi0agk","display_url":"bit.ly/1mi0agk"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-12T09:42:48.000Z","conversation_id":"443683519219662848","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"443683519219662848","author_id":"64681292","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: Meeting highlights from the #PRAC 3-6 March 2014 http://t.co/Qd7bdQzWhJ #pharmacovigilance #drugsafety","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":60,"end":82,"url":"http://t.co/Qd7bdQzWhJ","expanded_url":"http://j.mp/1lwcyIP","display_url":"j.mp/1lwcyIP"}],"hashtags":[{"start":39,"end":44,"tag":"PRAC"},{"start":83,"end":101,"tag":"pharmacovigilance"},{"start":102,"end":113,"tag":"drugsafety"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-12T08:16:29.000Z","conversation_id":"443661794121633792","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"443661794121633792","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News wants to hear what we think of their #Twitter feed? Tell them how to better serve patients #BeSocial http://t.co/ev6jPfaLcz","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":111,"end":133,"url":"http://t.co/ev6jPfaLcz","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":[{"start":47,"end":55,"tag":"Twitter"},{"start":101,"end":110,"tag":"BeSocial"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-11T13:33:38.000Z","conversation_id":"443379220073689088","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"443379220073689088","author_id":"140344419","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @EU_Commission Thank you - very helpful!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-10T14:45:27.000Z","conversation_id":"443022598331719680","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"443033884650135552"}],"id":"443034908286812160","author_id":"329999446","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@GeoMurariu However please note that we don't approve medicines. The @EU_Commission approves after we've given an opinion.","entities":{"mentions":[{"start":0,"end":11,"username":"GeoMurariu","id":"1125798749727539202"},{"start":69,"end":83,"username":"EU_Commission","id":"157981564"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-10T14:41:23.000Z","conversation_id":"443022598331719680","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"443033688855834624"}],"id":"443033884650135552","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News and @US_FDA extend pilot programme for parallel assessment of quality-by-design applications http://t.co/rS3TVr7iq4 #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":21,"username":"US_FDA","id":"208120290"}],"urls":[{"start":103,"end":125,"url":"http://t.co/rS3TVr7iq4","expanded_url":"http://j.mp/1i275cw","display_url":"j.mp/1i275cw"}],"hashtags":[{"start":126,"end":137,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-10T14:28:01.000Z","conversation_id":"443030518993809408","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"443030518993809408","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Hi, where can I find a complete list of drugs approved in 2013 by the EMA? So the EU equivalent of this - http://t.co/vKqAup91CO","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/vKqAup91CO","expanded_url":"http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Reports.NewOriginalNDA#navigation","display_url":"accessdata.fda.gov/scripts/cder/d…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-10T13:56:33.000Z","conversation_id":"443022598331719680","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"443022598331719680","author_id":"329999446","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@ema_news #Ataxia S #Wales #raredisease #charity #MixingWithTheBigBoys #Pharma #Orphan #medicine cc @Em_L_Hughes @DawnieMorgan @jccolyer","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":100,"end":112,"username":"Em_L_Hughes","id":"335343087"},{"start":113,"end":126,"username":"DawnieMorgan","id":"37254356"},{"start":127,"end":136,"username":"jccolyer","id":"21026095"}],"urls":{},"hashtags":[{"start":10,"end":17,"tag":"Ataxia"},{"start":20,"end":26,"tag":"Wales"},{"start":27,"end":39,"tag":"raredisease"},{"start":40,"end":48,"tag":"charity"},{"start":49,"end":70,"tag":"MixingWithTheBigBoys"},{"start":71,"end":78,"tag":"Pharma"},{"start":79,"end":86,"tag":"Orphan"},{"start":87,"end":96,"tag":"medicine"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-10T13:30:54.000Z","conversation_id":"443016146682662912","possibly_sensitive":false,"lang":"und","referenced_tweets":{},"id":"443016146682662912","author_id":"226603998","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Thanks for sharing that update - it's now live here: http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":63,"end":85,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-10T11:13:03.000Z","conversation_id":"442977479574429696","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"442977479574429696"}],"id":"442981452545007616","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News definitely adding that tweet to my site. http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":51,"end":73,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-08T19:56:02.000Z","conversation_id":"441912105214943232","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"441912105214943232"}],"id":"442388293364486144","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News recommend restricting the use of #domperidone http://t.co/Rq3rHsppex","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/Rq3rHsppex","expanded_url":"http://bit.ly/1fLi36Y","display_url":"bit.ly/1fLi36Y"}],"hashtags":[{"start":43,"end":55,"tag":"domperidone"}],"annotations":{},"cashtags":{}},"created_at":"2014-03-08T09:18:46.000Z","conversation_id":"442227916298924032","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"442227916298924032","author_id":"62116349","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News In my situation this is the most frightening drug (literally!) because it put me in serotonin syndrome Hallucinating being dead.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-08T06:40:10.000Z","conversation_id":"423837136668741632","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"423837136668741632"}],"id":"442188004753301506","author_id":"432519961","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Amerika ve Avrupa ilaç ajansları 2 yıl daha birlikte çalışacak.. @Titck2,  @EMA_News, @US_FDA: http://t.co/GbiOkmfy5O","entities":{"mentions":[{"start":65,"end":72,"username":"titck2","id":"1486319532364943361"},{"start":75,"end":84,"username":"EMA_News","id":"116716199"},{"start":86,"end":93,"username":"US_FDA","id":"208120290"}],"urls":[{"start":95,"end":117,"url":"http://t.co/GbiOkmfy5O","expanded_url":"http://bit.ly/1g2QmFt","display_url":"bit.ly/1g2QmFt"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-07T12:19:57.000Z","conversation_id":"441887814486339584","possibly_sensitive":false,"lang":"tr","referenced_tweets":[{"type":"replied_to","id":"441887814486339584"}],"id":"441911127346544640","author_id":"434758377","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Live from the Clinic returns in April! Appointments now available, visit: http://t.co/k0FP33rLru  for an appointment.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":84,"end":106,"url":"http://t.co/k0FP33rLru","expanded_url":"http://is.gd/EBApply","display_url":"is.gd/EBApply"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-07T10:04:36.000Z","conversation_id":"441877063369502720","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"441877063369502720","author_id":"1159798933","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News definitely adding that tweet to my site. http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":51,"end":73,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-06T09:56:03.000Z","conversation_id":"441511772135387136","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"441511772135387136"}],"id":"441512524278935552","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News Please share @ITVWales report of Wales #Raredisease plan launched on Rare Disease day http://t.co/g7fh3tgPpV  #rddwales","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":23,"end":32,"username":"ITVWales","id":"166942410"}],"urls":[{"start":96,"end":118,"url":"http://t.co/g7fh3tgPpV","expanded_url":"http://ow.ly/uaCJF","display_url":"ow.ly/uaCJF"}],"hashtags":[{"start":49,"end":61,"tag":"Raredisease"},{"start":120,"end":129,"tag":"rddwales"}],"annotations":[{"start":43,"end":47,"probability":0.9074,"type":"Place","normalized_text":"Wales"},{"start":79,"end":94,"probability":0.5744,"type":"Other","normalized_text":"Rare Disease day"}],"cashtags":{}},"created_at":"2014-03-05T07:17:10.000Z","conversation_id":"441110152343990272","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"441110152343990272","author_id":"226603998","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Great update - see it live here: http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":43,"end":65,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-04T15:58:02.000Z","conversation_id":"440876007118348288","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"440876007118348288"}],"id":"440878846645391362","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News http://t.co/KMspDXMVuC","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":10,"end":32,"url":"http://t.co/KMspDXMVuC","expanded_url":"http://www.youtube.com/watch?v=k7JAb9O4frM","display_url":"youtube.com/watch?v=k7JAb9…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-03-01T09:45:36.000Z","conversation_id":"439697953918566401","possibly_sensitive":false,"lang":"und","referenced_tweets":{},"id":"439697953918566401","author_id":"340331522","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"LinkedIn","text":"@EMA_News: Now published- pharmacovigilance practice guideline module on risk-minimisation measures: http://t.co/tbLnJynlTk","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":101,"end":123,"url":"http://t.co/tbLnJynlTk","expanded_url":"http://bit.ly/1d0iBDp","display_url":"bit.ly/1d0iBDp"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-28T21:41:37.000Z","conversation_id":"439515757349961728","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"439515757349961728","author_id":"318743706","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News :) http://t.co/cU6mh9yzh7","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":13,"end":35,"url":"http://t.co/cU6mh9yzh7","expanded_url":"https://twitter.com/MMGHealth/status/439443788507774976/photo/1","display_url":"pic.twitter.com/cU6mh9yzh7"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-28T16:55:38.000Z","conversation_id":"438626046074953728","possibly_sensitive":false,"lang":"und","referenced_tweets":[{"type":"replied_to","id":"438626046074953728"}],"id":"439443788507774976","author_id":"525474752","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":["3_439443788511969280"]},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News Así se hace transparencia","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-28T12:19:57.000Z","conversation_id":"439369935668936704","possibly_sensitive":false,"lang":"es","referenced_tweets":[{"type":"replied_to","id":"439369935668936704"}],"id":"439374411670380544","author_id":"261573281","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Had to share that one! It's now featured on http://t.co/KSKlNHWh1y","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":54,"end":76,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-28T10:31:03.000Z","conversation_id":"438327181207691264","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"438327181207691264"}],"id":"439347004201009152","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News withdraw #Bisphosphonates #Ketorolac","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":19,"end":35,"tag":"Bisphosphonates"},{"start":36,"end":46,"tag":"Ketorolac"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-26T16:34:49.000Z","conversation_id":"438626046074953728","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"438626046074953728"}],"id":"438713776079405056","author_id":"982666808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News withdraw harmful drugs","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-26T16:34:28.000Z","conversation_id":"438626046074953728","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"438626046074953728"}],"id":"438713684748423168","author_id":"982666808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News definitely adding that tweet to my @RebelMouse http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":56,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":57,"end":79,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-25T19:26:02.000Z","conversation_id":"438364385091010560","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"438364385091010560"}],"id":"438394477070516224","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @EU_enterprise @EU_Health Does the EC have such social media guidelines? If yes, who drafts them? DG COMM?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_enterprise","id":"2562735307"},{"start":25,"end":35,"username":"EU_Health","id":"606325697"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-25T16:40:14.000Z","conversation_id":"438341840572776448","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"438344026258149377"}],"id":"438352748665651200","author_id":"2254792730","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Hi! Do you have social media guidance for the pharma industry like the FDA does? thanks!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":81,"end":83,"probability":0.9078,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"created_at":"2014-02-25T15:56:53.000Z","conversation_id":"438341840572776448","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"438341840572776448","author_id":"2254792730","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News gives second positive opinion for a #paediatric-use marketing authorisation http://t.co/QcI1bLvC7K #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":86,"end":108,"url":"http://t.co/QcI1bLvC7K","expanded_url":"http://j.mp/1hqWzta","display_url":"j.mp/1hqWzta"}],"hashtags":[{"start":46,"end":57,"tag":"paediatric"},{"start":109,"end":120,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-25T11:15:40.000Z","conversation_id":"438271069842317312","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"438271069842317312","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News my father was on sunitinib. #Bisphosphonates #Ketorolac without his consent","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":38,"end":54,"tag":"Bisphosphonates"},{"start":55,"end":65,"tag":"Ketorolac"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-24T19:31:58.000Z","conversation_id":"438011501840855040","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"438011501840855040"}],"id":"438033579873169409","author_id":"982666808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News 4 sleeps to @rarediseaseday #UK events @rarediseaseuk @GeneticAll_UK #rdd14 #raredisease #rddwales","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":22,"end":37,"username":"rarediseaseday","id":"19982434"},{"start":49,"end":63,"username":"rarediseaseuk","id":"274030199"},{"start":64,"end":78,"username":"GeneticAll_UK","id":"413849446"}],"urls":{},"hashtags":[{"start":38,"end":41,"tag":"UK"},{"start":79,"end":85,"tag":"rdd14"},{"start":86,"end":98,"tag":"raredisease"},{"start":99,"end":108,"tag":"rddwales"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-24T10:42:15.000Z","conversation_id":"437900272795283457","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"437900272795283457","author_id":"226603998","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News withdraw harmful drugs","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-24T01:53:30.000Z","conversation_id":"437767207339425792","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"437767207339425792","author_id":"982666808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News @MHRAgovuk MHRA to withdraw harmful drugs. #Bisphosphonates #Ketorolac","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"MHRAgovuk","id":"330993102"}],"urls":{},"hashtags":[{"start":53,"end":69,"tag":"Bisphosphonates"},{"start":70,"end":80,"tag":"Ketorolac"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-24T01:40:33.000Z","conversation_id":"436849994252181504","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"436849994252181504"}],"id":"437763948281344000","author_id":"982666808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News possibility to submit info in relation to #valproateinpregnancy yet document unavailable to download...?? @nicolerambles","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":116,"end":130,"username":"nicolerambles","id":"292108067"}],"urls":{},"hashtags":[{"start":52,"end":73,"tag":"valproateinpregnancy"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-23T22:16:10.000Z","conversation_id":"437712514239852544","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"437712514239852544","author_id":"250163834","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News possibility to submit info in relation to #valproateinpregnancy yet document unavailable to download... not surprising @Emma4facs","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":129,"end":139,"username":"Emma4facs","id":"277466861"}],"urls":{},"hashtags":[{"start":52,"end":73,"tag":"valproateinpregnancy"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-23T22:15:15.000Z","conversation_id":"437712284362629120","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"437712284362629120","author_id":"250163834","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News just featured you on my @RebelMouse http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":34,"end":45,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":46,"end":68,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-21T21:25:03.000Z","conversation_id":"436920210600112128","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"436930995577962496"}],"id":"436974874163412992","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News #CHMP gives orphan #biotech @BioMarin #MPSIVA drug #Vimizim green light; $BMRN market cap up $2bn in past 14 days to $11.4bn","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":38,"end":47,"username":"BioMarin","id":"51282370"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":29,"end":37,"tag":"biotech"},{"start":48,"end":55,"tag":"MPSIVA"},{"start":61,"end":69,"tag":"Vimizim"}],"annotations":{},"cashtags":[{"start":83,"end":88,"tag":"BMRN"}]},"created_at":"2014-02-21T12:36:36.000Z","conversation_id":"436841887899844608","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"436841887899844608","author_id":"243228907","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News it's noon UK time - where are those meeting highlights?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":20,"end":21,"probability":0.8946,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"created_at":"2014-02-21T12:04:07.000Z","conversation_id":"436833713213947904","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"436833713213947904","author_id":"380500399","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News welcomes new Head of IT Development Department http://t.co/3MerjhS1Bz #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":57,"end":79,"url":"http://t.co/3MerjhS1Bz","expanded_url":"http://j.mp/Md9cOn","display_url":"j.mp/Md9cOn"}],"hashtags":[{"start":80,"end":91,"tag":"regulatory"}],"annotations":[{"start":23,"end":55,"probability":0.6239,"type":"Organization","normalized_text":"Head of IT Development Department"}],"cashtags":{}},"created_at":"2014-02-19T21:10:13.000Z","conversation_id":"436246367766605824","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"436246367766605824","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News: la agenda del CHMP de esta semana!! El viernes los highlights... http://t.co/rJMZGMPSQt","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":76,"end":98,"url":"http://t.co/rJMZGMPSQt","expanded_url":"http://bit.ly/LO8I1U","display_url":"bit.ly/LO8I1U"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-19T21:03:37.000Z","conversation_id":"436244706528219136","possibly_sensitive":false,"lang":"ca","referenced_tweets":{},"id":"436244706528219136","author_id":"1171477128","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News had to share this on my @RebelMouse. Thank you! http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":34,"end":45,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":58,"end":80,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-19T16:09:03.000Z","conversation_id":"436143081889730560","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"436143081889730560"}],"id":"436170575317598209","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News @SusanWer @ampariu @_SEOM  @CRCTU @UICC @docjavip @giasison @wild_diva @EAPCOnlus @cancerEU @_M_Masa @ONAcom thx for yr RTs!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"SusanWer","id":"224614927"},{"start":20,"end":28,"username":"ampariu","id":"267831890"},{"start":29,"end":35,"username":"_SEOM","id":"555051765"},{"start":37,"end":43,"username":"CRCTU","id":"1193633406"},{"start":44,"end":49,"username":"uicc","id":"53023973"},{"start":50,"end":59,"username":"docjavip","id":"1030110686"},{"start":60,"end":69,"username":"giasison","id":"65594160"},{"start":70,"end":80,"username":"wild_diva","id":"65461631"},{"start":92,"end":101,"username":"cancereu","id":"140344419"},{"start":102,"end":110,"username":"_M_Masa","id":"31432586"},{"start":111,"end":118,"username":"ONAcom","id":"30891529"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-19T13:55:17.000Z","conversation_id":"436136913251364864","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"436136913251364864","author_id":"69232855","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @Emma4facs review into Valproate &amp; other substances in pregnancy...maybe not enough input.  #INFACT's figs agreed by UK @MHRAgovuk","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"},{"start":134,"end":144,"username":"MHRAgovuk","id":"330993102"}],"urls":{},"hashtags":[{"start":106,"end":113,"tag":"INFACT"}],"annotations":[{"start":127,"end":128,"probability":0.809,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"created_at":"2014-02-18T16:01:32.000Z","conversation_id":"435806294776102912","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"435806294776102912","author_id":"250163834","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News trounces @US_FDA in 2013 #drug approval tally: 81 vs. 27 http://t.co/d71g1mkFJr","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":19,"end":26,"username":"US_FDA","id":"208120290"}],"urls":[{"start":67,"end":89,"url":"http://t.co/d71g1mkFJr","expanded_url":"http://bit.ly/1bnpttH","display_url":"bit.ly/1bnpttH"}],"hashtags":[{"start":35,"end":40,"tag":"drug"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-16T15:00:17.000Z","conversation_id":"435066104394706945","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"435066104394706945","author_id":"847536019","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News  Product specific guidances for demonstration of bioeqivalence for 16 actives released for public comment.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-16T03:47:47.000Z","conversation_id":"434264704291450880","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"434264704291450880"}],"id":"434896865977303040","author_id":"2198604157","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News retweet this short documentry http://t.co/c7co1iFqYw … to raise awareness #haemophilia #awareness","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":40,"end":62,"url":"http://t.co/c7co1iFqYw","expanded_url":"http://www.youtube.com/watch?v=ajyrS2zfSHU&feature=youtu.be","display_url":"youtube.com/watch?v=ajyrS2…"}],"hashtags":[{"start":84,"end":96,"tag":"haemophilia"},{"start":97,"end":107,"tag":"awareness"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-15T18:23:29.000Z","conversation_id":"434754855341547521","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"434754855341547521","author_id":"49340629","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News introduces product numbers to track #medicines through #pre-authorisation procedures http://t.co/uRbKUqIWu5 #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/uRbKUqIWu5","expanded_url":"http://j.mp/1nwCxQ0","display_url":"j.mp/1nwCxQ0"}],"hashtags":[{"start":46,"end":56,"tag":"medicines"},{"start":65,"end":69,"tag":"pre"},{"start":118,"end":129,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-13T21:56:32.000Z","conversation_id":"434083695511609344","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"434083695511609344","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News clarifies interpretation of new variation classification categories\nhttp://t.co/DiMzFjUp0q","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":78,"end":100,"url":"http://t.co/DiMzFjUp0q","expanded_url":"http://lnkd.in/bJ5Cg37","display_url":"lnkd.in/bJ5Cg37"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-11T19:57:39.000Z","conversation_id":"433329003634491392","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"433329003634491392","author_id":"1242516320","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Couldn't have said it better! That tweet is now on my @RebelMouse http://t.co/UoFUSPodMU http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":64,"end":75,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":99,"end":121,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"},{"start":76,"end":98,"url":"http://t.co/UoFUSPodMU","expanded_url":"https://twitter.com/RebelMouse/status/406384118117580800/photo/1","display_url":"pic.twitter.com/UoFUSPodMU"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-09T17:51:02.000Z","conversation_id":"385031787141148672","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"385031787141148672"}],"id":"432572362987692032","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":["3_406384118121775105"]},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Public consultation now open on update of best practice wrt #3Rs: http://t.co/szjKAXz3P4” reducing animal testing in #pharma","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":78,"end":100,"url":"http://t.co/szjKAXz3P4","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"hashtags":[{"start":72,"end":76,"tag":"3Rs"},{"start":129,"end":136,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-07T21:40:21.000Z","conversation_id":"431825118810365952","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"431825118810365952"}],"id":"431905294097350656","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"RT @EMA_News: We've just published the #PRAC meeting highlights:  http://t.co/xoriEwpbIG”","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":66,"end":88,"url":"http://t.co/xoriEwpbIG","expanded_url":"http://bit.ly/Mxa6FR","display_url":"bit.ly/Mxa6FR"}],"hashtags":[{"start":39,"end":44,"tag":"PRAC"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-07T13:03:31.000Z","conversation_id":"431761648748347392","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"431761648748347392"}],"id":"431775229267152896","author_id":"35511598","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Just a question. Why, dont we ever control Tmax? Never understood (sometimes clinicaly relevant)","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-07T12:43:42.000Z","conversation_id":"431766052519677952","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"431766052519677952"}],"id":"431770241165565953","author_id":"377336516","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Thanks for sharing! You're now featured on http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":53,"end":75,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-07T10:12:02.000Z","conversation_id":"431729705080086529","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"431729705080086529"}],"id":"431732076422115328","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Pls share Only 4 sleeps before #Wales #raredisease Day reception in #Senedd #Cardiff hosted by @RebeccaEvansAM on 11th Feb.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":41,"end":47,"tag":"Wales"},{"start":48,"end":60,"tag":"raredisease"},{"start":78,"end":85,"tag":"Senedd"},{"start":86,"end":94,"tag":"Cardiff"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-07T09:39:03.000Z","conversation_id":"431723772719005697","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"431723772719005697","author_id":"226603998","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: 11 out of the 81 human #drugs we recommended for marketing authorisation in 2013 were for #rarediseases: http://t.co/M3rHI4iEMU","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/M3rHI4iEMU","expanded_url":"http://bit.ly/1foANVR","display_url":"bit.ly/1foANVR"}],"hashtags":[{"start":35,"end":41,"tag":"drugs"},{"start":102,"end":115,"tag":"rarediseases"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-06T21:47:40.000Z","conversation_id":"430357244220567552","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"430357244220567552"}],"id":"431544746847506433","author_id":"51445321","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We've published the EPAR for #Sovaldi (#sofosbuvir) to treat #hepatitisC in adults: http://t.co/lDjTKnMsTy”YA ESTÁN AQUIIII!!!!","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/lDjTKnMsTy","expanded_url":"http://bit.ly/1lAybf1","display_url":"bit.ly/1lAybf1"}],"hashtags":[{"start":41,"end":49,"tag":"Sovaldi"},{"start":51,"end":62,"tag":"sofosbuvir"},{"start":73,"end":84,"tag":"hepatitisC"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-06T11:19:19.000Z","conversation_id":"431376241577324544","possibly_sensitive":false,"lang":"es","referenced_tweets":[{"type":"replied_to","id":"431376241577324544"}],"id":"431386619086897152","author_id":"286245228","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News @sefh_","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":16,"username":"sefh_","id":"914462377"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-05T23:17:38.000Z","conversation_id":"430666062338600960","possibly_sensitive":false,"lang":"und","referenced_tweets":[{"type":"replied_to","id":"430666062338600960"}],"id":"431205001177088000","author_id":"2208098471","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@VanessaVanHalen ...Lenalidomide Celgene Europe (976 days, negative opinion); Xagrid (832 days, positive opinion).","entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":[{"start":41,"end":46,"probability":0.4584,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"created_at":"2014-02-05T15:48:33.000Z","conversation_id":"430926683273986048","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"431091742293884929"}],"id":"431091988033982464","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: Committee for #orphanmedicines – overview of 2013 and looking ahead http://t.co/cS8DBBBUvo #COMP #RareDisease","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/cS8DBBBUvo","expanded_url":"http://j.mp/LvGnfA","display_url":"j.mp/LvGnfA"}],"hashtags":[{"start":25,"end":41,"tag":"orphanmedicines"},{"start":102,"end":107,"tag":"COMP"},{"start":108,"end":120,"tag":"RareDisease"}],"annotations":{},"cashtags":{}},"created_at":"2014-02-04T18:51:32.000Z","conversation_id":"430775647724503041","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"430775647724503041","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Help support #RareDisease Day awareness on Twitter this year. We need your voice on this http://t.co/Od4qCIIasW","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/Od4qCIIasW","expanded_url":"http://thndr.it/1iPSEdF","display_url":"thndr.it/1iPSEdF"}],"hashtags":[{"start":23,"end":35,"tag":"RareDisease"}],"annotations":[{"start":53,"end":59,"probability":0.6331,"type":"Product","normalized_text":"Twitter"}],"cashtags":{}},"created_at":"2014-02-04T16:10:48.000Z","conversation_id":"430735198150352896","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"430735198150352896","author_id":"19982434","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Thanks for sharing. See your update on my @RebelMouse: http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":52,"end":63,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":65,"end":87,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-03T20:04:03.000Z","conversation_id":"430395236133511168","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"430429471888658433"}],"id":"430431508944654336","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News SME, academic, public bodies and public-private institutions: an important source of innovation+bolster pipelines of larger pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-03T12:03:25.000Z","conversation_id":"430310553999798272","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"430310553999798272","author_id":"328653957","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@VanessaVanHalen If you'd like a more detailed response, please send your question to us at http://t.co/81mvfkEvbJ.","entities":{"mentions":{},"urls":[{"start":92,"end":114,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-03T09:36:45.000Z","conversation_id":"429388398470889472","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"430273350838263808"}],"id":"430273642631802880","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: who are the originators of innovative medicines in EU? 17% are public bodies http://t.co/JdZWteN6ke” http://t.co/cDDcdwelWm","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":89,"end":111,"url":"http://t.co/JdZWteN6ke","expanded_url":"http://bit.ly/1gwFKBf","display_url":"bit.ly/1gwFKBf"},{"start":113,"end":135,"url":"http://t.co/cDDcdwelWm","expanded_url":"http://www.nature.com/nrd/journal/v13/n2/full/nrd4232.html","display_url":"nature.com/nrd/journal/v1…"}],"hashtags":{},"annotations":[{"start":63,"end":64,"probability":0.6376,"type":"Place","normalized_text":"EU"}],"cashtags":{}},"created_at":"2014-02-03T09:16:27.000Z","conversation_id":"430267392581570560","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"430267392581570560"}],"id":"430268536213491712","author_id":"16947313","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News you're live on my @RebelMouse http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":28,"end":39,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":40,"end":62,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-02-02T17:56:02.000Z","conversation_id":"428900615251845120","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"428900615251845120"}],"id":"430036906458746881","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@sTuDiO54x For more information in your country please contact the national authority - contact details on our site: http://t.co/OHmO1q7yPu","entities":{"mentions":[{"start":0,"end":10,"username":"sTuDiO54x","id":"22255878"}],"urls":[{"start":117,"end":139,"url":"http://t.co/OHmO1q7yPu","expanded_url":"http://bit.ly/ZoTtg0","display_url":"bit.ly/ZoTtg0"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-31T09:56:18.000Z","conversation_id":"428925100986212354","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"429190564509388800"}],"id":"429191400694222848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News When is Daclatasvir going to be released for the EU??","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":18,"end":28,"probability":0.6677,"type":"Person","normalized_text":"Daclatasvir"}],"cashtags":{}},"created_at":"2014-01-30T22:43:28.000Z","conversation_id":"428925100986212354","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"428925100986212354"}],"id":"429022076343554048","author_id":"22255878","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Thanks for sharing. See your update on my @RebelMouse: http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":52,"end":63,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":65,"end":87,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-30T16:23:02.000Z","conversation_id":"428925100986212354","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"428925100986212354"}],"id":"428926337769021440","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web App","text":"@EMA_News Congratulazioni all'EMA che per la prima volta ha pubblicato i verbali delle riunioni delle commissioni che valutano i farmaci !!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-29T15:52:17.000Z","conversation_id":"428481304682700800","possibly_sensitive":false,"lang":"it","referenced_tweets":[{"type":"replied_to","id":"428481304682700800"}],"id":"428556211127336961","author_id":"2178765794","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommended mkting auth. for 16 new medicines for #cancer treatmt in 2013, 12 w/ new active substance http://t.co/n4o7TCeRiA","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/n4o7TCeRiA","expanded_url":"http://ow.ly/t41a1","display_url":"ow.ly/t41a1"}],"hashtags":[{"start":60,"end":67,"tag":"cancer"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-29T11:53:54.000Z","conversation_id":"428496221247135744","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"428496221247135744","author_id":"69232855","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News For the 1st time published the meeting minutes of the Committees. \nThis is Transparency. Great!\nWill EU Agencies do the same?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-29T10:02:35.000Z","conversation_id":"428468206500474880","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"428468206500474880","author_id":"220854424","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News publishes minutes of #CHMP, #CVMP and CAT meetings for the first time http://t.co/XBYtmdY0dF #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/XBYtmdY0dF","expanded_url":"http://j.mp/1fkz6L3","display_url":"j.mp/1fkz6L3"}],"hashtags":[{"start":31,"end":36,"tag":"CHMP"},{"start":38,"end":43,"tag":"CVMP"},{"start":103,"end":114,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-28T20:15:23.000Z","conversation_id":"428260034510745600","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"428260034510745600","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@louis_ide The recommendation has been postponed because there are still issues that our pharmacovigilance committee needs answering.","entities":{"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-28T09:29:02.000Z","conversation_id":"428095843179065344","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"428095843179065344"}],"id":"428097372871458816","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News When can we expect advice #domperidone: it is #urgent. Why #postpone every time?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":36,"end":48,"tag":"domperidone"},{"start":56,"end":63,"tag":"urgent"},{"start":69,"end":78,"tag":"postpone"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-28T09:17:12.000Z","conversation_id":"428088936766771200","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"428088936766771200"}],"id":"428094395124969472","author_id":"1548804618","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: Review of emergency #contraceptives started http://t.co/QtG0xZA6CK #productsafety","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/QtG0xZA6CK","expanded_url":"http://j.mp/1iDPLwC","display_url":"j.mp/1iDPLwC"}],"hashtags":[{"start":31,"end":46,"tag":"contraceptives"},{"start":78,"end":92,"tag":"productsafety"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-27T21:29:13.000Z","conversation_id":"427916225243394048","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"427916225243394048","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News You made my @RebelMouse http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":22,"end":33,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":34,"end":56,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-26T11:28:03.000Z","conversation_id":"426691399715946497","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"426691399715946497"}],"id":"427402550116372480","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Facebook","text":"@EMA_News: Review of emergency contraceptives started - does increased bodyweight &amp; BMI reduce their efficacy? ... http://t.co/nx5Gq8wR83","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":119,"end":141,"url":"http://t.co/nx5Gq8wR83","expanded_url":"http://fb.me/XQeea0I7","display_url":"fb.me/XQeea0I7"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-24T20:23:46.000Z","conversation_id":"426812593815437312","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"426812593815437312","author_id":"318584391","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News CHMP recommends EU approval of a new formulation of @Roche #MabThera for patients with non-#Hodgkin #lymphoma #cancer #pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":62,"end":68,"username":"Roche","id":"20815041"}],"urls":{},"hashtags":[{"start":69,"end":78,"tag":"MabThera"},{"start":101,"end":109,"tag":"Hodgkin"},{"start":110,"end":119,"tag":"lymphoma"},{"start":120,"end":127,"tag":"cancer"},{"start":128,"end":135,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-24T16:46:52.000Z","conversation_id":"426758008983396352","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"426758008983396352","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News L'Europe se penche sur l'efficacité des contraceptifs d'urgence en fonction du poids.Voir mon enquête p.34:http://t.co/89HNFmCaVd.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/89HNFmCaVd","expanded_url":"http://bit.ly/1jsybeR","display_url":"bit.ly/1jsybeR"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-24T15:19:00.000Z","conversation_id":"426735895312879616","possibly_sensitive":false,"lang":"fr","referenced_tweets":{},"id":"426735895312879616","author_id":"307539793","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News Lancement d'une réévaluation de l'efficacité des contraceptifs d'urgence en fonction du poids. Cf. p.34:http://t.co/uaTwNR53SA.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/uaTwNR53SA","expanded_url":"http://bit.ly/1jsybeR","display_url":"bit.ly/1jsybeR"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-24T15:18:02.000Z","conversation_id":"426735653427380224","possibly_sensitive":false,"lang":"fr","referenced_tweets":{},"id":"426735653427380224","author_id":"1339508364","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News CHMP recommends lifting suspension of marketing for Vibativ. Marketing hold stems from poor GMP seen in 2012 OH plant inspection.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":62,"end":68,"probability":0.5864,"type":"Organization","normalized_text":"Vibativ"}],"cashtags":{}},"created_at":"2014-01-24T12:40:05.000Z","conversation_id":"426695904197107712","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"426695904197107712","author_id":"96485229","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Thanks for sharing! It's now featured on http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":51,"end":73,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-24T11:49:03.000Z","conversation_id":"426681749369024512","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"426681749369024512"}],"id":"426683057752772608","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Did you approve mabthera sq in today's meeting?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-24T11:45:58.000Z","conversation_id":"426682285224521728","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"426682285224521728","author_id":"362772214","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News So we won't see Jan minutes until the Friday of the Feb meeting?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-22T17:49:52.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"426048345074049024"}],"id":"426049086538534912","author_id":"614450788","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News OK thanks. But note that there are no minutes from the Dec '13 meeting, just highlights that mention minutes coming early jan.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-22T17:39:39.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"426045852231426048"}],"id":"426046517380513794","author_id":"614450788","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News I don't see minutes from the Dec meeting. When are minutes published and where can i find them? Thanks again!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-22T17:31:24.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425926768411697152"}],"id":"426044437924298752","author_id":"614450788","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News You made my @RebelMouse http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":22,"end":33,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":34,"end":56,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-22T10:10:02.000Z","conversation_id":"425932234604814337","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425932234604814337"}],"id":"425933367633534976","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News is Scenesse available now? What is being discussed at this point? Thank you.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":13,"end":20,"probability":0.3543,"type":"Person","normalized_text":"Scenesse"}],"cashtags":{}},"created_at":"2014-01-21T18:59:40.000Z","conversation_id":"425704264661360640","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425704264661360640","author_id":"344763008","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News thanks so much.  How will we know if an oral explanation actually takes place this week?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-21T18:07:00.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425685220067921920"}],"id":"425691010442596352","author_id":"614450788","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News Thank you.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-21T17:42:32.000Z","conversation_id":"425666668686090240","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425669403863433216"}],"id":"425684852566790144","author_id":"423776545","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News will CHMP go for opinion on vintafolide during February's meeting since its up for oral discussion this week?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-21T16:57:00.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425673392335773697","author_id":"614450788","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News thanks!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-21T16:02:21.000Z","conversation_id":"425655211177574400","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425658574606729216"}],"id":"425659643135012864","author_id":"597154294","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News looking at this week chmp agenda is vintafolide going to have an chmp opinion this week?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-21T15:44:45.000Z","conversation_id":"425655211177574400","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425655211177574400","author_id":"597154294","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web App","text":"Latest developments in EU regulatory procedures from @EMA_News @IFAHEurope info day 13-14 March http://t.co/xxuXrmDSSK #RegulatoryAffairs","entities":{"mentions":[{"start":53,"end":62,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/xxuXrmDSSK","expanded_url":"http://bit.ly/1dQ4DEq","display_url":"bit.ly/1dQ4DEq"}],"hashtags":[{"start":119,"end":137,"tag":"RegulatoryAffairs"}],"annotations":[{"start":23,"end":24,"probability":0.7222,"type":"Place","normalized_text":"EU"}],"cashtags":{}},"created_at":"2014-01-21T10:04:00.000Z","conversation_id":"425566738093076480","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425566738093076480"}],"id":"425569461220159488","author_id":"200109222","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News recommends 81 #medicines for #marketing authorisation in 2013 http://t.co/1D1JE0CLnI #advancedtherapies #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":72,"end":94,"url":"http://t.co/1D1JE0CLnI","expanded_url":"http://j.mp/1igADow","display_url":"j.mp/1igADow"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"},{"start":39,"end":49,"tag":"marketing"},{"start":95,"end":113,"tag":"advancedtherapies"},{"start":114,"end":122,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T19:21:21.000Z","conversation_id":"425347333820137474","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425347333820137474","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News i ask about the PAR (not EPAR) mentioned in the PSUR-WSP DE/H/PSUR/0022/001","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-20T17:32:38.000Z","conversation_id":"425287357923721216","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425291626890539008"}],"id":"425319972022149121","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News And no PAR for Mefloquine. Ok. When it is like that.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":25,"end":34,"probability":0.3758,"type":"Person","normalized_text":"Mefloquine"}],"cashtags":{}},"created_at":"2014-01-20T16:35:28.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425303392982798336"}],"id":"425305589074247680","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Ok. So you say there was no \"Referral Procedure\" for Mefloquine in the last years. Thanks for this answer at least.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-20T16:34:26.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425303392982798336"}],"id":"425305326150119424","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Dont get me wrong. But there are a lot of Documents missing referred to #Guidelines and #BPG.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":82,"end":93,"tag":"Guidelines"},{"start":98,"end":102,"tag":"BPG"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T16:32:50.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425303392982798336"}],"id":"425304923966685184","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Yes. Other Medicines-Documents who \"mention\" it. And the PRAC f. Nov.2013. But nothing about #Lariam itself","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":103,"end":110,"tag":"Lariam"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T16:30:59.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425303392982798336"}],"id":"425304458302468096","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Like i said before. I wrote already and dont get answer. Its really strange that #Lariam® (#Mefloquine) is not in #EMA Database","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":91,"end":98,"tag":"Lariam"},{"start":101,"end":112,"tag":"Mefloquine"},{"start":124,"end":128,"tag":"EMA"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T16:17:19.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425298945850347520"}],"id":"425301018960613377","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News And still strange that there are no documents on your website about the whole procedure. After all discussions and changings.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:54:45.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425294022588895232"}],"id":"425295342364422144","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Thanks. Already done last year. But no answer. :(","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:52:26.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425294022588895232"}],"id":"425294756877324288","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News I know this PRAC Minute. I ask for the PSUR-WSP DE/H/PSUR/0022/001. Took 4 Years (until 2013) for the FAR/CSP. Without a RefProc?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:46:01.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425291295620206592"}],"id":"425293143156613120","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News It took 1 Year for ROCHE to answer the #RFI within the #PSUR-WSP for #Lariam. #BPG give 14 Day Time. Consequences for ROCHE?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":49,"end":53,"tag":"RFI"},{"start":65,"end":70,"tag":"PSUR"},{"start":79,"end":86,"tag":"Lariam"},{"start":88,"end":92,"tag":"BPG"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:43:03.000Z","conversation_id":"425292396906033152","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425292396906033152","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News No Documents related to the PSUR-WSP DE/H/PSUR/0022/001 for #Lariam® (#Mefloquine) on the #EMA Website? After all discussions....","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":70,"end":77,"tag":"Lariam"},{"start":80,"end":91,"tag":"Mefloquine"},{"start":100,"end":104,"tag":"EMA"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:37:48.000Z","conversation_id":"425275897512755200","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425275897512755200"}],"id":"425291073296941056","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News When will the #EMA publish the PAR for #Lariam® (#Mefloquine) from the #PSUR-#WSP DE/H/PSUR/0022/001 from 2009?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":24,"end":28,"tag":"EMA"},{"start":49,"end":56,"tag":"Lariam"},{"start":59,"end":70,"tag":"Mefloquine"},{"start":81,"end":86,"tag":"PSUR"},{"start":87,"end":91,"tag":"WSP"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:35:25.000Z","conversation_id":"425275897512755200","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425275897512755200"}],"id":"425290475365343232","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News No PAR for #Lariam® (#Mefloquine) available? But there was a Ammended #PAR circulating in the #PSUR-WSP DE/H/PSUR/0022/001 in 2009","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":21,"end":28,"tag":"Lariam"},{"start":31,"end":42,"tag":"Mefloquine"},{"start":80,"end":84,"tag":"PAR"},{"start":104,"end":109,"tag":"PSUR"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:32:17.000Z","conversation_id":"425275897512755200","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425275897512755200"}],"id":"425289688597803008","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News No \"#Referral #Procedure\" for Lariam® (#Mefloquine) during the #PSUR-#WSP DE/H/PSUR/0022/001? Strange... referring to the #BPG","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":14,"end":23,"tag":"Referral"},{"start":24,"end":34,"tag":"Procedure"},{"start":49,"end":60,"tag":"Mefloquine"},{"start":73,"end":78,"tag":"PSUR"},{"start":79,"end":83,"tag":"WSP"},{"start":132,"end":136,"tag":"BPG"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:29:32.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425288995694592001","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News From #DLP for #PSUR-WSP #DE/H/PSUR/0022/001 in 2009 it took 4 Years for the #FAR/#CSP in 2013. This doesnt follow the #BPG","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":15,"end":19,"tag":"DLP"},{"start":24,"end":29,"tag":"PSUR"},{"start":34,"end":37,"tag":"DE"},{"start":86,"end":90,"tag":"FAR"},{"start":91,"end":95,"tag":"CSP"},{"start":128,"end":132,"tag":"BPG"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:26:41.000Z","conversation_id":"425288276363075585","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425288276363075585","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News No PAR for #Lariam® (#Mefloquine) available? But there was a Ammended #PAR circulating in the #PSUR-WSP DE/H/PSUR/0022/001","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":21,"end":28,"tag":"Lariam"},{"start":31,"end":42,"tag":"Mefloquine"},{"start":80,"end":84,"tag":"PAR"},{"start":104,"end":109,"tag":"PSUR"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:23:02.000Z","conversation_id":"425287357923721216","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425287357923721216","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News No Documents found in \"Document Search\" for #Lariam® (#Mefloquine) in the Document Libary...Strange after all the discussions","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":54,"end":61,"tag":"Lariam"},{"start":64,"end":75,"tag":"Mefloquine"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T15:21:16.000Z","conversation_id":"425286916175441920","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425286916175441920","author_id":"1171771501","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News recommends 81 medicines for marketing authorisation in 2013 http://t.co/PTPNHkCSKD #regulatoryaffairs","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":70,"end":92,"url":"http://t.co/PTPNHkCSKD","expanded_url":"http://bit.ly/KwWVDD","display_url":"bit.ly/KwWVDD"}],"hashtags":[{"start":93,"end":111,"tag":"regulatoryaffairs"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-20T14:59:14.000Z","conversation_id":"425281369086783488","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"425281369086783488","author_id":"200109222","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News had to share this on my site. Thank you! http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":51,"end":73,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-20T14:47:03.000Z","conversation_id":"425229600256696320","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"425229600256696320"}],"id":"425278301876518912","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News veröffentlicht Leitlinie zur klinischen Untersuchung von Arzneimitteln zur Behandlung von Lipidstörungen: http://t.co/ch7T1kihVe","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ch7T1kihVe","expanded_url":"http://bit.ly/1dfVOSZ","display_url":"bit.ly/1dfVOSZ"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-17T12:30:27.000Z","conversation_id":"424156765060489216","possibly_sensitive":false,"lang":"de","referenced_tweets":{},"id":"424156765060489216","author_id":"223456379","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News will you cover mabthera subcutaneous next Friday ?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-17T09:49:43.000Z","conversation_id":"424111658752278528","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"424111658752278528"}],"id":"424116312953323521","author_id":"362772214","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @EU_Commission ok","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-16T20:21:39.000Z","conversation_id":"420439570862206976","possibly_sensitive":false,"lang":"und","referenced_tweets":[{"type":"replied_to","id":"423865361906143232"}],"id":"423912954967244800","author_id":"261643662","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News suspende la autorización a ranelato de estroncio para #osteoporosis x dudas sobre seguridad http://t.co/dCpcDpj4dD","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/dCpcDpj4dD","expanded_url":"http://www.elglobal.net/noticias-medicamento/2014-01-14/industria-farmaceutica/el-prac-recomienda-suspender-la-comercializacion-del-ranelato-de-estroncio/pagina.aspx?idart=806286","display_url":"elglobal.net/noticias-medic…"}],"hashtags":[{"start":64,"end":77,"tag":"osteoporosis"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-15T12:14:58.000Z","conversation_id":"423428090765664256","possibly_sensitive":false,"lang":"es","referenced_tweets":{},"id":"423428090765664256","author_id":"1003782248","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: #PRAC recommends suspending use of #Protelos/#Osseor http://t.co/XLuYVCSoGt #pharmacovigilance #osteoporosis","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":64,"end":86,"url":"http://t.co/XLuYVCSoGt","expanded_url":"http://j.mp/1gBfwJC","display_url":"j.mp/1gBfwJC"}],"hashtags":[{"start":11,"end":16,"tag":"PRAC"},{"start":46,"end":55,"tag":"Protelos"},{"start":56,"end":63,"tag":"Osseor"},{"start":87,"end":105,"tag":"pharmacovigilance"},{"start":106,"end":119,"tag":"osteoporosis"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-13T19:06:41.000Z","conversation_id":"422806925533642752","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"422806925533642752","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Any news about GVP module XVI? Like...will it be published soon?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":25,"end":38,"probability":0.2728,"type":"Other","normalized_text":"GVP module XVI"}],"cashtags":{}},"created_at":"2014-01-13T11:24:15.000Z","conversation_id":"422690550219677696","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"422690550219677696","author_id":"14648460","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Had to share that one! It's now featured on http://t.co/YFvN9hKwcJ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":54,"end":76,"url":"http://t.co/YFvN9hKwcJ","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-10T15:36:03.000Z","conversation_id":"421648886475005953","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"421648886475005953"}],"id":"421666754478497792","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Windows Phone","text":"Yes you should! \"@EMA_News: Apply for our 2014 traineeship programme. Details and application form on our website: http://t.co/881cUjKEqs\"","entities":{"mentions":[{"start":17,"end":26,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/881cUjKEqs","expanded_url":"http://bit.ly/Uc0JfN","display_url":"bit.ly/Uc0JfN"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-10T14:33:18.000Z","conversation_id":"421648886475005953","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"421648886475005953"}],"id":"421650964429701120","author_id":"9751972","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Did mabthera subcut get positive opinion in this week's meeting?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-10T09:24:18.000Z","conversation_id":"421573200145707008","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"421573200145707008","author_id":"362772214","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Mabthera is a line extension. Included in this week's prac meeting. When are we going to get the results? This week or next month?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-08T09:31:56.000Z","conversation_id":"420850346680782848","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"420850346680782848","author_id":"362772214","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News My Specialist is not working in the same area of research &amp; I had to find a Trial for myself, which then Closed Recruitement sadly","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-06T11:15:46.000Z","conversation_id":"419170307492954112","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"420143226566098944"}],"id":"420151701228638208","author_id":"16842175","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News OK-its not your role to help terminal cancer patients without expert medical knowledge find a suitable Trial-who does that role?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":113,"end":121,"probability":0.514,"type":"Person","normalized_text":"Trial-who"}],"cashtags":{}},"created_at":"2014-01-06T10:12:21.000Z","conversation_id":"419170307492954112","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"420125593150042112"}],"id":"420135742090657793","author_id":"16842175","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News please I would like to ask about what GPhP stand for in # #pharmacovigilance  concept ? Thx","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":68,"end":86,"tag":"pharmacovigilance"}],"annotations":[{"start":48,"end":51,"probability":0.4189,"type":"Person","normalized_text":"GPhP"}],"cashtags":{}},"created_at":"2014-01-04T21:18:18.000Z","conversation_id":"419578559041380352","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"419578559041380352","author_id":"355424757","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News EudraCT Number: 2011-005132-26  Sponsor Protocol Number: CA209-025 Trials was reported closed in the GB weeks ago. Please confirm","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-03T18:16:03.000Z","conversation_id":"419170307492954112","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"419170307492954112","author_id":"16842175","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News To advise, Merck, Roche &amp; BM-S have new breakthrough immune therapy cancer drugs that can save many terminal cancer patients.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":28,"end":32,"probability":0.3808,"type":"Person","normalized_text":"Roche"},{"start":36,"end":39,"probability":0.3065,"type":"Organization","normalized_text":"BM-S"}],"cashtags":{}},"created_at":"2014-01-03T18:06:47.000Z","conversation_id":"419167973924823041","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"419167973924823041","author_id":"16842175","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Your website has no information on the new breakthroughs in cancer immune therapy. Looks like you lead medicine from the rear...","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-03T18:02:41.000Z","conversation_id":"419166942591586305","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"419166942591586305","author_id":"16842175","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News New challenge seeks submissions describing rare phenotypes. Get involved http://t.co/xRsTPhbHeQ #InnovationChallenge","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/xRsTPhbHeQ","expanded_url":"http://bit.ly/16ziA3U","display_url":"bit.ly/16ziA3U"}],"hashtags":[{"start":106,"end":126,"tag":"InnovationChallenge"}],"annotations":{},"cashtags":{}},"created_at":"2014-01-03T12:29:00.000Z","conversation_id":"419082968414433280","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"419082968414433280","author_id":"1361869286","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends conditional marketing auth. for Cabozantinib for treatmt of Medullary Thyroid Cancer http://t.co/kjIK2MbeoI","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/kjIK2MbeoI","expanded_url":"http://ow.ly/sdQju","display_url":"ow.ly/sdQju"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2014-01-02T21:29:15.000Z","conversation_id":"418856539475423232","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"418856539475423232","author_id":"69232855","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News can u please post out to the community your response to Risk/Benefit for new drugs for DMD collected in August #urgency","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":121,"end":129,"tag":"urgency"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-27T00:39:19.000Z","conversation_id":"416367653788590080","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"416367653788590080","author_id":"554667907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Published the assessment report #EPAR for #Kadcyla (#trastuzumab emtansine) for #breastcancer @EMA_News http://t.co/YjUuliG4gN","entities":{"mentions":[{"start":94,"end":103,"username":"EMA_News","id":"116716199"}],"urls":[{"start":104,"end":126,"url":"http://t.co/YjUuliG4gN","expanded_url":"http://bit.ly/1jpyZCo","display_url":"bit.ly/1jpyZCo"}],"hashtags":[{"start":32,"end":37,"tag":"EPAR"},{"start":42,"end":50,"tag":"Kadcyla"},{"start":52,"end":64,"tag":"trastuzumab"},{"start":80,"end":93,"tag":"breastcancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-23T14:12:58.000Z","conversation_id":"414055830460583936","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"414055830460583936"}],"id":"415122865433100288","author_id":"633978297","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: A few days left to comment on our draft concept paper revising guidance on manuf of finished dosage form: http://t.co/Pz5c0ni4Mj","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/Pz5c0ni4Mj","expanded_url":"http://bit.ly/18Wdi2W","display_url":"bit.ly/18Wdi2W"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-20T12:40:34.000Z","conversation_id":"414004005950353408","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"414004005950353408"}],"id":"414012447952240640","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News #CHMP recommends use of Exelixis' COMETRIQ cabozantinib for progressive, unresectable locally Advanced or Metastatic  MTC #cancer","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":132,"end":139,"tag":"cancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-20T08:36:17.000Z","conversation_id":"413950974223732736","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"413950974223732736","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News now publishing meeting agendas for all #scientific committees http://t.co/Jougy08ZzJ #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":72,"end":94,"url":"http://t.co/Jougy08ZzJ","expanded_url":"http://j.mp/18Um1lW","display_url":"j.mp/18Um1lW"}],"hashtags":[{"start":49,"end":60,"tag":"scientific"},{"start":95,"end":106,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-19T19:31:05.000Z","conversation_id":"413753369224691712","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"413753369224691712","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We launched a generic medicines application inspections initiative with the @US_FDA: http://t.co/MzocVGwrre”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":88,"end":95,"username":"US_FDA","id":"208120290"}],"urls":[{"start":97,"end":119,"url":"http://t.co/MzocVGwrre","expanded_url":"http://bit.ly/19cEIqS","display_url":"bit.ly/19cEIqS"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-19T12:17:25.000Z","conversation_id":"413625897808179200","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"413625897808179200"}],"id":"413644236295536640","author_id":"51445321","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @US_FDA Diagnosis of my beautiful boy has smashed this family into a thousand pieces.U can't imagine. #help @accesstomedicine DMD","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"urls":{},"hashtags":[{"start":112,"end":117,"tag":"help"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-18T22:59:44.000Z","conversation_id":"413443493068292096","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"413443493068292096","author_id":"554667907","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Statements of non-compliance with #GMP are now publicly available on #EudraGMDP: http://t.co/trELqB2TS8”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/trELqB2TS8","expanded_url":"http://bit.ly/1fmIjB1","display_url":"bit.ly/1fmIjB1"}],"hashtags":[{"start":46,"end":50,"tag":"GMP"},{"start":81,"end":91,"tag":"EudraGMDP"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-18T20:18:38.000Z","conversation_id":"413320907516805121","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"413320907516805121"}],"id":"413402947603931136","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News #HTA report for Fluenz Tetra, #influenza vaccine for use in children: http://t.co/HgFtmEMoDg #HTAC","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/HgFtmEMoDg","expanded_url":"http://bit.ly/1bMUtyV","display_url":"bit.ly/1bMUtyV"}],"hashtags":[{"start":10,"end":14,"tag":"HTA"},{"start":40,"end":50,"tag":"influenza"},{"start":103,"end":108,"tag":"HTAC"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-18T15:55:29.000Z","conversation_id":"413336723960381440","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"413336723960381440","author_id":"1588972196","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News http://t.co/F0SKNo0ivl","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":10,"end":32,"url":"http://t.co/F0SKNo0ivl","expanded_url":"http://storeslem.blogspot.no/2013/12/cisordinolen-pavirker-venene_12.html","display_url":"storeslem.blogspot.no/2013/12/cisord…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-18T15:46:46.000Z","conversation_id":"413334530099924994","possibly_sensitive":false,"lang":"und","referenced_tweets":{},"id":"413334530099924994","author_id":"261891519","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"EU Medicines Agency zoekt hoofd communicatie via @EMA_News \nhttp://t.co/wlyS12bhzm #vacancy #recruitment","entities":{"mentions":[{"start":49,"end":58,"username":"EMA_News","id":"116716199"}],"urls":[{"start":60,"end":82,"url":"http://t.co/wlyS12bhzm","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"hashtags":[{"start":83,"end":91,"tag":"vacancy"},{"start":92,"end":104,"tag":"recruitment"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-18T11:41:20.000Z","conversation_id":"413266343551827968","possibly_sensitive":false,"lang":"nl","referenced_tweets":[{"type":"replied_to","id":"413266343551827968"}],"id":"413272765110968321","author_id":"137970368","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News definitely adding that tweet to my @RebelMouse https://t.co/U5dHlh77OB","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":56,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":57,"end":80,"url":"https://t.co/U5dHlh77OB","expanded_url":"https://www.rebelmouse.com/evepie/","display_url":"rebelmouse.com/evepie/"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-18T11:41:02.000Z","conversation_id":"413271855496060928","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"413271855496060928"}],"id":"413272690943090688","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@FinansciCenk MabThera is not included in the December CHMP agenda so it is not scheduled for discussion this month: http://t.co/vvjHnoel2U","entities":{"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"urls":[{"start":117,"end":139,"url":"http://t.co/vvjHnoel2U","expanded_url":"http://bit.ly/1bckwQ9","display_url":"bit.ly/1bckwQ9"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-18T11:24:57.000Z","conversation_id":"413248888129081344","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"413268315616718848"}],"id":"413268642583683072","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@FinansciCenk However, we do not include the outcomes in our 'highlights' press release on the Friday after the CHMP meeting.","entities":{"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-18T11:23:39.000Z","conversation_id":"413248888129081344","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"413268133458087936"}],"id":"413268315616718848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News in #London has a #vacancy for a head of Communication Department, Stakeholder and Communication Division http://t.co/ypBdujKRaM","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/ypBdujKRaM","expanded_url":"http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:371A:0001:0001:EN:PDF","display_url":"eur-lex.europa.eu/LexUriServ/Lex…"}],"hashtags":[{"start":13,"end":20,"tag":"London"},{"start":27,"end":35,"tag":"vacancy"}],"annotations":[{"start":50,"end":73,"probability":0.6196,"type":"Organization","normalized_text":"Communication Department"}],"cashtags":{}},"created_at":"2013-12-18T10:07:14.000Z","conversation_id":"413249085882118144","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"413249085882118144","author_id":"294028805","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News are routes of new admin included in the agenda? One of your tweets says yes one no. Will Mabthera be discussed this friday?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-18T10:06:27.000Z","conversation_id":"413248888129081344","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"413248888129081344","author_id":"362772214","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Can't say/won't say when CT data disclosure policy might be finalised. No hostage to fortune that way. http://t.co/dkhyHVStFW","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/dkhyHVStFW","expanded_url":"http://bit.ly/J2jrUb","display_url":"bit.ly/J2jrUb"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-17T14:17:06.000Z","conversation_id":"412949577491165184","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412949577491165184","author_id":"552617924","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News guidance on publication and access to clinical trial data expected in 2014 http://t.co/jdgHYNQm31 #clinicaltrials","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":85,"end":107,"url":"http://t.co/jdgHYNQm31","expanded_url":"http://bit.ly/1fjDb0I","display_url":"bit.ly/1fjDb0I"}],"hashtags":[{"start":108,"end":123,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-17T14:15:01.000Z","conversation_id":"412949056256618496","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412949056256618496","author_id":"71542880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News management board endorses work program 2014 revealing new priorities &amp; greater transparency re committee meeting agendas #pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":135,"end":142,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-17T14:08:36.000Z","conversation_id":"412947438178009088","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412947438178009088","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News operating costs will rise to €125M in 2014 from €101.6M in 2013 and €112.8M in 2012 #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":94,"end":101,"tag":"pharma"},{"start":102,"end":110,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-17T13:59:24.000Z","conversation_id":"412945125854027776","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412945125854027776","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News admin running costs forecast to drop to €64.4M in 2014 from €65.2M in 2013 but were only €30.8M in 2012 #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":114,"end":121,"tag":"pharma"},{"start":122,"end":130,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-17T13:57:34.000Z","conversation_id":"412944664828735488","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412944664828735488","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News staff costs are expected to rise from €69.5M in 2012 and €78.3M in 2013 to a few cents short of €100M in 2014 #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":120,"end":127,"tag":"pharma"},{"start":128,"end":136,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-17T13:47:47.000Z","conversation_id":"412942200738037760","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412942200738037760","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News expects to attract €236M in fees for services rendered in 2014 compared with €200M in 2013 and €174M in 2012 #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":119,"end":126,"tag":"pharma"},{"start":127,"end":135,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-17T13:43:42.000Z","conversation_id":"412941174043705344","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412941174043705344","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News #HTA report on #Memantine Accord (generic of #Axura) for #Alzheimer's disease: http://t.co/CBAzzCbL3n","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":89,"end":111,"url":"http://t.co/CBAzzCbL3n","expanded_url":"http://bit.ly/1bKGY6b","display_url":"bit.ly/1bKGY6b"}],"hashtags":[{"start":10,"end":14,"tag":"HTA"},{"start":25,"end":35,"tag":"Memantine"},{"start":55,"end":61,"tag":"Axura"},{"start":67,"end":77,"tag":"Alzheimer"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-16T19:55:07.000Z","conversation_id":"412672255953731584","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"412672255953731584","author_id":"1588972196","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News thank you i'm a MD and my initiative in the #belgian #senate resulted already in obliged prescription, step 1.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":54,"end":62,"tag":"belgian"},{"start":63,"end":70,"tag":"senate"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-16T17:50:21.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"412640030633385984"}],"id":"412640856592896000","author_id":"1548804618","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@louis_ide Full details of the ongoing review are here: http://t.co/nQwHuqrpnr","entities":{"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"urls":[{"start":56,"end":78,"url":"http://t.co/nQwHuqrpnr","expanded_url":"http://bit.ly/19ulYBT","display_url":"bit.ly/19ulYBT"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-16T17:47:55.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"412640030633385984"}],"id":"412640244052135937","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Should we worry? Such a delay... #FDA never approved. In #Belgium 200 #deaths annually, what if #domperidone doesn't 'work'.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":43,"end":47,"tag":"FDA"},{"start":67,"end":75,"tag":"Belgium"},{"start":80,"end":87,"tag":"deaths"},{"start":106,"end":118,"tag":"domperidone"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-16T16:33:33.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"412620192955383808"}],"id":"412621529583599616","author_id":"1548804618","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News When are you revealing decisions about #domperidone? It was promised earlier and postponed to december.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":49,"end":61,"tag":"domperidone"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-16T16:23:19.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"412615439596781568"}],"id":"412618955539238913","author_id":"1548804618","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @Emma4facs @epilepsyaction More emphasis needed on #AEDsinpregnancy #teratogenicity #Valproatesyndrome 500 born each year in UK RT","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"},{"start":21,"end":36,"username":"epilepsyaction","id":"17411532"}],"urls":{},"hashtags":[{"start":61,"end":77,"tag":"AEDsinpregnancy"},{"start":78,"end":93,"tag":"teratogenicity"},{"start":94,"end":112,"tag":"Valproatesyndrome"}],"annotations":[{"start":135,"end":136,"probability":0.9899,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"created_at":"2013-12-13T15:19:43.000Z","conversation_id":"411515784314114048","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"411515784314114048","author_id":"250163834","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News:Our human medicine committee, CHMP is meeting next week. We're publishing the highlights on Friday: http://t.co/8E5xz9uMMp” $HALO","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":111,"end":133,"url":"http://t.co/8E5xz9uMMp","expanded_url":"http://bit.ly/19lLTel","display_url":"bit.ly/19lLTel"}],"hashtags":{},"annotations":{},"cashtags":[{"start":135,"end":140,"tag":"HALO"}]},"created_at":"2013-12-13T09:17:09.000Z","conversation_id":"411423347470524416","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"411423347470524416"}],"id":"411424544528687104","author_id":"2201973482","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: Meeting highlights from the #PRAC meeting held on 2-5 December 2013 http://t.co/ydfaDK3CHf #pharmacovigilance","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/ydfaDK3CHf","expanded_url":"http://j.mp/1hMY0FJ","display_url":"j.mp/1hMY0FJ"}],"hashtags":[{"start":39,"end":44,"tag":"PRAC"},{"start":102,"end":120,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-11T18:40:45.000Z","conversation_id":"410841602999848960","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"410841602999848960","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News/#HTAs collaboration: in the future a lifecycle approach to #medicines is necessary - #EMA_PCWP","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"HTAs"},{"start":69,"end":79,"tag":"medicines"},{"start":95,"end":104,"tag":"EMA_PCWP"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-11T15:24:16.000Z","conversation_id":"410792153388826624","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"410792153388826624","author_id":"1299643704","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News committed to collaboration with initiatives such as @imI_JU and @JPNDeurope, says Isaac #G8dementia","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":62,"end":69,"username":"imi_ju","id":"1473203261469790214"},{"start":74,"end":85,"username":"JPNDeurope","id":"300289123"}],"urls":{},"hashtags":[{"start":98,"end":109,"tag":"G8dementia"}],"annotations":[{"start":92,"end":96,"probability":0.9561,"type":"Person","normalized_text":"Isaac"}],"cashtags":{}},"created_at":"2013-12-11T12:21:15.000Z","conversation_id":"410746095547871232","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"410746095547871232","author_id":"1536274003","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News you asked us our view as a parent on Risk/Benefit for new drugs for Duchenne. What next? We await your reply #wehavelimitedtime RT","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":119,"end":137,"tag":"wehavelimitedtime"}],"annotations":[{"start":78,"end":85,"probability":0.2389,"type":"Organization","normalized_text":"Duchenne"}],"cashtags":{}},"created_at":"2013-12-10T20:25:33.000Z","conversation_id":"410505588242939905","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"410505588242939905","author_id":"554667907","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @LV_MPA: Monthly report from the CHMP (November 2013) http://t.co/LgzG3kkcQz”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":22,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":69,"end":91,"url":"http://t.co/LgzG3kkcQz","expanded_url":"http://bit.ly/1ffBKkg","display_url":"bit.ly/1ffBKkg"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-10T11:32:57.000Z","conversation_id":"410342623254024192","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"410342623254024192"}],"id":"410371555739586561","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News amplía incentivos para #medicamentoshuérfanos #aelmhu @FEDER_ONG http://t.co/nS9bFEXGXF","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":64,"end":74,"username":"FEDER_ONG","id":"19394390"}],"urls":[{"start":75,"end":97,"url":"http://t.co/nS9bFEXGXF","expanded_url":"http://www.elglobal.net/noticias-medicamento/2013-12-09/industria-farmaceutica/la-ema-amplia-sus-incentivos-para-los-medicamentos-huerfanos/pagina.aspx?idart=796292","display_url":"elglobal.net/noticias-medic…"}],"hashtags":[{"start":33,"end":55,"tag":"medicamentoshuérfanos"},{"start":56,"end":63,"tag":"aelmhu"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-09T13:58:53.000Z","conversation_id":"410045893249753088","possibly_sensitive":false,"lang":"es","referenced_tweets":{},"id":"410045893249753088","author_id":"1003782248","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @INFARMED_IP: New requirements for notification of withdrawal of medicines http://t.co/j6hCBXuyFN” #pharma #biotech #medtech","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":27,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":90,"end":112,"url":"http://t.co/j6hCBXuyFN","expanded_url":"http://bit.ly/Iwj1pr","display_url":"bit.ly/Iwj1pr"}],"hashtags":[{"start":114,"end":121,"tag":"pharma"},{"start":122,"end":130,"tag":"biotech"},{"start":131,"end":139,"tag":"medtech"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-06T16:54:49.000Z","conversation_id":"409002743143997440","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"409002743143997440"}],"id":"409003002230747136","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News Is it enough to encourage biotech companies to develop these products? #OrphanDrugs","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":81,"end":93,"tag":"OrphanDrugs"}],"annotations":{},"cashtags":{}},"created_at":"2013-12-03T10:54:46.000Z","conversation_id":"407822577571491840","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"407822577571491840"}],"id":"407825230250643456","author_id":"105275296","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends changes in use of ponatinib (leukaemia treatmt) to minimise risk of thrombosis http://t.co/ev2NcwLImu","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":100,"end":122,"url":"http://t.co/ev2NcwLImu","expanded_url":"http://ow.ly/rm9mI","display_url":"ow.ly/rm9mI"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-12-02T12:36:55.000Z","conversation_id":"407488550394142720","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"407488550394142720","author_id":"69232855","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Good stuff. MT “@EMA_News: It's World #AIDS Day on 1 December. Read about our activities on medicines for #HIV: http://t.co/obFDwDRWFB”","entities":{"mentions":[{"start":16,"end":25,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/obFDwDRWFB","expanded_url":"http://bit.ly/1iWdAhb","display_url":"bit.ly/1iWdAhb"}],"hashtags":[{"start":38,"end":43,"tag":"AIDS"},{"start":106,"end":110,"tag":"HIV"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-28T18:57:36.000Z","conversation_id":"406105545859284992","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"406105545859284992"}],"id":"406134800312201216","author_id":"253672396","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: 90% #pymes #pharma que piden asesoramiento científico consigue autorización de comercialización http://t.co/MZi96f4qIA","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/MZi96f4qIA","expanded_url":"http://www.elglobal.net/elglobal/articulo.aspx?idart=793323&idcat=784&tipo=2","display_url":"elglobal.net/elglobal/artic…"}],"hashtags":[{"start":15,"end":21,"tag":"pymes"},{"start":22,"end":29,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-28T12:14:40.000Z","conversation_id":"406033400114327552","possibly_sensitive":false,"lang":"es","referenced_tweets":{},"id":"406033400114327552","author_id":"1003782248","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News thanks so much for sharing. Just added it to my site https://t.co/U5dHlh77OB","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":63,"end":86,"url":"https://t.co/U5dHlh77OB","expanded_url":"https://www.rebelmouse.com/evepie/","display_url":"rebelmouse.com/evepie/"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-27T09:37:03.000Z","conversation_id":"405630274286780416","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"405630274286780416"}],"id":"405631343025205248","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News are you in anyway involved with making this #TPP agreement? http://t.co/0KrkreBHCF","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":70,"end":92,"url":"http://t.co/0KrkreBHCF","expanded_url":"http://www.abc.net.au/news/2013-11-26/the-secret-trade-deal-favouring-big-drug-companies/5118460","display_url":"abc.net.au/news/2013-11-2…"}],"hashtags":[{"start":54,"end":58,"tag":"TPP"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-26T11:04:06.000Z","conversation_id":"405290862344536064","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"405290862344536064","author_id":"40722651","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends refusal of Marketing Authorisation for Masitinib, intended for treatment of #GIST http://t.co/9DvBxt11DG","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/9DvBxt11DG","expanded_url":"http://ow.ly/rbHei","display_url":"ow.ly/rbHei"}],"hashtags":[{"start":97,"end":102,"tag":"GIST"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-26T10:03:27.000Z","conversation_id":"405275601562787840","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"405275601562787840","author_id":"69232855","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"RT @EMA_News We recommended approval of #sofosbuvir for the treatment of chronic #hepatitis C: http://t.co/PD4x77Y1X8","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/PD4x77Y1X8","expanded_url":"http://bit.ly/1bIip72","display_url":"bit.ly/1bIip72"}],"hashtags":[{"start":40,"end":51,"tag":"sofosbuvir"},{"start":81,"end":91,"tag":"hepatitis"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-25T18:52:38.000Z","conversation_id":"404927514843152384","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"404927514843152384"}],"id":"405046387676418048","author_id":"914462377","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"RT @EMA_News We advised on compassionate use of #daclatasvir: http://t.co/MBEzsbkSmh","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":62,"end":84,"url":"http://t.co/MBEzsbkSmh","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"hashtags":[{"start":48,"end":60,"tag":"daclatasvir"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-25T18:52:21.000Z","conversation_id":"404927660783988736","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"404927660783988736"}],"id":"405046314284482560","author_id":"914462377","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"RT @EMA_News We recommended two new treatment options for #tuberculosis: http://t.co/se4E4IsCRf","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":73,"end":95,"url":"http://t.co/se4E4IsCRf","expanded_url":"http://bit.ly/1i1ALJf","display_url":"bit.ly/1i1ALJf"}],"hashtags":[{"start":58,"end":71,"tag":"tuberculosis"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-25T18:52:01.000Z","conversation_id":"404927978422800384","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"404927978422800384"}],"id":"405046232843706368","author_id":"914462377","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"RT @EMA_News We recommended approval of new #HIV medicine: http://t.co/Oym7KWP8Dd","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":59,"end":81,"url":"http://t.co/Oym7KWP8Dd","expanded_url":"http://bit.ly/1emapMW","display_url":"bit.ly/1emapMW"}],"hashtags":[{"start":44,"end":48,"tag":"HIV"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-25T18:51:45.000Z","conversation_id":"404928286175674368","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"404928286175674368"}],"id":"405046164501708800","author_id":"914462377","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"RT @EMA_News We recommended extending use of #Abraxane to include treatment of #pancreatic #cancer: http://t.co/Tw0GwA8KVM","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":100,"end":122,"url":"http://t.co/Tw0GwA8KVM","expanded_url":"http://bit.ly/1i1AYfp","display_url":"bit.ly/1i1AYfp"}],"hashtags":[{"start":45,"end":54,"tag":"Abraxane"},{"start":79,"end":90,"tag":"pancreatic"},{"start":91,"end":98,"tag":"cancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-25T18:50:50.000Z","conversation_id":"404928483668668416","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"404928483668668416"}],"id":"405045934435758080","author_id":"914462377","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"Los beneficios de anticonceptivos orales combinados superan a los riesgos (PRAC)@EMA_News http://t.co/OfpQwugTFj","entities":{"mentions":[{"start":80,"end":89,"username":"EMA_News","id":"116716199"}],"urls":[{"start":90,"end":112,"url":"http://t.co/OfpQwugTFj","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-25T15:33:26.000Z","conversation_id":"404926163421630464","possibly_sensitive":false,"lang":"es","referenced_tweets":[{"type":"replied_to","id":"404926163421630464"}],"id":"404996255832883200","author_id":"256435789","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Dear Canary Wharf neighbors \nBook your thanksgiving parties lunch/ dinner from Thursday to Sunday. Hope to see you @LeSecretdesR","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":125,"end":138,"username":"LeSecretdesR","id":"1857882480"}],"urls":{},"hashtags":{},"annotations":[{"start":15,"end":26,"probability":0.264,"type":"Place","normalized_text":"Canary Wharf"},{"start":49,"end":60,"probability":0.6692,"type":"Other","normalized_text":"thanksgiving"}],"cashtags":{}},"created_at":"2013-11-25T12:04:14.000Z","conversation_id":"404943609176133632","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"404943609176133632","author_id":"1857882480","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends change indic.for Cetuximab to RAS Wild-type Metastatic Colorectal Cancer http://t.co/Dm5L8GhF1C","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/Dm5L8GhF1C","expanded_url":"http://ow.ly/r9iuE","display_url":"ow.ly/r9iuE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-25T11:26:27.000Z","conversation_id":"404934101624684544","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"404934101624684544","author_id":"69232855","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Tivicay shown effective in patients with resistant HIV virus\n@EMA_News: We recommended approval of new #HIV medicine http://t.co/iHX0XFdzBa","entities":{"mentions":[{"start":61,"end":70,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/iHX0XFdzBa","expanded_url":"http://bit.ly/1emapMW","display_url":"bit.ly/1emapMW"}],"hashtags":[{"start":103,"end":107,"tag":"HIV"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-25T11:05:54.000Z","conversation_id":"404928286175674368","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"404928286175674368"}],"id":"404928927388667904","author_id":"1566153090","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News - Press Release:  \"European Medicines Agency recommends two new treatment options for tuberculosis\" http://t.co/iaHmobdIQp","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/iaHmobdIQp","expanded_url":"http://bit.ly/18hx5iq","display_url":"bit.ly/18hx5iq"}],"hashtags":{},"annotations":[{"start":29,"end":53,"probability":0.6601,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"created_at":"2013-11-25T09:20:10.000Z","conversation_id":"404902320711815169","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"404902320711815169","author_id":"50802199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Saving that tweet! It's now featured on https://t.co/U5dHlh77OB","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":50,"end":73,"url":"https://t.co/U5dHlh77OB","expanded_url":"https://www.rebelmouse.com/evepie/","display_url":"rebelmouse.com/evepie/"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-23T17:15:02.000Z","conversation_id":"403882908366417920","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"403882908366417920"}],"id":"404297050533425152","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News 's CHMP Says Combined Hormonal Contraceptives Still Safe on Balance, Mirroring Earlier Assessments http://t.co/piEvfqRh6c","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/piEvfqRh6c","expanded_url":"http://ow.ly/r6eUR","display_url":"ow.ly/r6eUR"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-22T20:29:07.000Z","conversation_id":"403983504641650688","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"403983504641650688","author_id":"73774967","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News advises on compassionate use of #daclatasvir http://t.co/ySOqYQRtqj #HepatitisC #sofosbuvir","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/ySOqYQRtqj","expanded_url":"http://j.mp/17zmHQa","display_url":"j.mp/17zmHQa"}],"hashtags":[{"start":42,"end":54,"tag":"daclatasvir"},{"start":78,"end":89,"tag":"HepatitisC"},{"start":90,"end":101,"tag":"sofosbuvir"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-22T16:37:23.000Z","conversation_id":"403925186698694657","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"403925186698694657","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We've just published the CHMP meeting highlights: http://t.co/B1VZgsi24e”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":62,"end":84,"url":"http://t.co/B1VZgsi24e","expanded_url":"http://bit.ly/1fqSKGT","display_url":"bit.ly/1fqSKGT"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-22T15:14:34.000Z","conversation_id":"403882908366417920","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"403882908366417920"}],"id":"403904345705811968","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"Hopelijk nu einde aan debat “@EMA_News: Benefits of combined hormonal contraceptives continue to outweigh risks: http://t.co/MOjETlYwE2”","entities":{"mentions":[{"start":29,"end":38,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/MOjETlYwE2","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-22T12:23:35.000Z","conversation_id":"403860484606418944","possibly_sensitive":false,"lang":"nl","referenced_tweets":[{"type":"replied_to","id":"403860484606418944"}],"id":"403861313321201664","author_id":"210934369","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @EPSA_Online @emsa_europe Following the release of the AMR paper do you think it would be useful to reply to this consultation?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"EPSA_Online","id":"104839524"},{"start":23,"end":35,"username":"emsa_europe","id":"443963165"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-22T09:31:06.000Z","conversation_id":"403813536201068544","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"403813536201068544"}],"id":"403817906263175168","author_id":"440170995","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We finalised review of medicines concerned by Roche pharmacovigilance inspection: http://t.co/XX0jCi0wrD”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/XX0jCi0wrD","expanded_url":"http://bit.ly/1aOLRHy","display_url":"bit.ly/1aOLRHy"}],"hashtags":{},"annotations":[{"start":58,"end":62,"probability":0.4695,"type":"Person","normalized_text":"Roche"}],"cashtags":{}},"created_at":"2013-11-21T20:06:37.000Z","conversation_id":"403110718049771521","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"403110718049771521"}],"id":"403615452582379521","author_id":"1600732507","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"place_id":"8907ab3ca1490878","coordinates":{"type":"Point","coordinates":[-0.295,51.5943]}}},{"source":"Twitter Web Client","text":"@EMA_News and @EUnetHTA agree 3-year work plan http://t.co/5j8Sd6qsPx #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":23,"username":"EUnetHTA","id":"56493220"}],"urls":[{"start":47,"end":69,"url":"http://t.co/5j8Sd6qsPx","expanded_url":"http://j.mp/1bMWM9j","display_url":"j.mp/1bMWM9j"}],"hashtags":[{"start":70,"end":81,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-19T15:31:55.000Z","conversation_id":"402821546651054080","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"402821546651054080","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News encourages companies to submit quality type-I #variations for 2013 by end of November http://t.co/t4SFMZM8hX #regulatory","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/t4SFMZM8hX","expanded_url":"http://j.mp/1h0xFUo","display_url":"j.mp/1h0xFUo"}],"hashtags":[{"start":56,"end":67,"tag":"variations"},{"start":119,"end":130,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-19T15:24:52.000Z","conversation_id":"402819770778521600","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"402819770778521600","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EUnetHTA and @EMA_News 3-yr work plan big step forward in public health role to help new medicines get to patients http://t.co/65QpbhAo3d","entities":{"mentions":[{"start":0,"end":9,"username":"EUnetHTA","id":"56493220"},{"start":14,"end":23,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/65QpbhAo3d","expanded_url":"http://bit.ly/1aOAM9m","display_url":"bit.ly/1aOAM9m"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-19T12:04:43.000Z","conversation_id":"402739254440513536","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"402739254440513536"}],"id":"402769402544013312","author_id":"113148426","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"Hoeveel risico zijn we bereid te nemen? “@EMA_News: Excessive risk aversion not in best interest of public health: http://t.co/gWFNzUX2fO”","entities":{"mentions":[{"start":41,"end":50,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/gWFNzUX2fO","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-18T11:27:20.000Z","conversation_id":"402388994295472128","possibly_sensitive":false,"lang":"nl","referenced_tweets":[{"type":"replied_to","id":"402388994295472128"}],"id":"402397607378833408","author_id":"210934369","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News thanks so much for sharing. Just added it to my site https://t.co/U5dHlh77OB","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":63,"end":86,"url":"https://t.co/U5dHlh77OB","expanded_url":"https://www.rebelmouse.com/evepie/","display_url":"rebelmouse.com/evepie/"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-17T22:39:03.000Z","conversation_id":"401314703114522624","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"401314703114522624"}],"id":"402204262111129600","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News:article on the risks of risk aversion in drug #regulation,  by senior EMA staff,committee members: http://t.co/o6xjhn2p4T","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/o6xjhn2p4T","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"hashtags":[{"start":57,"end":68,"tag":"regulation"}],"annotations":[{"start":81,"end":83,"probability":0.6776,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"created_at":"2013-11-15T18:55:35.000Z","conversation_id":"401314703114522624","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"401314703114522624"}],"id":"401423249772654592","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News:published 16 product-specific guidance documents on demonstrating #bioequivalence, open for consultation: http://t.co/lx4Ebz8v14”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/lx4Ebz8v14","expanded_url":"http://bit.ly/1ifPXQq","display_url":"bit.ly/1ifPXQq"}],"hashtags":[{"start":77,"end":92,"tag":"bioequivalence"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-15T18:50:22.000Z","conversation_id":"401354309168013312","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"401354309168013312"}],"id":"401421935995027456","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News explores ways to further involve patients in the benefit-risk assessment of medicines: http://t.co/lJMTFomnrG","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":97,"end":119,"url":"http://t.co/lJMTFomnrG","expanded_url":"http://goo.gl/Mwksj9","display_url":"goo.gl/Mwksj9"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-15T08:35:16.000Z","conversation_id":"401267141669687296","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"401267141669687296","author_id":"180728609","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Registration open for annual EMA review of the year and outlook for 2014, on 28-29 November in London: http://t.co/vb0oOVrJ3N”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/vb0oOVrJ3N","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"hashtags":{},"annotations":[{"start":107,"end":112,"probability":0.9907,"type":"Place","normalized_text":"London"}],"cashtags":{}},"created_at":"2013-11-14T21:46:39.000Z","conversation_id":"401026888480460800","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"401026888480460800"}],"id":"401103910481723392","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: The annual EMA review of the year and outlook for 2014 takes place on 28-29 November in London: http://t.co/vb0oOVrJ3N”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/vb0oOVrJ3N","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"hashtags":{},"annotations":[{"start":100,"end":105,"probability":0.9918,"type":"Place","normalized_text":"London"}],"cashtags":{}},"created_at":"2013-11-14T11:52:09.000Z","conversation_id":"400946463574069248","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"400946463574069248"}],"id":"400954299528015872","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"RebelMouse Application","text":"@EMA_News Your tweet really makes this page stronger: https://t.co/U5dHlh77OB","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":54,"end":77,"url":"https://t.co/U5dHlh77OB","expanded_url":"https://www.rebelmouse.com/evepie/","display_url":"rebelmouse.com/evepie/"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-14T10:54:03.000Z","conversation_id":"400569418544971776","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"400569418544971776"}],"id":"400939678863753216","author_id":"134450541","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News : Public Input on Clinical Trials Transparency 'Unprecedented,' May Cause Delays http://t.co/idWzpNDFDk","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":91,"end":113,"url":"http://t.co/idWzpNDFDk","expanded_url":"http://ow.ly/qMDuA","display_url":"ow.ly/qMDuA"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-13T16:43:20.000Z","conversation_id":"400665190691528704","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"400665190691528704","author_id":"73774967","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @Aifa_ufficiale: All information on #medicines a click away. We present the Medicines Databank #AIFA http://t.co/G7u77VmLTj”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":30,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":116,"end":138,"url":"http://t.co/G7u77VmLTj","expanded_url":"http://bit.ly/1gJghTN","display_url":"bit.ly/1gJghTN"}],"hashtags":[{"start":51,"end":61,"tag":"medicines"},{"start":110,"end":115,"tag":"AIFA"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-13T13:14:29.000Z","conversation_id":"400599420137259008","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"400599420137259008"}],"id":"400612631951966208","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News Interesting thought though...","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-13T10:46:49.000Z","conversation_id":"400572507893161984","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"400574018836656128"}],"id":"400575473299632128","author_id":"552617924","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Reviewing the more than 1000 consultation responses may \"delay finalisation of policy\". By how long? Until after EU court ruling?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":123,"end":124,"probability":0.5868,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"created_at":"2013-11-13T10:35:02.000Z","conversation_id":"400572507893161984","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"400572507893161984","author_id":"552617924","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News provides update on our policy on the publication of clinical-trial data http://t.co/oBRhm4iYu2 #ctdata #pharna #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":82,"end":104,"url":"http://t.co/oBRhm4iYu2","expanded_url":"http://bit.ly/18ra6LY","display_url":"bit.ly/18ra6LY"}],"hashtags":[{"start":105,"end":112,"tag":"ctdata"},{"start":113,"end":120,"tag":"pharna"},{"start":121,"end":129,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-13T10:25:40.000Z","conversation_id":"400569418544971776","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"400569418544971776"}],"id":"400570149482557440","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News ENCePP  \"usefulness\" to #Pharma industry? One attendee at plenary mtg. calls it \"a scandal\" to even discuss it.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":34,"end":41,"tag":"Pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-12T12:07:57.000Z","conversation_id":"400233503931269120","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"400233503931269120","author_id":"432633912","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News ENCePP plenary mtg. Major disagreement over engagement with and \"usefulness\" to industry.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-12T12:03:48.000Z","conversation_id":"400232456785510400","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"400232456785510400","author_id":"432633912","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: Meeting highlights from the #PRAC (4-7 November 2013) http://t.co/mObW1TnUYk #pharmacovigilance #drugsafety","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":65,"end":87,"url":"http://t.co/mObW1TnUYk","expanded_url":"http://j.mp/16UZjMQ","display_url":"j.mp/16UZjMQ"}],"hashtags":[{"start":39,"end":44,"tag":"PRAC"},{"start":88,"end":106,"tag":"pharmacovigilance"},{"start":107,"end":118,"tag":"drugsafety"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-11T08:43:26.000Z","conversation_id":"399819645068132352","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"399819645068132352","author_id":"524685920","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Thank you for posting your analysis of definitions of \"antibiotics.\" Cited here: http://t.co/0MG8OY88C2 #antibiotic #resistance","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":91,"end":113,"url":"http://t.co/0MG8OY88C2","expanded_url":"http://colinpurrington.com/2013/antibiotics-work-against-viruses/","display_url":"colinpurrington.com/2013/antibioti…"}],"hashtags":[{"start":114,"end":125,"tag":"antibiotic"},{"start":126,"end":137,"tag":"resistance"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-10T16:45:15.000Z","conversation_id":"399578511955881986","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"399578511955881986","author_id":"59842124","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: PRAC recommends suspension of #diacerein-containing medicines: http://t.co/Uv7ZSiCLTR”\nCc @Pirouette4 ;-)","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":102,"end":113,"username":"Pirouette4","id":"115990590"}],"urls":[{"start":75,"end":97,"url":"http://t.co/Uv7ZSiCLTR","expanded_url":"http://bit.ly/HCA0Wn","display_url":"bit.ly/HCA0Wn"}],"hashtags":[{"start":42,"end":52,"tag":"diacerein"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-08T17:48:02.000Z","conversation_id":"398788629373661184","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"398788629373661184"}],"id":"398869535555866624","author_id":"829162375","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Why do you have so much planed downtime on your EMA website? (Do not observe this with any other wbsite!)","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-08T16:02:00.000Z","conversation_id":"398842309665517568","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"398842309665517568"}],"id":"398842851250823168","author_id":"40722651","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"place_id":"e42ed02b50d62e29","coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News D. Mackay:\"Coordinating prudent use of #antimicrobals in human and veterinary medicine\" -&gt; Healthy animals = safe food @FloodBreda","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":132,"end":143,"username":"FloodBreda","id":"1285591051"}],"urls":{},"hashtags":[{"start":49,"end":63,"tag":"antimicrobals"}],"annotations":[{"start":10,"end":18,"probability":0.6135,"type":"Person","normalized_text":"D. Mackay"}],"cashtags":{}},"created_at":"2013-11-08T13:17:34.000Z","conversation_id":"398801469052575744","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"398801469052575744","author_id":"1299643704","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News new #guidance on developing #antibacterials vs #multidrugresistant #pathogens crucial to #pharma #biotech: http://t.co/36DdGQPoSf","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/36DdGQPoSf","expanded_url":"http://bit.ly/1dPzSy7","display_url":"bit.ly/1dPzSy7"}],"hashtags":[{"start":14,"end":23,"tag":"guidance"},{"start":38,"end":53,"tag":"antibacterials"},{"start":57,"end":76,"tag":"multidrugresistant"},{"start":77,"end":87,"tag":"pathogens"},{"start":99,"end":106,"tag":"pharma"},{"start":107,"end":115,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-07T11:56:21.000Z","conversation_id":"398418642632585219","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"398418642632585219","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"LinkedIn","text":"@EMA_News is recruiting a new Head of IT Operations, Head of HR and a Management Accountant #jobs …http://t.co/XKT6xDaZ76","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/XKT6xDaZ76","expanded_url":"http://lnkd.in/bkeykJG","display_url":"lnkd.in/bkeykJG"}],"hashtags":[{"start":92,"end":97,"tag":"jobs"}],"annotations":{},"cashtags":{}},"created_at":"2013-11-06T12:15:07.000Z","conversation_id":"398060980044693504","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"398060980044693504","author_id":"17485749","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @FDA_Drug_Info","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"FDA_Drug_Info","id":"53039176"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-11-04T14:15:08.000Z","conversation_id":"397352051811692545","possibly_sensitive":false,"lang":"und","referenced_tweets":[{"type":"replied_to","id":"397352051811692545"}],"id":"397366407228588032","author_id":"560986046","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News Exec Dir Guido Rasi annual hearing at @Europarl_EN @EP_Environment Committee today.  Themes include efficiencies and transparency.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":48,"end":60,"username":"Europarl_EN","id":"36329597"},{"start":61,"end":76,"username":"EP_Environment","id":"951333319"}],"urls":{},"hashtags":{},"annotations":[{"start":15,"end":28,"probability":0.7827,"type":"Person","normalized_text":"Dir Guido Rasi"}],"cashtags":{}},"created_at":"2013-11-04T07:55:32.000Z","conversation_id":"397270878230417409","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"397270878230417409","author_id":"113148426","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News holding a Workshop on #Biosimilars to discuss draft guidelines for Biosimilars. Info and live Video: http://t.co/C4oNUGOTxG","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":111,"end":133,"url":"http://t.co/C4oNUGOTxG","expanded_url":"http://bit.ly/18q5OqW","display_url":"bit.ly/18q5OqW"}],"hashtags":[{"start":32,"end":44,"tag":"Biosimilars"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-31T11:00:30.000Z","conversation_id":"395867871143673856","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"395867871143673856","author_id":"784869524","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"RT @EMA_News: 1 day left to comment on need to revise condition–specific guidance on the eval. of anti-#cancer med. : http://t.co/e8X0mauq41","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/e8X0mauq41","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"hashtags":[{"start":103,"end":110,"tag":"cancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-30T13:01:41.000Z","conversation_id":"395522053295443968","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"395522053295443968"}],"id":"395535983384727552","author_id":"15536425","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"RT @EMA_News @HAIEurope Protecting Citizens' Health: Transparency of #ClinicalTrials Data in the EU http://t.co/zvGItw6ifS #ctdata","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"},{"start":13,"end":23,"username":"HAIEurope","id":"3314634701"}],"urls":[{"start":100,"end":122,"url":"http://t.co/zvGItw6ifS","expanded_url":"http://bit.ly/1a9Xrga","display_url":"bit.ly/1a9Xrga"}],"hashtags":[{"start":69,"end":84,"tag":"ClinicalTrials"},{"start":123,"end":130,"tag":"ctdata"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-30T11:27:58.000Z","conversation_id":"395491279347261440","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"395491279347261440"}],"id":"395512398733672448","author_id":"34651221","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News Looks to Formalize Involvement of Patients Within the Regulatory Process http://t.co/xPo7P7K8ys","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/xPo7P7K8ys","expanded_url":"http://ow.ly/qhZKL","display_url":"ow.ly/qhZKL"}],"hashtags":{},"annotations":[{"start":19,"end":27,"probability":0.3965,"type":"Organization","normalized_text":"Formalize"}],"cashtags":{}},"created_at":"2013-10-29T16:25:26.000Z","conversation_id":"395224870365454336","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"395224870365454336","author_id":"73774967","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"Good to see #EMA engaging re benefit-risk assessment and #patients' views, safety-risk balanced with faster approval? @TargetMD @EMA_News","entities":{"mentions":[{"start":128,"end":137,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":12,"end":16,"tag":"EMA"},{"start":57,"end":66,"tag":"patients"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-29T15:03:04.000Z","conversation_id":"395198251882008577","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"395198251882008577"}],"id":"395204143285280768","author_id":"1734766740","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News warning on risk of Arterial Thrombosis with Ponatinib http://t.co/wHznK5tXrO","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":64,"end":86,"url":"http://t.co/wHznK5tXrO","expanded_url":"http://ow.ly/qeIuJ","display_url":"ow.ly/qeIuJ"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-28T11:42:25.000Z","conversation_id":"394791256465080320","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"394791256465080320","author_id":"69232855","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"⚠⚠ “@EMA_News: Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/CoJWo1gc4H”","entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":98,"end":120,"url":"http://t.co/CoJWo1gc4H","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"hashtags":[{"start":30,"end":38,"tag":"insulin"},{"start":48,"end":56,"tag":"NovoMix"},{"start":60,"end":68,"tag":"FlexPen"},{"start":73,"end":81,"tag":"Penfill"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-28T11:37:31.000Z","conversation_id":"394788597666029568","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"394788597666029568"}],"id":"394790023260016640","author_id":"250753435","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News please please understand the pain Duchenne brings to families.help us get drugs to patients quicker Risk/Benefit #hope $SRPT RT","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":123,"end":128,"tag":"hope"}],"annotations":[{"start":44,"end":51,"probability":0.3032,"type":"Person","normalized_text":"Duchenne"}],"cashtags":[{"start":129,"end":134,"tag":"SRPT"}]},"created_at":"2013-10-26T10:54:43.000Z","conversation_id":"394054478737186816","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"394054478737186816","author_id":"554667907","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We've just published the CHMP meeting highlights: October 2013 http://t.co/2780lKwL6z”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/2780lKwL6z","expanded_url":"http://bit.ly/168zqJ5","display_url":"bit.ly/168zqJ5"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-25T16:20:17.000Z","conversation_id":"393714745758732289","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"393714745758732289"}],"id":"393774020799504384","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/oSsyzLphys” for #diabetes #UK","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/oSsyzLphys","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"hashtags":[{"start":27,"end":35,"tag":"insulin"},{"start":45,"end":53,"tag":"NovoMix"},{"start":57,"end":65,"tag":"FlexPen"},{"start":70,"end":78,"tag":"Penfill"},{"start":123,"end":132,"tag":"diabetes"},{"start":133,"end":136,"tag":"UK"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-25T12:20:20.000Z","conversation_id":"393701613736833024","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"393701613736833024"}],"id":"393713637162221568","author_id":"129802718","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News let's go, give us CHMP opinions","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-25T12:06:31.000Z","conversation_id":"393710158712303616","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"393710158712303616","author_id":"138820530","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News advises on compassionate use of #sofosbuvir for patients with chronic #hepatitis C infection before or after liver transplantation","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":42,"end":53,"tag":"sofosbuvir"},{"start":80,"end":90,"tag":"hepatitis"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-25T11:24:21.000Z","conversation_id":"393699546314051584","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"393699546314051584","author_id":"243228907","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News advises on compassionate use of #sofosbuvir for patients with chronic #hepatitis C infection before or after liver transplantation","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":42,"end":53,"tag":"sofosbuvir"},{"start":80,"end":90,"tag":"hepatitis"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-25T11:23:00.000Z","conversation_id":"393699206336380928","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"393699206336380928","author_id":"21079030","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: One week left to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/0W7bcwGkHk”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/0W7bcwGkHk","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"hashtags":[{"start":68,"end":79,"tag":"phthalates"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-24T18:36:03.000Z","conversation_id":"393337393517821953","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"393337393517821953"}],"id":"393445799352606720","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: One week -comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/npWhlGUO64”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/npWhlGUO64","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"hashtags":[{"start":68,"end":77,"tag":"parabens"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-24T18:35:55.000Z","conversation_id":"393337506659176449","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"393337506659176449"}],"id":"393445767534620672","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: One week left to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/kYwjLFB3wg”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":111,"end":133,"url":"http://t.co/kYwjLFB3wg","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"hashtags":[{"start":96,"end":108,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-24T18:35:34.000Z","conversation_id":"393337653833134080","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"393337653833134080"}],"id":"393445680125341698","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News report on Antibiotic use in farming. Netherlands is now mid-table in EU, major drop in use since 2010!  http://t.co/VIgEwZbi3k","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/VIgEwZbi3k","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/10/WC500152311.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"annotations":[{"start":47,"end":57,"probability":0.9645,"type":"Place","normalized_text":"Netherlands"},{"start":79,"end":80,"probability":0.7984,"type":"Place","normalized_text":"EU"}],"cashtags":{}},"created_at":"2013-10-23T06:55:56.000Z","conversation_id":"392907224344850432","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"392907224344850432","author_id":"221009551","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: What does the #blacktriangle mean? Find out about additional monitoring of medicines  watching our video: http://t.co/t16OX4MRoc","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/t16OX4MRoc","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":26,"end":40,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-22T15:52:26.000Z","conversation_id":"392566375182368768","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"392566375182368768"}],"id":"392679851016323072","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"iOS","text":"@ema_news argues access to #ctdata will benefit drug developers and patients. New paper in @NEJM today  http://t.co/oWnSvu4FKK","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":91,"end":96,"username":"NEJM","id":"25950355"}],"urls":[{"start":104,"end":126,"url":"http://t.co/oWnSvu4FKK","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001926.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":27,"end":34,"tag":"ctdata"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-22T10:09:22.000Z","conversation_id":"392593512661012480","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"392593512661012480","author_id":"113148426","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: Paper supports #clinicaltrials data disclosure benefits for R&amp;D, efficiency &amp; #transparency  http://t.co/uyPYbEHaff #ctdata”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/uyPYbEHaff","expanded_url":"http://bit.ly/18FtKak","display_url":"bit.ly/18FtKak"}],"hashtags":[{"start":27,"end":42,"tag":"clinicaltrials"},{"start":98,"end":111,"tag":"transparency"},{"start":136,"end":143,"tag":"ctdata"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-22T09:34:23.000Z","conversation_id":"392579123450638336","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"392579123450638336"}],"id":"392584711546998784","author_id":"1108967047","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News #CHMP agrees to all major items of #vasopharm’s planned EU P3 study protocol of VAS203 in patients with traumatic brain injury","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":45,"end":55,"tag":"vasopharm"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-22T07:57:48.000Z","conversation_id":"392560403248869376","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"392560403248869376","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @NEJM new article out today 'Access to Patient-Level Trial Data — A Boon to Drug Developers' http://t.co/YdnkbjjZZD #ctdata","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":15,"username":"NEJM","id":"25950355"}],"urls":[{"start":103,"end":125,"url":"http://t.co/YdnkbjjZZD","expanded_url":"http://nej.md/17FxncR","display_url":"nej.md/17FxncR"}],"hashtags":[{"start":126,"end":133,"tag":"ctdata"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-22T07:23:36.000Z","conversation_id":"392551797933744128","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"392551797933744128","author_id":"113148426","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @INFARMED_IP: Voluntary recall of batches of the medicine Captopril Zentiva http://t.co/iSwyoRNINT”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":27,"username":"INFARMED_IP","id":"1392501529"}],"urls":[{"start":91,"end":113,"url":"http://t.co/iSwyoRNINT","expanded_url":"http://bit.ly/1i1qnvC","display_url":"bit.ly/1i1qnvC"}],"hashtags":{},"annotations":[{"start":73,"end":89,"probability":0.3292,"type":"Person","normalized_text":"Captopril Zentiva"}],"cashtags":{}},"created_at":"2013-10-18T18:46:02.000Z","conversation_id":"391153508210049024","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"391153508210049024"}],"id":"391273987583799296","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @AEMPSGOB: Intravenous hydroxyethyl starch: use restrictions http://t.co/GrfsW98mbz”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":24,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":76,"end":98,"url":"http://t.co/GrfsW98mbz","expanded_url":"http://bit.ly/17tO1Mu","display_url":"bit.ly/17tO1Mu"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-16T16:00:18.000Z","conversation_id":"390501644112101376","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"390501644112101376"}],"id":"390507503420973056","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We've published the assessment report for #Giotrif (#afatinib) for non-small-cell #lungcancer @ http://t.co/NE0HJN6msZ”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/NE0HJN6msZ","expanded_url":"http://bit.ly/1fCB0bA","display_url":"bit.ly/1fCB0bA"}],"hashtags":[{"start":54,"end":62,"tag":"Giotrif"},{"start":64,"end":73,"tag":"afatinib"},{"start":94,"end":105,"tag":"lungcancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-16T15:04:11.000Z","conversation_id":"390481272726102017","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"390481272726102017"}],"id":"390493381765640192","author_id":"633978297","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Important vs antibiotic resistance @EMA_News latest report on 2011 veterinary antimicrobial sales in 25 EU/EEA states http://t.co/1dhZ2c9yDP","entities":{"mentions":[{"start":35,"end":44,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/1dhZ2c9yDP","expanded_url":"http://bit.ly/GPunDM","display_url":"bit.ly/GPunDM"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-16T09:05:18.000Z","conversation_id":"390397214305972226","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"390397214305972226"}],"id":"390403065184260096","author_id":"243228907","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News We welcome 3rd ESVAC report &amp; support transparency of use of #animalmedicines. Statement: http://t.co/qZoldnQHTM  @EU_Health","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":128,"end":138,"username":"EU_Health","id":"606325697"}],"urls":[{"start":104,"end":126,"url":"http://t.co/qZoldnQHTM","expanded_url":"http://bit.ly/1an6DhR","display_url":"bit.ly/1an6DhR"}],"hashtags":[{"start":75,"end":91,"tag":"animalmedicines"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-15T14:24:05.000Z","conversation_id":"390120902777516033","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"390120902777516033","author_id":"1017044760","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Ustream.TV","text":"@EMA_News well said! when the medicines shortage is there we have to see to it! (live at http://t.co/iXn1ZT8BhE)","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":89,"end":111,"url":"http://t.co/iXn1ZT8BhE","expanded_url":"http://ustre.am/Ps5U","display_url":"ustre.am/Ps5U"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-14T14:40:15.000Z","conversation_id":"389762581285462016","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"389762581285462016","author_id":"140344419","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News thanks! wonder if our comment to the draft position paper has been taken into consideration..","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-14T14:35:04.000Z","conversation_id":"389759765196189696","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"389760468337696770"}],"id":"389761276043218944","author_id":"140344419","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News live discussion on solutions to shortages of drugs, \"hot\" issue in Europe-position of patient groups?http://t.co/lqKFF9NKit","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":111,"end":133,"url":"http://t.co/lqKFF9NKit","expanded_url":"http://www.ustream.tv/channel/european-medicines-agency","display_url":"ustream.tv/channel/europe…"}],"hashtags":{},"annotations":[{"start":77,"end":82,"probability":0.994,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"created_at":"2013-10-14T14:34:06.000Z","conversation_id":"389742290832334848","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"389759633230798848"}],"id":"389761032001839105","author_id":"140344419","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News what's the hashtag?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-14T14:23:16.000Z","conversation_id":"389742290832334848","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"389742290832334848"}],"id":"389758309231640576","author_id":"140344419","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News lanza una nueva versión de EudraCT como un paso más hacia la transparencia de los ensayos clínicos http://t.co/whByE35zLy","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/whByE35zLy","expanded_url":"http://bit.ly/GRAiZH","display_url":"bit.ly/GRAiZH"}],"hashtags":{},"annotations":[{"start":37,"end":43,"probability":0.2954,"type":"Other","normalized_text":"EudraCT"}],"cashtags":{}},"created_at":"2013-10-14T10:07:27.000Z","conversation_id":"389693927059513344","possibly_sensitive":false,"lang":"es","referenced_tweets":{},"id":"389693927059513344","author_id":"596292370","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: Watch live broadcast workshop on preventing shortages due to manufacturing &amp; quality problems: http://t.co/CLs0piOcnu” #pharma","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":111,"end":133,"url":"http://t.co/CLs0piOcnu","expanded_url":"http://bit.ly/1akvPpd","display_url":"bit.ly/1akvPpd"}],"hashtags":[{"start":135,"end":142,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-14T09:37:55.000Z","conversation_id":"389678190886924288","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"389678190886924288"}],"id":"389686495961186304","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News favorable aux contraceptifs 3ème et 4ème générations http://t.co/zsGhrySw6d","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":63,"end":85,"url":"http://t.co/zsGhrySw6d","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001916.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-14T07:53:30.000Z","conversation_id":"389660217392103424","possibly_sensitive":false,"lang":"fr","referenced_tweets":{},"id":"389660217392103424","author_id":"1482049878","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"MT “@EMA_News: PRAC meeting highlights: http://t.co/VtYZiNb0l6” Stop using HES, oral contraceptives ok, reviewing valproate in pregnancy","entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":40,"end":62,"url":"http://t.co/VtYZiNb0l6","expanded_url":"http://bit.ly/15YE1Q3","display_url":"bit.ly/15YE1Q3"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-11T11:43:14.000Z","conversation_id":"388623345287450624","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"388623345287450624"}],"id":"388630871462273024","author_id":"515837126","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@dennisandre “@EMA_News: We've just published the PRAC meeting highlights: http://t.co/grNWWXocl5”","entities":{"mentions":[{"start":0,"end":12,"username":"dennisandre","id":"17994531"},{"start":14,"end":23,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/grNWWXocl5","expanded_url":"http://bit.ly/15YE1Q3","display_url":"bit.ly/15YE1Q3"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-11T11:15:49.000Z","conversation_id":"388623345287450624","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"388623345287450624"}],"id":"388623972239429632","author_id":"23810643","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: hosting workshop-prevention of product shortages due to manufacturing and quality problems on 14 October: http://t.co/BbheEHSihT","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/BbheEHSihT","expanded_url":"http://bit.ly/1acjgwa","display_url":"bit.ly/1acjgwa"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-10T14:45:40.000Z","conversation_id":"388258176665399296","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"388258176665399296"}],"id":"388314391751716864","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: What does the #blacktriangle on medicines mean? Watch our video: http://t.co/t16OX4MRoc”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":77,"end":99,"url":"http://t.co/t16OX4MRoc","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":26,"end":40,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-07T18:07:17.000Z","conversation_id":"387130284593803264","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"387130284593803264"}],"id":"387277969208909824","author_id":"514255564","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @drdjpanchal to watch","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"drdjpanchal","id":"597167039"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-07T11:26:33.000Z","conversation_id":"387172956381528064","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"387172956381528064"}],"id":"387177122068180992","author_id":"1600732507","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Thanks,","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-07T10:22:18.000Z","conversation_id":"387130470867017728","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"387155461805309952"}],"id":"387160951935356928","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News EMA recommendations based on safety signals #rarediseases #orphandrugs http://t.co/fi538thMN4","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":81,"end":103,"url":"http://t.co/fi538thMN4","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/10/news_detail_001907.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":54,"end":67,"tag":"rarediseases"},{"start":68,"end":80,"tag":"orphandrugs"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-07T08:47:21.000Z","conversation_id":"387137056733806592","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"387137056733806592","author_id":"1430840870","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News more than 400 reports (WHO) of AE's involving mental disorders  following  Stamaril vaccination.Why is this not investigated?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-07T08:38:39.000Z","conversation_id":"387130470867017728","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"387130470867017728"}],"id":"387134868431179776","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News: We've published the assessment report for #Inflectra (#infliximab), a #biosimilar of #Remicade: http://t.co/DIpN62gCld","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/DIpN62gCld","expanded_url":"http://bit.ly/16JZcWX","display_url":"bit.ly/16JZcWX"}],"hashtags":[{"start":53,"end":63,"tag":"Inflectra"},{"start":65,"end":76,"tag":"infliximab"},{"start":81,"end":92,"tag":"biosimilar"},{"start":96,"end":105,"tag":"Remicade"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-04T15:47:32.000Z","conversation_id":"386155634766659584","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"386155634766659584","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Find out what the #blacktriangle means and how additional monitoring works: http://t.co/t16OX4MRoc”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/t16OX4MRoc","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":30,"end":44,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-04T12:25:39.000Z","conversation_id":"386089083480457216","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"386089083480457216"}],"id":"386104831154618368","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Our website is down at the moment due to technical problems. We're working on getting it back up as soon as possible. Apologies.","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-04T12:25:14.000Z","conversation_id":"386093396764262400","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"386093396764262400"}],"id":"386104726624165889","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News no innovation in UK of course","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":27,"end":28,"probability":0.9866,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"created_at":"2013-10-04T11:06:41.000Z","conversation_id":"386044426146959360","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"386044426146959360"}],"id":"386084958609362944","author_id":"362672893","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Windows Phone","text":"@EMA_News \"Public Health\" should be added to your list of conflicts of interest categories http://t.co/rqs8pLXM88","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":91,"end":113,"url":"http://t.co/rqs8pLXM88","expanded_url":"http://www.bmj.com/content/347/bmj.f5535/rr/664108","display_url":"bmj.com/content/347/bm…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-04T06:59:15.000Z","conversation_id":"385684292044476416","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"385684292044476416"}],"id":"386022686994231296","author_id":"14433267","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Concluye periodo de audiencia xa política de #transparencia en #EECC. En vigor dsd 2014. @EFPIA expectante http://t.co/BNDFvMGpmy","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":99,"end":105,"username":"EFPIA","id":"52084584"}],"urls":[{"start":117,"end":139,"url":"http://t.co/BNDFvMGpmy","expanded_url":"http://bit.ly/1fL4y7O","display_url":"bit.ly/1fL4y7O"}],"hashtags":[{"start":55,"end":69,"tag":"transparencia"},{"start":73,"end":78,"tag":"EECC"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-03T09:53:57.000Z","conversation_id":"385704265102020608","possibly_sensitive":false,"lang":"es","referenced_tweets":{},"id":"385704265102020608","author_id":"1003782248","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"#Triángulonegro en medicamentos q requieren especial seguimiento, qué significa @EMA_News #blacktriangle http://t.co/c7I6IZbXXz”","entities":{"mentions":[{"start":80,"end":89,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":127,"url":"http://t.co/c7I6IZbXXz","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"hashtags":[{"start":0,"end":15,"tag":"Triángulonegro"},{"start":90,"end":104,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-01T17:23:13.000Z","conversation_id":"384996429652963328","possibly_sensitive":false,"lang":"es","referenced_tweets":[{"type":"replied_to","id":"384996429652963328"}],"id":"385092549729583105","author_id":"243301370","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@ema_news  @blackpoolcrc @velascozamora With recent emphasis on #clinicaltrials matching - take a look at the TRUTH! http://t.co/5EW2ddaPMw","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":25,"end":39,"username":"velascozamora","id":"182561601"}],"urls":[{"start":117,"end":139,"url":"http://t.co/5EW2ddaPMw","expanded_url":"http://curelauncher.com/news/when-people-cancer-need-treatment-don%E2%80%99t-they-have-right-know-all-their-options","display_url":"curelauncher.com/news/when-peop…"}],"hashtags":[{"start":64,"end":79,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-01T15:23:42.000Z","conversation_id":"385062473130201088","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"385062473130201088","author_id":"790421354","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Many thanks for the clarification! It has been fixed in the website","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-01T13:04:32.000Z","conversation_id":"384971025286307840","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"384984474796457984"}],"id":"385027451706802177","author_id":"184756856","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"Perhaps not the best symbol?\n@EMA_News The #blacktriangle &amp; additional monitoring http://t.co/0U0EHhFlLI http://t.co/ivftUAaX3S","entities":{"mentions":[{"start":29,"end":38,"username":"EMA_News","id":"116716199"}],"urls":[{"start":86,"end":108,"url":"http://t.co/0U0EHhFlLI","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"},{"start":109,"end":131,"url":"http://t.co/ivftUAaX3S","expanded_url":"https://twitter.com/lakemedel/status/385017286404235265/photo/1","display_url":"pic.twitter.com/ivftUAaX3S"}],"hashtags":[{"start":43,"end":57,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-01T12:24:09.000Z","conversation_id":"385017286404235265","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"385017286404235265","author_id":"207897978","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":["3_385017286408429568"]},"geo":{"coordinates":{"coordinates":{}}}},{"source":"LinkedIn","text":"@EMA_News: Our video and factsheet explaining the #blacktriangle &amp; additional monitoring in all EU languages are now…http://t.co/zScufRoPYm","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":121,"end":143,"url":"http://t.co/zScufRoPYm","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"hashtags":[{"start":50,"end":64,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-01T11:06:24.000Z","conversation_id":"384997723012734977","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"384997723012734977","author_id":"318743706","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News It could be an interesting concept in highlighting devices that need close post-market monitoring.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-10-01T11:02:05.000Z","conversation_id":"384963559614316544","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"384989111255572480"}],"id":"384996637023944705","author_id":"183177433","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"And for #medicaldevices?“@EMA_News: We've published a video and factshee on blacktriangle &amp; additional monitoring: http://t.co/lpjc1AN9rU”","entities":{"mentions":[{"start":25,"end":34,"username":"EMA_News","id":"116716199"}],"urls":[{"start":119,"end":141,"url":"http://t.co/lpjc1AN9rU","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"hashtags":[{"start":8,"end":23,"tag":"medicaldevices"}],"annotations":{},"cashtags":{}},"created_at":"2013-10-01T09:56:06.000Z","conversation_id":"384963559614316544","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"384963559614316544"}],"id":"384980031728279552","author_id":"183177433","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News will host a workshop on regulatory options in the fight against antimicrobial resistance http://t.co/qPbLOIuFAu #AMR #vaccines","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/qPbLOIuFAu","expanded_url":"http://bit.ly/1h5d2Sr","display_url":"bit.ly/1h5d2Sr"}],"hashtags":[{"start":122,"end":126,"tag":"AMR"},{"start":127,"end":136,"tag":"vaccines"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-30T09:12:50.000Z","conversation_id":"384606756032098304","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"384606756032098304","author_id":"1262320285","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: #advancedtherapies committee has issued its first recommendation for certification of non-clinical data: http://t.co/rJlVyV0eAf”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/rJlVyV0eAf","expanded_url":"http://bit.ly/1fqLhIw","display_url":"bit.ly/1fqLhIw"}],"hashtags":[{"start":12,"end":30,"tag":"advancedtherapies"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-27T09:43:52.000Z","conversation_id":"383506032338563072","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"383506032338563072"}],"id":"383527402162618368","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We're holding a workshop on #biosimilars on 31 October. A few places are available: http://t.co/yXUR6iBy1z”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/yXUR6iBy1z","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"hashtags":[{"start":40,"end":52,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-26T13:21:17.000Z","conversation_id":"383141810156998656","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"383141810156998656"}],"id":"383219728220975104","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends change to everolimus marketing auth. indic. for SEGA assoc.w/ tuberous sclerosis complex (TSC) http://t.co/AQhK7dLehz","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/AQhK7dLehz","expanded_url":"http://ow.ly/peyM9","display_url":"ow.ly/peyM9"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-26T13:03:36.000Z","conversation_id":"383215276424450048","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"383215276424450048","author_id":"69232855","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News publishes assessment report for #Lemtrada (#alemtuzumab) to treat #multiplesclerosis: http://t.co/ixo1vofNXy” #pharma #biotech","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":97,"end":119,"url":"http://t.co/ixo1vofNXy","expanded_url":"http://bit.ly/1be3fwf","display_url":"bit.ly/1be3fwf"}],"hashtags":[{"start":43,"end":52,"tag":"Lemtrada"},{"start":54,"end":66,"tag":"alemtuzumab"},{"start":77,"end":95,"tag":"multiplesclerosis"},{"start":121,"end":128,"tag":"pharma"},{"start":129,"end":137,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-26T09:15:24.000Z","conversation_id":"383148983629398016","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"383148983629398016"}],"id":"383157847183613952","author_id":"243228907","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We're organising a workshop on #biosimilars on 31 October: http://t.co/yXUR6iBy1z”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":71,"end":93,"url":"http://t.co/yXUR6iBy1z","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"hashtags":[{"start":43,"end":55,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-25T19:32:51.000Z","conversation_id":"382902466805006336","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"382902466805006336"}],"id":"382950848743370752","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends ext. of Ipilimumab indic,.to previously untreated unresectable or metastatic #melanoma http://t.co/x7XNih4ixC","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/x7XNih4ixC","expanded_url":"http://ow.ly/pc4C9","display_url":"ow.ly/pc4C9"}],"hashtags":[{"start":98,"end":107,"tag":"melanoma"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-25T11:39:38.000Z","conversation_id":"382831759299452928","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"382831759299452928","author_id":"69232855","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends granting mkting auth. for Trastuzumab Emtansine for metastatic #breastcancer http://t.co/xXeyBukhrw","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":98,"end":120,"url":"http://t.co/xXeyBukhrw","expanded_url":"http://ow.ly/p9Oms","display_url":"ow.ly/p9Oms"}],"hashtags":[{"start":84,"end":97,"tag":"breastcancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-24T12:06:06.000Z","conversation_id":"382476030055047168","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"382476030055047168","author_id":"69232855","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: One more week to comment on concept paper on development of product-specific guidance on #bioequivalence: http://t.co/JNRxFnFivV","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/JNRxFnFivV","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"hashtags":[{"start":101,"end":116,"tag":"bioequivalence"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-23T14:04:54.000Z","conversation_id":"382066775531065344","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"382066775531065344"}],"id":"382143540538904576","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends granting mkting auth. for Radium-223 Chloride for castration-resistant #prostatecancer http://t.co/Vp0DawUIzK","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/Vp0DawUIzK","expanded_url":"http://ow.ly/p72i4","display_url":"ow.ly/p72i4"}],"hashtags":[{"start":92,"end":107,"tag":"prostatecancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-23T08:55:38.000Z","conversation_id":"382065709360373760","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"382065709360373760","author_id":"69232855","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We've just published the CHMP meeting highlights: http://t.co/7lrQMeyuKt”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":62,"end":84,"url":"http://t.co/7lrQMeyuKt","expanded_url":"http://bit.ly/18fpSwm","display_url":"bit.ly/18fpSwm"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-20T16:44:00.000Z","conversation_id":"381015199429689345","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"381015199429689345"}],"id":"381096416044941312","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@MarvinOLicious @fezziwig2008 Alternatively you can follow the MabThera RSS feed at http://t.co/CCjJny8Cc9.","entities":{"mentions":[{"start":0,"end":15,"username":"MarvinOLicious","id":"595127053"},{"start":16,"end":29,"username":"fezziwig2008","id":"376154503"}],"urls":[{"start":84,"end":106,"url":"http://t.co/CCjJny8Cc9","expanded_url":"http://bit.ly/18Hk4rE","display_url":"bit.ly/18Hk4rE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-20T11:51:10.000Z","conversation_id":"381022536055934976","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"381022536055934976"}],"id":"381022721930694656","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Does this imply that Xogigo now is approved for the European market? Or is that a different proses?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":31,"end":36,"probability":0.3582,"type":"Person","normalized_text":"Xogigo"}],"cashtags":{}},"created_at":"2013-09-20T11:26:47.000Z","conversation_id":"381015199429689345","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"381015199429689345"}],"id":"381016584208142337","author_id":"40722651","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News #CHMP gives positive opinion to @GSK drugs #RELVAR #ELLIPTA for treatment of #asthma or #COPD #respiratory #pharma #Theravance","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":42,"end":46,"username":"GSK","id":"5383942"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":53,"end":60,"tag":"RELVAR"},{"start":61,"end":69,"tag":"ELLIPTA"},{"start":87,"end":94,"tag":"asthma"},{"start":98,"end":103,"tag":"COPD"},{"start":104,"end":116,"tag":"respiratory"},{"start":117,"end":124,"tag":"pharma"},{"start":125,"end":136,"tag":"Theravance"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-19T19:27:33.000Z","conversation_id":"380775184724406272","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"380775184724406272","author_id":"243228907","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News #CHMP gives receives positive opinion fEurope for the treatment of asthma and COPD","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-19T19:21:07.000Z","conversation_id":"380773567644049408","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"380773567644049408","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Our websites &amp; other online tools will be unavailable from 5.30pm tomorrow London time - Monday morning: http://t.co/FW8xS13XAq”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":121,"end":143,"url":"http://t.co/FW8xS13XAq","expanded_url":"http://bit.ly/155UOjL","display_url":"bit.ly/155UOjL"}],"hashtags":{},"annotations":[{"start":87,"end":92,"probability":0.9216,"type":"Place","normalized_text":"London"}],"cashtags":{}},"created_at":"2013-09-19T18:37:36.000Z","conversation_id":"380648022536753152","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"380648022536753152"}],"id":"380762615078998016","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Published the assessment report for #Tafinlar (#dabrafenib) for the treatment of #melanoma @EMA_News  #GSK http://t.co/d5TjzaxLNy","entities":{"mentions":[{"start":91,"end":100,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/d5TjzaxLNy","expanded_url":"http://bit.ly/19glED1","display_url":"bit.ly/19glED1"}],"hashtags":[{"start":36,"end":45,"tag":"Tafinlar"},{"start":47,"end":58,"tag":"dabrafenib"},{"start":81,"end":90,"tag":"melanoma"},{"start":102,"end":106,"tag":"GSK"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-19T10:31:58.000Z","conversation_id":"380616630759600128","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"380616630759600128"}],"id":"380640401985929216","author_id":"633978297","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Quite a change but it looks much leaner though. Hope you have a smooth transition!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-18T15:05:17.000Z","conversation_id":"379912320048037889","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"379912320048037889"}],"id":"380346796536393728","author_id":"51995902","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News aprueba la indicación de panitumumab para CCR sin mutación de RAS \n http://t.co/WTa0xYISqY","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":78,"end":100,"url":"http://t.co/WTa0xYISqY","expanded_url":"http://ow.ly/oYrSp","display_url":"ow.ly/oYrSp"}],"hashtags":{},"annotations":[{"start":52,"end":54,"probability":0.4643,"type":"Organization","normalized_text":"CCR"},{"start":72,"end":74,"probability":0.5367,"type":"Organization","normalized_text":"RAS"}],"cashtags":{}},"created_at":"2013-09-18T13:15:14.000Z","conversation_id":"380319100893134848","possibly_sensitive":false,"lang":"es","referenced_tweets":{},"id":"380319100893134848","author_id":"392623482","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Paediatric Committee elects new Chair and Vice-Chair: http://t.co/sJQS79k3tU","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":64,"end":86,"url":"http://t.co/sJQS79k3tU","expanded_url":"http://goo.gl/a0Btlw","display_url":"goo.gl/a0Btlw"}],"hashtags":{},"annotations":[{"start":10,"end":29,"probability":0.6159,"type":"Organization","normalized_text":"Paediatric Committee"}],"cashtags":{}},"created_at":"2013-09-17T10:44:12.000Z","conversation_id":"379918706018500609","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"379918706018500609","author_id":"717962540","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News There is a typo in your announcement of #stirvarga EPAR. It is regorafenib, not regorafenig.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":50,"end":60,"tag":"stirvarga"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-16T09:50:17.000Z","conversation_id":"379526822683111425","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"379526822683111425"}],"id":"379542747796873216","author_id":"633978297","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"How might #medtech be affected? “@EMA_News: We've just announced details of our new organisational structure: http://t.co/dnaxZ2GssX”","entities":{"mentions":[{"start":33,"end":42,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/dnaxZ2GssX","expanded_url":"http://bit.ly/17CRM4l","display_url":"bit.ly/17CRM4l"}],"hashtags":[{"start":10,"end":18,"tag":"medtech"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-16T09:50:11.000Z","conversation_id":"379533142170017792","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"379533142170017792"}],"id":"379542725408096256","author_id":"183177433","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News has heard views from stakeholders on #conflictsofinterests policy for scientific experts: http://t.co/ifrmQQjsYG deadline 18 Sept","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":100,"end":122,"url":"http://t.co/ifrmQQjsYG","expanded_url":"http://bit.ly/1aEgPbM","display_url":"bit.ly/1aEgPbM"}],"hashtags":[{"start":47,"end":68,"tag":"conflictsofinterests"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-12T09:10:38.000Z","conversation_id":"378083218764746752","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"378083218764746752","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @pharmatweat Same problems. Thought it was instal issues. There is no print button, and multiple MedDRA risk terms not possible.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"pharmatweat","id":"1725069487"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-11T15:26:10.000Z","conversation_id":"374840221033975808","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"374847673691803649"}],"id":"377815337099464704","author_id":"206819876","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"RT “@EMA_News: Registration is open for a workshop on designation of #orphan medicines and grants: http://t.co/Nqo31aLa6i” #OrphanDrugs","entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/Nqo31aLa6i","expanded_url":"http://bit.ly/19pHuoj","display_url":"bit.ly/19pHuoj"}],"hashtags":[{"start":69,"end":76,"tag":"orphan"},{"start":123,"end":135,"tag":"OrphanDrugs"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-06T16:55:36.000Z","conversation_id":"376022929274077184","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"376022929274077184"}],"id":"376025905925459968","author_id":"266609916","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News publishes assessment report for #Aubagio (#teriflunomide) to treat #multiplesclerosis: http://t.co/LiuYuXI0UX #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":97,"end":119,"url":"http://t.co/LiuYuXI0UX","expanded_url":"http://bit.ly/18HYvaY","display_url":"bit.ly/18HYvaY"}],"hashtags":[{"start":42,"end":50,"tag":"Aubagio"},{"start":52,"end":66,"tag":"teriflunomide"},{"start":77,"end":95,"tag":"multiplesclerosis"},{"start":120,"end":127,"tag":"pharma"},{"start":128,"end":136,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-06T15:19:32.000Z","conversation_id":"375996325349040128","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375996325349040128"}],"id":"376001728573095936","author_id":"243228907","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News @PrescrireMieux How do you expect them to become experts? Academics need input from industry.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"PrescrireMieux","id":"247239882"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-06T13:29:55.000Z","conversation_id":"375944616584830976","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375944616584830976"}],"id":"375974142383636480","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News Thx - couldn't find the multimedia tab on the event page //Anne","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":69,"end":72,"probability":0.6594,"type":"Person","normalized_text":"Anne"}],"cashtags":{}},"created_at":"2013-09-06T12:35:53.000Z","conversation_id":"375954872983490560","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375958739796623360"}],"id":"375960545020485632","author_id":"873777758","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News can't find the live video stream","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-06T12:15:13.000Z","conversation_id":"375954872983490560","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375954872983490560"}],"id":"375955342217056256","author_id":"873777758","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @PrescrireMieux some academics with no industry links still have potential to be conflicted ie when calling for \"more research\"","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"PrescrireMieux","id":"247239882"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-06T11:41:45.000Z","conversation_id":"375944616584830976","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375944616584830976"}],"id":"375946921531424768","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @PrescrireMieux why restrict talent pool? - just need transparency to stop experts giving slanted view #pharma #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"PrescrireMieux","id":"247239882"}],"urls":{},"hashtags":[{"start":113,"end":120,"tag":"pharma"},{"start":121,"end":129,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-06T11:39:10.000Z","conversation_id":"375944616584830976","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375944616584830976"}],"id":"375946272878108672","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News #PRAC meeting hi-lites http://t.co/Jh1IvH6uhN inc recom to restrict short-acting beta-agonist use in obstetric indications #pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":33,"end":55,"url":"http://t.co/Jh1IvH6uhN","expanded_url":"http://bit.ly/18z2J5R","display_url":"bit.ly/18z2J5R"}],"hashtags":[{"start":10,"end":15,"tag":"PRAC"},{"start":133,"end":140,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-06T11:15:11.000Z","conversation_id":"375938107369332736","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375938107369332736"}],"id":"375940234040844289","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@HJF29088181 We've fixed it now. Apologies for the error: http://t.co/2rOJ2z4H2k","entities":{"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"urls":[{"start":58,"end":80,"url":"http://t.co/2rOJ2z4H2k","expanded_url":"http://bit.ly/1aiGkzn","display_url":"bit.ly/1aiGkzn"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-04T11:26:50.000Z","conversation_id":"375157376451489793","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"375192039677509632"}],"id":"375218390782455808","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News ¿Se te ha roto la pantalla del móvil o ipod? Tenemos tu solución. http://t.co/rONvWqKRAv","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":76,"end":98,"url":"http://t.co/rONvWqKRAv","expanded_url":"http://danielfernandezlober.wix.com/reparaciones","display_url":"danielfernandezlober.wix.com/reparaciones"}],"hashtags":{},"annotations":[{"start":49,"end":52,"probability":0.8493,"type":"Product","normalized_text":"ipod"}],"cashtags":{}},"created_at":"2013-09-04T09:00:28.000Z","conversation_id":"375180140411498496","possibly_sensitive":false,"lang":"es","referenced_tweets":[{"type":"replied_to","id":"375180140411498496"}],"id":"375181557499039744","author_id":"1675439491","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News potentially 30,000 women damaged by #Essure and still not enough for the #FDA to step in! http://t.co/CHhyDaVSbp","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":100,"end":122,"url":"http://t.co/CHhyDaVSbp","expanded_url":"http://www.newschannel5.com/story/22924769/women-report-painful-side-effects-from-birth-control","display_url":"newschannel5.com/story/22924769…"}],"hashtags":[{"start":46,"end":53,"tag":"Essure"},{"start":83,"end":87,"tag":"FDA"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-04T01:49:36.000Z","conversation_id":"375073127429984256","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"375073127429984256","author_id":"1300585957","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"Have submitted details via link.  In short, not possible to generate human readable output. Can't add &gt;1 MedDRA term to each risk @EMA_News","entities":{"mentions":[{"start":133,"end":142,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-03T12:36:32.000Z","conversation_id":"374840221033975808","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"374847673691803649"}],"id":"374873545358077953","author_id":"1725069487","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News has EC approved celltrion's remsima","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-03T10:17:54.000Z","conversation_id":"374838657544249344","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"374838657544249344","author_id":"223692135","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @URPLWMiPB: The #blacktriangle symbol does not mean that the use of these medicines is subject to greater risk.”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":25,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":[{"start":31,"end":45,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-09-02T19:12:11.000Z","conversation_id":"374467317188796417","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"374467317188796417"}],"id":"374610727103111169","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@fezziwig2008 Alternatively, follow our Herceptin RSS feed: http://t.co/WibaOR4TXu","entities":{"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"urls":[{"start":60,"end":82,"url":"http://t.co/WibaOR4TXu","expanded_url":"http://bit.ly/17jahY5","display_url":"bit.ly/17jahY5"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-02T15:58:48.000Z","conversation_id":"374560385853956097","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"374561807119425536"}],"id":"374562060476379136","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@fezziwig2008 We will update our information on Herceptin after the Commission decision is granted. Keep an eye on http://t.co/VPOTJIMp13.","entities":{"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"urls":[{"start":115,"end":137,"url":"http://t.co/VPOTJIMp13","expanded_url":"http://bit.ly/1bofovI","display_url":"bit.ly/1bofovI"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-09-02T15:57:48.000Z","conversation_id":"374560385853956097","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"374561391140962304"}],"id":"374561807119425536","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @EP_Environment: New medicines to display #blacktriangle from September http://t.co/POhPkrg1po lead MEP @LindaMcAvanMEP”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":30,"username":"EP_Environment","id":"951333319"},{"start":119,"end":134,"username":"LindaMcAvanMEP","id":"166509226"}],"urls":[{"start":87,"end":109,"url":"http://t.co/POhPkrg1po","expanded_url":"http://bit.ly/15aEYPg","display_url":"bit.ly/15aEYPg"}],"hashtags":[{"start":57,"end":71,"tag":"blacktriangle"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-30T12:26:51.000Z","conversation_id":"373407343670992896","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"373407343670992896"}],"id":"373421554375606272","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@fezziwig2008 However, it may take us 15 days to publish all of the updated information on our website after the decision is granted.","entities":{"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-30T12:24:23.000Z","conversation_id":"373414548604481536","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"373420505099161601"}],"id":"373420933937389568","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@fezziwig2008 The @EU_Commission register of medicinal products is at http://t.co/VOX6tkW6Bm. It includes a list of recent decisions.","entities":{"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":18,"end":32,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":70,"end":92,"url":"http://t.co/VOX6tkW6Bm","expanded_url":"http://bit.ly/1dWC2wD","display_url":"bit.ly/1dWC2wD"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-30T12:16:36.000Z","conversation_id":"373414548604481536","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"373418626113888256"}],"id":"373418975591690240","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @LV_MPA: Monthly report from the Committee for Medicinal Products for Human Use (July 2013): http://t.co/TaPrcGXoFZ”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":22,"username":"LV_MPA","id":"77047226"}],"urls":[{"start":108,"end":130,"url":"http://t.co/TaPrcGXoFZ","expanded_url":"http://bit.ly/1bW1T5J","display_url":"bit.ly/1bW1T5J"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-22T14:14:15.000Z","conversation_id":"370509205620654080","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"370509205620654080"}],"id":"370549481336762368","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"kwiat arniki górskiej udomowiony lub ufarmakowiony “@EMA_News: #herbal monograph on #Arnica montana (Arnica flower): http://t.co/3LVzjIRVWO”","entities":{"mentions":[{"start":52,"end":61,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/3LVzjIRVWO","expanded_url":"http://bit.ly/16gs5T8","display_url":"bit.ly/16gs5T8"}],"hashtags":[{"start":63,"end":70,"tag":"herbal"},{"start":84,"end":91,"tag":"Arnica"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-22T10:10:17.000Z","conversation_id":"370483995076984832","possibly_sensitive":false,"lang":"pl","referenced_tweets":[{"type":"replied_to","id":"370483995076984832"}],"id":"370488083499991040","author_id":"65877691","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"RT “@EMA_News: Register now for our information day on using #MedDRA, including #medicationerrors, on 22 October: http://t.co/LPh6QxRDOF”","entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/LPh6QxRDOF","expanded_url":"http://bit.ly/14iub92","display_url":"bit.ly/14iub92"}],"hashtags":[{"start":61,"end":68,"tag":"MedDRA"},{"start":80,"end":97,"tag":"medicationerrors"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-21T11:07:39.000Z","conversation_id":"370138537544261632","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"370138537544261632"}],"id":"370140135486390272","author_id":"266609916","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We've published the first conclusions parallel assessment of quality-by-design applications with @US_FDA: http://t.co/cyx8jFi8wz","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":109,"end":116,"username":"US_FDA","id":"208120290"}],"urls":[{"start":118,"end":140,"url":"http://t.co/cyx8jFi8wz","expanded_url":"http://bit.ly/13CzwJR","display_url":"bit.ly/13CzwJR"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-20T16:35:13.000Z","conversation_id":"369823852404436994","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"369823852404436994"}],"id":"369860181699870720","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Echofon","text":"@EMA_News @webDM1 Thks for heads up,","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"webDM1","id":"758619698"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-19T13:30:59.000Z","conversation_id":"368421127447539713","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"369374395505995776"}],"id":"369451430920204289","author_id":"1496947920","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@wombarrapete @fiouw More details on orphan designations are here: http://t.co/nBhWNZiRJS http://t.co/jNm5SORCXx","entities":{"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"urls":[{"start":67,"end":89,"url":"http://t.co/nBhWNZiRJS","expanded_url":"http://bit.ly/16Zy2IA","display_url":"bit.ly/16Zy2IA"},{"start":90,"end":112,"url":"http://t.co/jNm5SORCXx","expanded_url":"http://bit.ly/150UJve","display_url":"bit.ly/150UJve"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-19T11:08:10.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"369415289110155264"}],"id":"369415488037605376","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@wombarrapete @fiouw Orphan designations are based on the seriousness &amp; rarity of the condition, &amp; the existence of alternative treatments.","entities":{"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-19T10:59:22.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"369412501634416640"}],"id":"369413271834476544","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News I thought smallpox was extinct?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-16T12:56:43.000Z","conversation_id":"368349468036694016","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"368349468036694016"}],"id":"368355640340905984","author_id":"362672893","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: New dossier-submission requirements for active-substance master files (ASMFs) into force on 1 September:  http://t.co/AvBfnVV8vw","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/AvBfnVV8vw","expanded_url":"http://bit.ly/13ztmF3","display_url":"bit.ly/13ztmF3"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-14T11:29:00.000Z","conversation_id":"367569934844694528","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"367569934844694528"}],"id":"367608790704988160","author_id":"514255564","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News: The EPAR for #Pomalidomide Celgene for the treatment of #multiplemyeloma is now available on our website: http://t.co/hNq3cnDMUT","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/hNq3cnDMUT","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":24,"end":37,"tag":"Pomalidomide"},{"start":67,"end":83,"tag":"multiplemyeloma"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-14T09:47:08.000Z","conversation_id":"367559740010016768","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"367559740010016768"}],"id":"367583155085389824","author_id":"633978297","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We've published the assessment report for #Pomalidomide Celgene for the treatment of #multiplemyeloma http://t.co/6qTnVcv1gU”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/6qTnVcv1gU","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":54,"end":67,"tag":"Pomalidomide"},{"start":97,"end":113,"tag":"multiplemyeloma"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-13T13:35:40.000Z","conversation_id":"367278045172080641","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"367278045172080641"}],"id":"367278282078957568","author_id":"286245228","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"place_id":"9c61116b741a2d09","coordinates":{"type":"Point","coordinates":[-4.5005,37.4095]}}},{"source":"Twitter for iPad","text":"@EMA_News seeks comments on inventory of #paediatric needs in #nephrourology: consultation open til 14 Nov: http://t.co/Gaad6Bvoft #biotech","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/Gaad6Bvoft","expanded_url":"http://bit.ly/19Ytoxl","display_url":"bit.ly/19Ytoxl"}],"hashtags":[{"start":41,"end":52,"tag":"paediatric"},{"start":62,"end":76,"tag":"nephrourology"},{"start":131,"end":139,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-13T08:41:33.000Z","conversation_id":"367204264525193216","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"367204264525193216","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News seeks comments on inventory of #paediatric needs in #nephrourology: consultation open until 14 Nov: http://t.co/Gaad6Bvoft #pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/Gaad6Bvoft","expanded_url":"http://bit.ly/19Ytoxl","display_url":"bit.ly/19Ytoxl"}],"hashtags":[{"start":41,"end":52,"tag":"paediatric"},{"start":62,"end":76,"tag":"nephrourology"},{"start":133,"end":140,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-13T08:41:04.000Z","conversation_id":"367202918207733761","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"367202918207733761"}],"id":"367204143418851328","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"2 weeks to comment on @EMA_News opinion on new disease progression &amp; trial evaluation model in #Alzheimer's : http://t.co/b0jg0OjpQo #pharma","entities":{"mentions":[{"start":22,"end":31,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/b0jg0OjpQo","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"hashtags":[{"start":99,"end":109,"tag":"Alzheimer"},{"start":137,"end":144,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-13T08:38:50.000Z","conversation_id":"367202214659358720","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"367202214659358720"}],"id":"367203579565989889","author_id":"243228907","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News RT? Economics of Cancer Research Symposium, 2nd September, NUI Galway. http://t.co/kiEfKZ47ZX #EconCancer","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":81,"end":103,"url":"http://t.co/kiEfKZ47ZX","expanded_url":"http://www.conference.ie/Conferences/index.asp?Conference=243","display_url":"conference.ie/Conferences/in…"}],"hashtags":[{"start":104,"end":115,"tag":"EconCancer"}],"annotations":[{"start":14,"end":51,"probability":0.3815,"type":"Other","normalized_text":"Economics of Cancer Research Symposium"},{"start":69,"end":78,"probability":0.453,"type":"Place","normalized_text":"NUI Galway"}],"cashtags":{}},"created_at":"2013-08-12T13:29:47.000Z","conversation_id":"366914410842816513","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"366914410842816513","author_id":"1397042496","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: Our guideline on the pharmaceutical development of medicines for #paediatric use is available:http://t.co/QwqWa0yGvu”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/QwqWa0yGvu","expanded_url":"http://bit.ly/11OPlKp","display_url":"bit.ly/11OPlKp"}],"hashtags":[{"start":77,"end":88,"tag":"paediatric"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-08T14:49:43.000Z","conversation_id":"365479746554961921","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"365479746554961921"}],"id":"365484975186907138","author_id":"296358959","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We've published guidance on the #validation process for initial marketing authorisations: http://t.co/i8v5Ajej3W”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/i8v5Ajej3W","expanded_url":"http://bit.ly/13eIszI","display_url":"bit.ly/13eIszI"}],"hashtags":[{"start":44,"end":55,"tag":"validation"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-05T13:25:27.000Z","conversation_id":"364329684139778048","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"364329684139778048"}],"id":"364376608078958595","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Assessment report for GLP-1 based therapies - http://t.co/vMIvgGeA4T","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/vMIvgGeA4T","expanded_url":"http://goo.gl/noLZgG","display_url":"goo.gl/noLZgG"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-03T11:15:49.000Z","conversation_id":"363619207897817088","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"363619207897817088","author_id":"79702114","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News: Send us your comments on our concept paper on development of product-specific guidance on #bioequivalence: http://t.co/AAQOfbPat8","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/AAQOfbPat8","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":101,"end":116,"tag":"bioequivalence"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-02T13:53:45.000Z","conversation_id":"363210354668474368","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"363210354668474368"}],"id":"363296564825325568","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Our concept paper on development of product-specific guidance on #bioequivalence is open for consultation http://t.co/OdZKvuK2jZ","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/OdZKvuK2jZ","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":77,"end":92,"tag":"bioequivalence"}],"annotations":{},"cashtags":{}},"created_at":"2013-08-01T17:04:20.000Z","conversation_id":"362950721869590528","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"362950721869590528"}],"id":"362982138162847744","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News recommends changes to use of Metoclopramide, aiming to reduce risk of neurological side effects http://t.co/P4ozgPj7mv","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/P4ozgPj7mv","expanded_url":"http://ow.ly/nx3uE","display_url":"ow.ly/nx3uE"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-08-01T13:03:55.000Z","conversation_id":"362921635528982528","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"362921635528982528","author_id":"69232855","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News:published a guideline on using starting materials and intermediates from different sources for biologicals http://t.co/2Ql1KYa04Z","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/2Ql1KYa04Z","expanded_url":"http://bit.ly/18Rdqpp","display_url":"bit.ly/18Rdqpp"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-31T19:50:37.000Z","conversation_id":"362518252104073216","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"362518252104073216"}],"id":"362661597409320960","author_id":"514255564","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@wombarrapete The clock stop is the time that the applicant company has to respond to our questions on the medicine being evaluated.","entities":{"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-30T11:12:31.000Z","conversation_id":"360726350052605952","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"362168665245892608"}],"id":"362168827154399232","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Tnx. As in Belgium approx. 200 (and Holland 300-400) people a year suffered SCDeath, the efficacy should urgently be revealed!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":21,"end":27,"probability":0.9905,"type":"Place","normalized_text":"Belgium"},{"start":46,"end":52,"probability":0.2921,"type":"Place","normalized_text":"Holland"}],"cashtags":{}},"created_at":"2013-07-30T08:53:59.000Z","conversation_id":"360690347334057984","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"362132260981440512"}],"id":"362133960878342145","author_id":"1548804618","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Comment on draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/htSdRfcGvl” #pharma #biotech","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":100,"end":122,"url":"http://t.co/htSdRfcGvl","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":34,"end":52,"tag":"pharmacovigilance"},{"start":124,"end":131,"tag":"pharma"},{"start":132,"end":140,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-29T11:03:44.000Z","conversation_id":"361800660603248640","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"361800660603248640"}],"id":"361804226822807553","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We recommend suspension of marketing authorisations for oral #ketoconazole: http://t.co/szAAUIluit”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/szAAUIluit","expanded_url":"http://bit.ly/13gJEkI","display_url":"bit.ly/13gJEkI"}],"hashtags":[{"start":73,"end":86,"tag":"ketoconazole"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-29T09:51:37.000Z","conversation_id":"361780557295783937","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"361780557295783937"}],"id":"361786079021498368","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We published the CHMP meeting highlights on Friday: http://t.co/uRMNDFhdWr”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":64,"end":86,"url":"http://t.co/uRMNDFhdWr","expanded_url":"http://bit.ly/1bUzNuf","display_url":"bit.ly/1bUzNuf"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-29T09:51:27.000Z","conversation_id":"361780390639312896","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"361780390639312896"}],"id":"361786036554186753","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We recommend changes to the use of #metoclopramide: http://t.co/b73iJYPjAv” dosis máxima 30mg/día.","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":64,"end":86,"url":"http://t.co/b73iJYPjAv","expanded_url":"http://bit.ly/1dZrdXF","display_url":"bit.ly/1dZrdXF"}],"hashtags":[{"start":47,"end":62,"tag":"metoclopramide"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-26T19:08:23.000Z","conversation_id":"360690347334057984","possibly_sensitive":false,"lang":"es","referenced_tweets":[{"type":"replied_to","id":"360690347334057984"}],"id":"360839031203962880","author_id":"917639060","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News raccomanda sospensione dell'AIC per medicinali contenenti #ketoconazolo orale http://t.co/3NzEla1pfV","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/3NzEla1pfV","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/comunicato-stampa-ema-sulla-raccomandazione-di-sospensione-delle-autorizzazioni-allimmission","display_url":"agenziafarmaco.gov.it/it/content/com…"}],"hashtags":[{"start":68,"end":81,"tag":"ketoconazolo"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-26T13:13:14.000Z","conversation_id":"360749655644053506","possibly_sensitive":false,"lang":"it","referenced_tweets":{},"id":"360749655644053506","author_id":"441940097","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News CHMP gives @Boehringer Ingelheim's #Afatinib positive opinion for patients with EGFR mutation positive lung #cancer in #EU #pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":21,"end":32,"username":"Boehringer","id":"17437735"}],"urls":{},"hashtags":[{"start":45,"end":54,"tag":"Afatinib"},{"start":118,"end":125,"tag":"cancer"},{"start":129,"end":132,"tag":"EU"},{"start":133,"end":140,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-26T12:34:23.000Z","conversation_id":"360739877756743683","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"360739877756743683","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"MT but stay tuned... “@EMA_News: No new concerns for #GLP-1 therapies identified on the basis of available evidence: http://t.co/NDpREyHBNE”","entities":{"mentions":[{"start":22,"end":31,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/NDpREyHBNE","expanded_url":"http://bit.ly/15PIQqa","display_url":"bit.ly/15PIQqa"}],"hashtags":[{"start":53,"end":57,"tag":"GLP"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-26T11:42:00.000Z","conversation_id":"360689641986338816","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"360689641986338816"}],"id":"360726692316188673","author_id":"1535265686","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News and when for #domperidone?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":23,"end":35,"tag":"domperidone"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-26T09:56:07.000Z","conversation_id":"360690347334057984","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"360690347334057984"}],"id":"360700049375772672","author_id":"1548804618","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News great step forward for the collective industry, and importantly patients. Check out our response http://t.co/MiZczSHigw","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/MiZczSHigw","expanded_url":"http://ow.ly/ngszi","display_url":"ow.ly/ngszi"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-24T12:19:21.000Z","conversation_id":"360011317425352705","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"360011317425352705","author_id":"525779070","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Two more weeks to comment on draft good #pharmacovigilance practice module: risk-minimisation measures: http://t.co/1yHo4t0nxN”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/1yHo4t0nxN","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":52,"end":70,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-22T13:45:58.000Z","conversation_id":"359224104353660931","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"359224104353660931"}],"id":"359308341148786688","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: PRAC: one year of public health promotion and protection: http://t.co/5ENbIxTLA2” #PtSafety","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":70,"end":92,"url":"http://t.co/5ENbIxTLA2","expanded_url":"http://bit.ly/14mS686","display_url":"bit.ly/14mS686"}],"hashtags":[{"start":94,"end":103,"tag":"PtSafety"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-19T16:12:34.000Z","conversation_id":"358254805031981057","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"358254805031981057"}],"id":"358258071258136577","author_id":"216527950","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News love you guys. Thank you for answering my e-mail, really really helpful :))","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-19T14:46:34.000Z","conversation_id":"358236425486991360","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"358236425486991360","author_id":"31437646","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Published  guideline on medicines for the treatment of urinary #incontinence: http://t.co/gKg5clasEz @EMA_News","entities":{"mentions":[{"start":101,"end":110,"username":"EMA_News","id":"116716199"}],"urls":[{"start":78,"end":100,"url":"http://t.co/gKg5clasEz","expanded_url":"http://bit.ly/15saNnQ","display_url":"bit.ly/15saNnQ"}],"hashtags":[{"start":63,"end":76,"tag":"incontinence"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-19T10:37:45.000Z","conversation_id":"358172232842887170","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"358172232842887170"}],"id":"358173811453071360","author_id":"158105629","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News extendeds public consultation on inventory of #paediatric needs to 26 July - one week to comment: http://t.co/K7asXZLQoh” #pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/K7asXZLQoh","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":56,"end":67,"tag":"paediatric"},{"start":132,"end":139,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-19T08:24:18.000Z","conversation_id":"358136462316806144","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"358136462316806144"}],"id":"358140227585441792","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Next week is the July #CHMP meeting. We're publishing the main outcomes on Friday: http://t.co/p7sD8SqNac” who winners &amp; losers?","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/p7sD8SqNac","expanded_url":"http://bit.ly/1bNmfiH","display_url":"bit.ly/1bNmfiH"}],"hashtags":[{"start":34,"end":39,"tag":"CHMP"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-19T08:22:12.000Z","conversation_id":"358137291010609152","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"358137291010609152"}],"id":"358139696796278785","author_id":"243228907","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Next week is the July #CHMP meeting. We're publishing the main outcomes on Friday: http://t.co/p7sD8SqNac” #pharma #biotech","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/p7sD8SqNac","expanded_url":"http://bit.ly/1bNmfiH","display_url":"bit.ly/1bNmfiH"}],"hashtags":[{"start":34,"end":39,"tag":"CHMP"},{"start":119,"end":126,"tag":"pharma"},{"start":127,"end":135,"tag":"biotech"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-19T08:21:45.000Z","conversation_id":"358137291010609152","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"358137291010609152"}],"id":"358139583667511296","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: From 4 Aug, marketing-authorisation holders will need to use updated application forms for variations: http://t.co/psIf9igBfG","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/psIf9igBfG","expanded_url":"http://bit.ly/18obr8n","display_url":"bit.ly/18obr8n"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-19T08:15:56.000Z","conversation_id":"358135964813635586","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"358135964813635586"}],"id":"358138119104626688","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News Really looking forward to #paediatric #drug development workshop in Nov with @SIOPEurope, #BDA and #encca. http://t.co/9v5NhzKx31","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":87,"end":98,"username":"SIOPEurope","id":"378478769"}],"urls":[{"start":117,"end":139,"url":"http://t.co/9v5NhzKx31","expanded_url":"http://bit.ly/1bL3E6I","display_url":"bit.ly/1bL3E6I"}],"hashtags":[{"start":36,"end":47,"tag":"paediatric"},{"start":48,"end":53,"tag":"drug"},{"start":100,"end":104,"tag":"BDA"},{"start":109,"end":115,"tag":"encca"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-19T07:22:22.000Z","conversation_id":"358124638120849408","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"358124638120849408","author_id":"378478769","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"We are now able to publish content to our website again. We're just ironing out the last few problems with documents already published.","entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-18T09:06:02.000Z","conversation_id":"357502255412428802","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"357506635725406208"}],"id":"357788342265462784","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"The website is live again now. Please bear with us while we continue to work on our technical problems.","entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-17T14:26:38.000Z","conversation_id":"357502255412428802","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"357502255412428802"}],"id":"357506635725406208","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News recommends variation to terms of mkting auth. for Panitumumab metastatic #colorectalcancer http://t.co/p9NJPUiFgr","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":101,"end":123,"url":"http://t.co/p9NJPUiFgr","expanded_url":"http://ow.ly/n2GZp","display_url":"ow.ly/n2GZp"}],"hashtags":[{"start":83,"end":100,"tag":"colorectalcancer"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-17T10:18:31.000Z","conversation_id":"357444194794618881","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"357444194794618881","author_id":"69232855","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News #COMP gives +ve nod to Alexion neuromyelitis optica treatment candidate Soliris eculizumab as orphan medicinal product designation","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"COMP"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-16T16:47:45.000Z","conversation_id":"357179757982523394","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"357179757982523394","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Our website is now back up and running. Apologies for the inconvenience.” Phew! Don't know how I would manage without this now.","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-16T11:02:15.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"357091472404774912"}],"id":"357092813462188033","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"Our website is now back up and running. Apologies for the inconvenience.","entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-16T10:56:56.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"356805472726163457"}],"id":"357091472404774912","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"Our website will be down until at least tomorrow morning because of ongoing technical problems. We apologise for the inconvenience.","entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-15T16:00:28.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"356766910630735872"}],"id":"356805472726163457","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"We've had to take our website down temporarily while we try to resolve the problems we're having. Apologies for the inconvenience.","entities":{"mentions":{},"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-15T13:27:14.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"356739492599701504"}],"id":"356766910630735872","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We're organising webinars to train applicants on electronic submission of single-assessment #PSURs: http://t.co/H00P15ZaT2”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/H00P15ZaT2","expanded_url":"http://bit.ly/12ojoct","display_url":"bit.ly/12ojoct"}],"hashtags":[{"start":104,"end":110,"tag":"PSURs"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-11T11:29:33.000Z","conversation_id":"355271290992607232","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355271290992607232"}],"id":"355287743867265025","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@trinevillemann As Stamaril is authorised nationally the issue would need to be officially referred to us. See: http://t.co/y7P9Z9gMFL","entities":{"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"urls":[{"start":112,"end":134,"url":"http://t.co/y7P9Z9gMFL","expanded_url":"http://bit.ly/133cMvv","display_url":"bit.ly/133cMvv"}],"hashtags":{},"annotations":[{"start":19,"end":26,"probability":0.3232,"type":"Organization","normalized_text":"Stamaril"}],"cashtags":{}},"created_at":"2013-07-11T10:32:55.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355269226325479426"}],"id":"355273489130856448","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Stamaril IS marketed in Greece. More than 20   reported AE's in the past 10 years! Will the EMA look into this?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":34,"end":39,"probability":0.988,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-11T10:09:08.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355265970102738944"}],"id":"355267503389286400","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News and since 2006  Stamaril has not  been regulated by the EMA in Greece ?Without the public knowing about it?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":26,"end":33,"probability":0.2951,"type":"Person","normalized_text":"Stamaril"},{"start":73,"end":78,"probability":0.9944,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-11T10:00:51.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355261524983549952"}],"id":"355265419902320643","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News so in  Greece Stamaril vaccine is not sold  and administered according to EMA rules and regulations?EOF not replying to emails.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":17,"end":22,"probability":0.973,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-11T09:58:00.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355258657795084288"}],"id":"355264705377468416","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News has no  Greek marketing authorisation holder been added to the referral after  2006?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-11T09:44:43.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355258468476788736"}],"id":"355261359857991680","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News a simple yes or no will do. Does EMA know who or which entity holds the martketing license for Stamaril in Greece?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":117,"end":122,"probability":0.9873,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-11T09:32:06.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355257027993411584"}],"id":"355258184644050945","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News ok, but why do you have all the other EU marketing license holders listed for Stamaril, but  not Greece?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":48,"end":49,"probability":0.6474,"type":"Organization","normalized_text":"EU"},{"start":107,"end":112,"probability":0.9722,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-11T09:23:56.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355254581632049154"}],"id":"355256131406405632","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News I know Stamaril does not have panEuropean license. Does EMA not know who has marketing license for Stamaril in Greece?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":17,"end":24,"probability":0.5584,"type":"Person","normalized_text":"Stamaril"},{"start":109,"end":116,"probability":0.324,"type":"Person","normalized_text":"Stamaril"},{"start":121,"end":126,"probability":0.9932,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-11T09:11:12.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355250683731128321"}],"id":"355252926798766080","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"@EMA_News should EMA not know who holds marketing authorisation for Stamaril in Greece like it knows for other EU-countries?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":80,"end":85,"probability":0.9934,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-11T08:59:26.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355243854540177408"}],"id":"355249962784784385","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News why is Greece not on EMA's list over EU Stamaril marketing authorisation holders?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":17,"end":22,"probability":0.9739,"type":"Place","normalized_text":"Greece"},{"start":31,"end":33,"probability":0.3919,"type":"Organization","normalized_text":"EMA"},{"start":47,"end":57,"probability":0.3584,"type":"Organization","normalized_text":"EU Stamaril"}],"cashtags":{}},"created_at":"2013-07-10T17:29:26.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355000975758606340"}],"id":"355015922769068032","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Thanks. I will. @WHO","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":30,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-10T16:52:30.000Z","conversation_id":"354573717747142657","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355003675850190850"}],"id":"355006626157178880","author_id":"40722651","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@trinevillemann Otherwise, try contacting the Greek medicines agency directly at relation@eof.gr for more info on the Greek authorisation.","entities":{"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-10T16:30:02.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"355000370117869568"}],"id":"355000975758606340","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"RT @EMA_News European Medicines Agency creates #Healthcare Professionals’ Working Party: http://t.co/Gx9pGjpMUK @vdgmeu","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"},{"start":112,"end":119,"username":"vdgmeu","id":"349775607"}],"urls":[{"start":89,"end":111,"url":"http://t.co/Gx9pGjpMUK","expanded_url":"http://bit.ly/13IQndb","display_url":"bit.ly/13IQndb"}],"hashtags":[{"start":47,"end":58,"tag":"Healthcare"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-10T08:25:13.000Z","conversation_id":"354607016880246785","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"354607016880246785"}],"id":"354878964415725568","author_id":"13636102","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News comment? | @WHO Until e-cigarettes are approved by competent regulatory body, consumers should be sadvised not to use them","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":21,"end":25,"username":"WHO","id":"14499829"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-09T12:12:16.000Z","conversation_id":"354573717747142657","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"354573717747142657","author_id":"40722651","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: One more week to apply for #vacancy #scientist to work in #quality of medicines. Deadline: 12 July 2013: http://t.co/t4leDuI6Js”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/t4leDuI6Js","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":39,"end":47,"tag":"vacancy"},{"start":48,"end":58,"tag":"scientist"},{"start":70,"end":78,"tag":"quality"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-05T16:20:05.000Z","conversation_id":"353163724019859457","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"353163724019859457"}],"id":"353186531147653120","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News Aperte le iscrizioni per il workshop EMA sul #conflitto di #interessi del 6 settembre 2013 http://t.co/XQkJnS2W8T","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":101,"end":123,"url":"http://t.co/XQkJnS2W8T","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/07/news_detail_001842.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":55,"end":65,"tag":"conflitto"},{"start":69,"end":79,"tag":"interessi"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-05T15:30:23.000Z","conversation_id":"353174023116566529","possibly_sensitive":false,"lang":"it","referenced_tweets":{},"id":"353174023116566529","author_id":"441940097","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News workshop on 'Best expertise vs conflicts of interests: Striking the right balance’ 6 Sept 13. Sign up here http://t.co/sSOcMvID8k","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/sSOcMvID8k","expanded_url":"http://bit.ly/18AnKRo","display_url":"bit.ly/18AnKRo"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-05T14:14:39.000Z","conversation_id":"353154963242881024","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"353154963242881024","author_id":"113148426","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News thanks! Already wrote an e-mail. Now waiting for the reply :)","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-05T13:13:30.000Z","conversation_id":"353139575587225601","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"353139575587225601","author_id":"31437646","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: draft concept paper on manufacture of the finished dosage form-open for consultation until 31 Dec 2013: http://t.co/tHp5huYep5”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/tHp5huYep5","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-04T16:22:45.000Z","conversation_id":"352801590698188800","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"352801590698188800"}],"id":"352824816031641601","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Concept paper on manufacture of the finished dosage form open for consultation: http://t.co/tHp5huYep5”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":92,"end":114,"url":"http://t.co/tHp5huYep5","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-04T10:31:03.000Z","conversation_id":"352720304407187456","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"352720304407187456"}],"id":"352736304968122368","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News Hi, can you please send me an e-mail address where I could ask you a question regarding residue depletion studies for VMP? Thx :)","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-07-03T17:03:47.000Z","conversation_id":"352472750625001472","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"352472750625001472","author_id":"31437646","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: #Falsified medicines directive requires written confirmation for importation of active substances http://t.co/XRROXbt8X2”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/XRROXbt8X2","expanded_url":"http://bit.ly/1cM8jTx","display_url":"bit.ly/1cM8jTx"}],"hashtags":[{"start":12,"end":22,"tag":"Falsified"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-02T18:26:59.000Z","conversation_id":"352052775942762496","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"352052775942762496"}],"id":"352131302050373632","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We welcome #croatia to the European medicines network http://t.co/tvm51CvY66”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":66,"end":88,"url":"http://t.co/tvm51CvY66","expanded_url":"http://bit.ly/11XW7KA","display_url":"bit.ly/11XW7KA"}],"hashtags":[{"start":23,"end":31,"tag":"croatia"}],"annotations":{},"cashtags":{}},"created_at":"2013-07-01T15:59:50.000Z","conversation_id":"351649135897751554","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"351649135897751554"}],"id":"351731882578296834","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News The conclusion being that it seems not possible to come to a conclusion based on traditional use of Sambucus niger, sounds OK.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":110,"end":123,"probability":0.235,"type":"Place","normalized_text":"Sambucus niger"}],"cashtags":{}},"created_at":"2013-07-01T10:38:20.000Z","conversation_id":"351649801722531841","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"351649801722531841"}],"id":"351650974588354561","author_id":"1238217276","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News who holds  marketing authorisation for Stamaril vaccine in Greece?  It's not on EMA's list -  yet vaccine is available in Greece.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":69,"end":74,"probability":0.9906,"type":"Place","normalized_text":"Greece"},{"start":132,"end":137,"probability":0.9884,"type":"Place","normalized_text":"Greece"}],"cashtags":{}},"created_at":"2013-07-01T10:16:18.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"351645431878520835","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"RT “@EMA_News: We've just published the CHMP highlights: http://t.co/4gMal2vGjn”","entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":57,"end":79,"url":"http://t.co/4gMal2vGjn","expanded_url":"http://bit.ly/14BLwar","display_url":"bit.ly/14BLwar"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-29T04:47:37.000Z","conversation_id":"350581290778624000","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350581290778624000"}],"id":"350837939867107328","author_id":"266609916","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Two days left to comment on @ICH_news guideline #mutagenic impurities in medicines &amp; #carcinogenic risk: http://t.co/xv9yoZ06pI","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":40,"end":49,"username":"ICH_news","id":"305434870"}],"urls":[{"start":121,"end":143,"url":"http://t.co/xv9yoZ06pI","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":60,"end":70,"tag":"mutagenic"},{"start":101,"end":114,"tag":"carcinogenic"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-28T18:01:47.000Z","conversation_id":"350572777423634432","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350572777423634432"}],"id":"350675408452198400","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Concept paper on statistical methodology - comparative assessment of quality attributes - consultation: http://t.co/ZaXwOKyMoV","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/ZaXwOKyMoV","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-28T17:42:52.000Z","conversation_id":"350616162826059777","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350616162826059777"}],"id":"350670650639257600","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News issues guidance on the use of codeine in children and diclofenac-containing medicines http://t.co/nntftEN97E #pharma #regulation","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/nntftEN97E","expanded_url":"http://bit.ly/19CQCd5","display_url":"bit.ly/19CQCd5"}],"hashtags":[{"start":119,"end":126,"tag":"pharma"},{"start":127,"end":138,"tag":"regulation"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-28T16:00:36.000Z","conversation_id":"350644910640209921","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"350644910640209921","author_id":"71542880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We've recommended approval of the first two #monoclonalantibody #biosimilars - #Remsima and #Inflectra: http://t.co/SdEd2pTX0h”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/SdEd2pTX0h","expanded_url":"http://bit.ly/10p8uBN","display_url":"bit.ly/10p8uBN"}],"hashtags":[{"start":56,"end":75,"tag":"monoclonalantibody"},{"start":76,"end":88,"tag":"biosimilars"},{"start":91,"end":99,"tag":"Remsima"},{"start":104,"end":114,"tag":"Inflectra"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-28T13:57:02.000Z","conversation_id":"350581781545762817","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350581781545762817"}],"id":"350613814154244096","author_id":"43617900","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We've recommended approval of the first two #monoclonalantibody #biosimilars - #Remsima and #Inflectra: http://t.co/iofrhXPIZc”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/iofrhXPIZc","expanded_url":"http://bit.ly/10p8uBN","display_url":"bit.ly/10p8uBN"}],"hashtags":[{"start":56,"end":75,"tag":"monoclonalantibody"},{"start":76,"end":88,"tag":"biosimilars"},{"start":91,"end":99,"tag":"Remsima"},{"start":104,"end":114,"tag":"Inflectra"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-28T12:50:30.000Z","conversation_id":"350581781545762817","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350581781545762817"}],"id":"350597071419609089","author_id":"498073573","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News CHMP recommends 10 new meds Remsima, Inflectra, Provenge, Tafinlar, Stivarga, Procysbi, Lemtrada, Cholib, Nexium Control, Evarrest","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-28T12:21:41.000Z","conversation_id":"350589822043295745","possibly_sensitive":false,"lang":"ca","referenced_tweets":{},"id":"350589822043295745","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Janetter","text":"6/28CHMP翌29　20：47 RT @EMA_News We've just published the CHMP highlights: http://t.co/o6eHD7rhIa","entities":{"mentions":[{"start":21,"end":30,"username":"EMA_News","id":"116716199"}],"urls":[{"start":73,"end":95,"url":"http://t.co/o6eHD7rhIa","expanded_url":"http://bit.ly/14BLwar","display_url":"bit.ly/14BLwar"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-28T11:49:12.000Z","conversation_id":"350581290778624000","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350581290778624000"}],"id":"350581646690500608","author_id":"115898830","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News recommends Remsima &amp; Inflectra (Remicade #biosimilars) use in a range of autoimmune diseases ie RA, Crohn’s ulcerative colitis etc","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":55,"end":67,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-28T11:48:24.000Z","conversation_id":"350581443325476864","possibly_sensitive":false,"lang":"ro","referenced_tweets":{},"id":"350581443325476864","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: Tomorrow some of our IT systems will be unavailable due to maintenance.: http://t.co/SZDmhEzgHS” här kan man lära förvarning","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":85,"end":107,"url":"http://t.co/SZDmhEzgHS","expanded_url":"http://bit.ly/13d10Vh","display_url":"bit.ly/13d10Vh"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-28T11:31:48.000Z","conversation_id":"350571882807959554","possibly_sensitive":false,"lang":"sv","referenced_tweets":[{"type":"replied_to","id":"350571882807959554"}],"id":"350577267656765443","author_id":"26791880","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Android","text":"@EMA_News  Remsima approved?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-28T09:38:45.000Z","conversation_id":"350546504722812928","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350546504722812928"}],"id":"350548817638195200","author_id":"1545818551","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":".@EMA_News @BushbyKate @EUnetHTA great collaboration, but EU starts meds down the orphan path, should make sure they reach their destination","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":11,"end":22,"username":"BushbyKate","id":"1216228962"},{"start":23,"end":32,"username":"EUnetHTA","id":"56493220"}],"urls":{},"hashtags":{},"annotations":[{"start":58,"end":59,"probability":0.3568,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"created_at":"2013-06-27T10:32:48.000Z","conversation_id":"350191962692919298","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350196209417322497"}],"id":"350200032403800064","author_id":"325032216","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @paulinemacco indeed but concerted action needed at some level- greater harmonisation of HTA welcome","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"paulinemacco","id":"325032216"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-27T10:14:32.000Z","conversation_id":"350191962692919298","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"350194869676945408"}],"id":"350195436017041408","author_id":"1216228962","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News releases for public consultation its draft policy on the publication and access to clinical-trial data http://t.co/4Uwn6obTD5","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/4Uwn6obTD5","expanded_url":"http://ow.ly/mp9y3","display_url":"ow.ly/mp9y3"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-26T14:32:06.000Z","conversation_id":"349897865306439680","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"349897865306439680","author_id":"1299022237","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News publishes guidance on how to submit single-assessment periodic safety update reports (#PSURs): http://t.co/uwIiP3DZL3” #pharma","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/uwIiP3DZL3","expanded_url":"http://bit.ly/12kOP2p","display_url":"bit.ly/12kOP2p"}],"hashtags":[{"start":97,"end":103,"tag":"PSURs"},{"start":130,"end":137,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-25T23:18:30.000Z","conversation_id":"349447228785573888","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"349447228785573888"}],"id":"349667948446744577","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"LinkedIn","text":"@EMA_News proposes 3 categories of access to clinical trial data #pharma #hcsmeu #alltrials via @pmlive http://t.co/MvL5idqAbV","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":96,"end":103,"username":"PMLIVE","id":"23783432"}],"urls":[{"start":104,"end":126,"url":"http://t.co/MvL5idqAbV","expanded_url":"http://lnkd.in/pMuP76","display_url":"lnkd.in/pMuP76"}],"hashtags":[{"start":65,"end":72,"tag":"pharma"},{"start":73,"end":80,"tag":"hcsmeu"},{"start":81,"end":91,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-25T12:33:39.000Z","conversation_id":"349505668228718593","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"349505668228718593","author_id":"16579894","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"Good news here! “@EMA_News: @EU_Commission has published its report on 5 years of the #Paediatric Regulation: http://t.co/q8xFonW3Xn”","entities":{"mentions":[{"start":17,"end":26,"username":"EMA_News","id":"116716199"},{"start":28,"end":42,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":110,"end":132,"url":"http://t.co/q8xFonW3Xn","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":[{"start":86,"end":97,"tag":"Paediatric"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-25T12:19:11.000Z","conversation_id":"349446946383069185","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"349446946383069185"}],"id":"349502028596252672","author_id":"1497946333","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News und #BfArM betreiben das Verbot einer Standardarznei bei Operationen, eine Alternative fehlt #HES http://t.co/6l7PcRncp4","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/6l7PcRncp4","expanded_url":"http://spon.de/adYfB","display_url":"spon.de/adYfB"}],"hashtags":[{"start":14,"end":20,"tag":"BfArM"},{"start":103,"end":107,"tag":"HES"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-25T11:47:50.000Z","conversation_id":"349494139974459392","possibly_sensitive":false,"lang":"de","referenced_tweets":{},"id":"349494139974459392","author_id":"17994531","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News publishes guidance on how to submit single-assessment periodic safety update reports (#PSURs): http://t.co/uwIiP3DZL3” #pharma","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/uwIiP3DZL3","expanded_url":"http://bit.ly/12kOP2p","display_url":"bit.ly/12kOP2p"}],"hashtags":[{"start":97,"end":103,"tag":"PSURs"},{"start":130,"end":137,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-25T08:45:34.000Z","conversation_id":"349447228785573888","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"349447228785573888"}],"id":"349448269996371968","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: European Commission has just published its report on Paediatric Regulation: http://t.co/k7QgRXPUvT”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/k7QgRXPUvT","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":{},"annotations":[{"start":12,"end":30,"probability":0.6895,"type":"Organization","normalized_text":"European Commission"},{"start":65,"end":85,"probability":0.4434,"type":"Other","normalized_text":"Paediatric Regulation"}],"cashtags":{}},"created_at":"2013-06-24T16:10:39.000Z","conversation_id":"349152739596570624","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"349152739596570624"}],"id":"349197892373860352","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News launches consultation on publication and access policy to data of #clinicaltrials Deadline: 30 September, http://t.co/0rgGwIA4ui","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/0rgGwIA4ui","expanded_url":"http://bit.ly/12ZDR8B","display_url":"bit.ly/12ZDR8B"}],"hashtags":[{"start":76,"end":91,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-24T14:42:08.000Z","conversation_id":"349175612302307329","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"349175612302307329","author_id":"784869524","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @AEMPSGOB: Information day on new good distribution practice for human medicines http://t.co/0ZOdxJPnB2”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":24,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":96,"end":118,"url":"http://t.co/0ZOdxJPnB2","expanded_url":"http://www.aemps.gob.es/eventosCongresos/inspe-Farma/2013/J_buena-practica-distribucion.htm","display_url":"aemps.gob.es/eventosCongres…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-20T18:56:16.000Z","conversation_id":"347708905595469824","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"347708905595469824"}],"id":"347790018338750466","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News: 6 #raccomandazioni per sconfiggere gli #errori medici\n  http://t.co/zll4Tya84X","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":67,"end":89,"url":"http://t.co/zll4Tya84X","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2013%2F05%2Fnews_detail_001796.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":13,"end":29,"tag":"raccomandazioni"},{"start":50,"end":57,"tag":"errori"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-20T13:22:30.000Z","conversation_id":"347706024293183488","possibly_sensitive":false,"lang":"it","referenced_tweets":{},"id":"347706024293183488","author_id":"137349917","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_news &amp; @ICH_news – ICH M7 being discussed @Informa_LS GTI conference (#GTI2013). The audience is being encouraged to submit comments","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":25,"username":"ICH_news","id":"305434870"},{"start":51,"end":62,"username":"Informa_LS","id":"63136204"}],"urls":{},"hashtags":[{"start":79,"end":87,"tag":"GTI2013"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-19T09:52:47.000Z","conversation_id":"347290859802357760","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"347290859802357760","author_id":"482482613","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News recommends suspending marketing authorisation on hydroxyethyl-starch (HES), as risks outweigh the benefits http://t.co/73VPgHqHJh","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/73VPgHqHJh","expanded_url":"http://bit.ly/19MjCy6","display_url":"bit.ly/19MjCy6"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-18T09:42:08.000Z","conversation_id":"346925790396559361","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"346925790396559361","author_id":"1114124408","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News Management board endorses revised EMA Code of Conduct. Board also discusses future challenges of the European #medicines network","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":120,"end":130,"tag":"medicines"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-17T19:33:19.000Z","conversation_id":"346712177312423936","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"346712177312423936","author_id":"243228907","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: PRAC recommends the same cardiovascular precautions for #diclofenac as for selective COX-2 inhibitors: http://t.co/6GVcnb847e”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/6GVcnb847e","expanded_url":"http://bit.ly/ZOnpVU","display_url":"bit.ly/ZOnpVU"}],"hashtags":[{"start":68,"end":79,"tag":"diclofenac"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-15T09:31:30.000Z","conversation_id":"345509336476418048","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"345509336476418048"}],"id":"345835950716375040","author_id":"216527950","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: PRAC recommends restricting the use of #codeine when used for pain relief in children: http://t.co/fF1d1EtrI2” #PtSafety","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/fF1d1EtrI2","expanded_url":"http://bit.ly/153cYMW","display_url":"bit.ly/153cYMW"}],"hashtags":[{"start":51,"end":59,"tag":"codeine"},{"start":123,"end":132,"tag":"PtSafety"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-15T09:31:17.000Z","conversation_id":"345510439532261376","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"345510439532261376"}],"id":"345835896353980416","author_id":"216527950","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @docdu16 \"utiliser la codéine uniquement si bénéfices&gt;risques\" #AhBaDaccordAlors Alternative dans les GS herpétique?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"docdu16","id":"292158149"}],"urls":{},"hashtags":[{"start":76,"end":93,"tag":"AhBaDaccordAlors"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-14T13:42:10.000Z","conversation_id":"345510439532261376","possibly_sensitive":false,"lang":"fr","referenced_tweets":[{"type":"replied_to","id":"345510439532261376"}],"id":"345536644931284992","author_id":"956329627","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: PRAC recommends suspending marketing authorisations for #hydroxyethylstarch solutions: http://t.co/59zPl0dnuV” &lt;-- excellent!","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/59zPl0dnuV","expanded_url":"http://bit.ly/10hNhfb","display_url":"bit.ly/10hNhfb"}],"hashtags":[{"start":68,"end":87,"tag":"hydroxyethylstarch"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-14T12:07:43.000Z","conversation_id":"345511231257448448","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"345511231257448448"}],"id":"345512875894382592","author_id":"292400876","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":2,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @sanidadgob Reform of medicine laws will offer more safety to citizens &amp; eliminate falsified medicines http://t.co/gQMpVAmiaa","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":26,"username":"sanidadgob","id":"232124120"}],"urls":[{"start":122,"end":144,"url":"http://t.co/gQMpVAmiaa","expanded_url":"http://msssi.es/gabinete/notas","display_url":"msssi.es/gabinete/notas"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-13T13:23:31.000Z","conversation_id":"345156426169200640","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"345156426169200640"}],"id":"345169561328418817","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: We're looking to #recruit a #scientist working in #quality of medicines. Apply by 12 July 2013: http://t.co/t4leDuI6Js #vacancy”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/t4leDuI6Js","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":29,"end":37,"tag":"recruit"},{"start":40,"end":50,"tag":"scientist"},{"start":62,"end":70,"tag":"quality"},{"start":131,"end":139,"tag":"vacancy"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-12T16:45:03.000Z","conversation_id":"344843319605600256","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"344843319605600256"}],"id":"344857891393658882","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: RT @AEMPSGOB: Problems with the supply of the medicine Epanutin (phenytoin) http://t.co/TIBayoFucr”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":24,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":88,"end":110,"url":"http://t.co/TIBayoFucr","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/problemasSuministro/2013/NI-AEMPS_07-2013-epanutin.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-12T16:43:42.000Z","conversation_id":"344844560914059265","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"344844560914059265"}],"id":"344857554456805376","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"TweetDeck","text":"@EMA_News  @the_prbb  @HSJDBCN @idibaps_es La immunologia dels trasplantaments, dimecres 19:00, c/Tuset 5, info@ http://t.co/pk4QyiZWj2","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":20,"username":"the_prbb","id":"123864717"},{"start":22,"end":30,"username":"HSJDBCN","id":"756505452515512324"}],"urls":[{"start":113,"end":135,"url":"http://t.co/pk4QyiZWj2","expanded_url":"http://ccimmunologia.wordpress.com/","display_url":"ccimmunologia.wordpress.com"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-11T09:59:01.000Z","conversation_id":"344393322284072960","possibly_sensitive":false,"lang":"ca","referenced_tweets":{},"id":"344393322284072960","author_id":"317401291","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News: published a revised guideline on #biosimilars containing biotechnology-derived proteins for consultation: http://t.co/2GVooYdHVW”","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/2GVooYdHVW","expanded_url":"http://bit.ly/15PEmjK","display_url":"bit.ly/15PEmjK"}],"hashtags":[{"start":44,"end":56,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-10T19:55:16.000Z","conversation_id":"344027796827426816","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"344027796827426816"}],"id":"344180985660833793","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Safari on iOS","text":"@EMA_News looking for digital consultancy for web design projects. Can you help us deliver health info to Europe? http://t.co/YZ9BYgb8qZ","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/YZ9BYgb8qZ","expanded_url":"http://ted.europa.eu/udl?uri=TED:NOTICE:185519-2013:TEXT:EN:HTML&src=0","display_url":"ted.europa.eu/udl?uri=TED:NO…"}],"hashtags":{},"annotations":[{"start":106,"end":111,"probability":0.9901,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"created_at":"2013-06-10T08:06:05.000Z","conversation_id":"344002513680363520","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"344002513680363520","author_id":"113148426","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"“@EMA_News: RT @AEMPSGOB: Tetrazepam (Myolastan): suspension of marketing http://t.co/Tu2jqRDfFr”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":24,"username":"AEMPSGOB","id":"326845755"}],"urls":[{"start":74,"end":96,"url":"http://t.co/Tu2jqRDfFr","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_15-2013-myolastan.htm","display_url":"aemps.gob.es/informa/notasI…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-07T14:26:46.000Z","conversation_id":"343002267152171008","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"343002267152171008"}],"id":"343011152076341250","author_id":"122015101","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"MT @EMA_News @eunethta and EMA met to discuss how regulators and HTA bodies can work together: http://t.co/Le79QcE0Kv good for #raredisease","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"},{"start":13,"end":22,"username":"EUnetHTA","id":"56493220"}],"urls":[{"start":95,"end":117,"url":"http://t.co/Le79QcE0Kv","expanded_url":"http://bit.ly/11J4l7U","display_url":"bit.ly/11J4l7U"}],"hashtags":[{"start":127,"end":139,"tag":"raredisease"}],"annotations":[{"start":27,"end":29,"probability":0.4069,"type":"Person","normalized_text":"EMA"}],"cashtags":{}},"created_at":"2013-06-07T09:45:27.000Z","conversation_id":"342935076029485056","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"342935076029485056"}],"id":"342940356700168192","author_id":"1216228962","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: #pharmacovigilance legislation apply centrally authorised medicines: new notification requirements: http://t.co/OXTa3RbuF6”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/OXTa3RbuF6","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":12,"end":30,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-06T09:51:59.000Z","conversation_id":"342557249912311808","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"342557249912311808"}],"id":"342579614188711936","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: New notification requirements for companies now apply, amendments to the #pharmacovigilance legislation: http://t.co/OXTa3RbuF6”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/OXTa3RbuF6","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":85,"end":103,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-05T20:23:59.000Z","conversation_id":"342303913128632320","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"342303913128632320"}],"id":"342376274242719744","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Hootsuite","text":"@EMA_News, @3NT, @Annals_Oncology, @BairdAM, @oncology23, @jrgralow, @drseisenberg, @aftimosp, @mlazqui Tx for yr RTs/Mts!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":15,"username":"3NT","id":"228845995"},{"start":17,"end":33,"username":"Annals_Oncology","id":"44614314"},{"start":35,"end":43,"username":"BairdAM","id":"912929083"},{"start":45,"end":56,"username":"oncology23","id":"125456212"},{"start":58,"end":67,"username":"jrgralow","id":"330036521"},{"start":69,"end":82,"username":"drseisenberg","id":"170039453"},{"start":84,"end":93,"username":"aftimosp","id":"177176270"},{"start":95,"end":103,"username":"mlazqui","id":"196132848"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-05T14:55:22.000Z","conversation_id":"342293576673271809","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"342293576673271809","author_id":"69232855","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Have now emailed  copies of  2 emails, your office never replied to. Please check your inbox - maybe also your spamfolder.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-05T14:33:52.000Z","conversation_id":"342270891427782656","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"342278031471149056"}],"id":"342288163445800961","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News Very strange. I will send my questions again.","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-05T14:00:08.000Z","conversation_id":"342270891427782656","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"342278031471149056"}],"id":"342279673323081728","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News why does your press office NEVER reply to emails?Does all media get that treatment or is it just me?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-05T13:34:47.000Z","conversation_id":"342270891427782656","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"342270891427782656"}],"id":"342273297259569153","author_id":"17966242","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Our guideline on the use of #bovine #serum in manufacture of human biological medicines now available: http://t.co/Crq4lCjypN”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/Crq4lCjypN","expanded_url":"http://bit.ly/11oxOIj","display_url":"bit.ly/11oxOIj"}],"hashtags":[{"start":40,"end":47,"tag":"bovine"},{"start":48,"end":54,"tag":"serum"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-04T14:33:00.000Z","conversation_id":"341892572500873216","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"341892572500873216"}],"id":"341925559758118913","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News @URPLWMiPB OK j'apprend le tchèque (?) et je saurai tout sur l'almitrine...","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-03T17:05:26.000Z","conversation_id":"341580097653981185","possibly_sensitive":false,"lang":"fr","referenced_tweets":[{"type":"replied_to","id":"341580097653981185"}],"id":"341601531679883265","author_id":"1180456747","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Mac","text":"@EMA_News A mobile app for every rare disease - an interesting article: http://t.co/CDCMPxWvGm","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":72,"end":94,"url":"http://t.co/CDCMPxWvGm","expanded_url":"http://techcrunch.com/2013/05/31/big-impact-on-a-small-budget-bens-friends-wants-to-build-a-web-mobile-support-network-for-every-rare-disease/","display_url":"techcrunch.com/2013/05/31/big…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-03T08:45:12.000Z","conversation_id":"341475644372303872","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"341475644372303872","author_id":"17485749","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Windows","text":"@EMA_News  You still havenot diceded to aprove Scenesse because you are not sure if EPP is an seriouw ilness? Please define serious????","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-02T21:13:30.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"334943140853198848"}],"id":"341301570757083136","author_id":"1367162942","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Janetter","text":"備忘録3/21CHMPmeeting highlights翌22日21:17 RT @EMA_News Meeting highlights from the Committee for Medicinal Products...  http://t.co/ByX4zMDet9","entities":{"mentions":[{"start":42,"end":51,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/ByX4zMDet9","expanded_url":"http://bit.ly/XuKjxf","display_url":"bit.ly/XuKjxf"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-06-01T12:20:07.000Z","conversation_id":"315074803528765440","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"315074803528765440"}],"id":"340804954111500288","author_id":"115898830","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Janetter","text":"備忘録　4/25CHMPmeeting highlights翌26日20:12 RT @EMA_News Meeting highlights from April #CHMP meeting have now been publ.. http://t.co/DKI4fzXcyT","entities":{"mentions":[{"start":43,"end":52,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/DKI4fzXcyT","expanded_url":"http://bit.ly/Y8Tjhj","display_url":"bit.ly/Y8Tjhj"}],"hashtags":[{"start":83,"end":88,"tag":"CHMP"}],"annotations":{},"cashtags":{}},"created_at":"2013-06-01T12:12:57.000Z","conversation_id":"327742015964053504","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"327742015964053504"}],"id":"340803151185707009","author_id":"115898830","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News recommends approval of #Celgene #drug #pomalidomide for the treatment of multiple #myeloma #cancer #biotech #pharma","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":33,"end":41,"tag":"Celgene"},{"start":42,"end":47,"tag":"drug"},{"start":48,"end":61,"tag":"pomalidomide"},{"start":92,"end":100,"tag":"myeloma"},{"start":101,"end":108,"tag":"cancer"},{"start":109,"end":117,"tag":"biotech"},{"start":118,"end":125,"tag":"pharma"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-31T12:16:42.000Z","conversation_id":"340441705348210689","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"340441705348210689","author_id":"243228907","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: Two more weeks to comment, guideline #pharmacovigilance for #vaccines &amp; annex: http://t.co/EnCB00bqpx http://t.co/bdXTkgsPfA”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/EnCB00bqpx","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":118,"end":140,"url":"http://t.co/bdXTkgsPfA","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":49,"end":67,"tag":"pharmacovigilance"},{"start":72,"end":81,"tag":"vaccines"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-29T17:04:03.000Z","conversation_id":"339658692687454208","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"339658692687454208"}],"id":"339789246246301698","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We're inviting comments, guideline on efficacy of #veterinary #antimicrobials. Deadline is 30/11/2013: http://t.co/CcpfiHNU3i”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/CcpfiHNU3i","expanded_url":"http://bit.ly/111YtX6","display_url":"bit.ly/111YtX6"}],"hashtags":[{"start":62,"end":73,"tag":"veterinary"},{"start":74,"end":89,"tag":"antimicrobials"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-29T17:04:03.000Z","conversation_id":"339667250107805696","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"339667250107805696"}],"id":"339789245881401346","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Websites","text":"Il EMA per uso umano ha formulato un parere positivo sul #dimetil-#fumarato http://t.co/aTZbFHHVLS\n@EMA_news #RRMS #CHMP #dimetilfumarato","entities":{"mentions":[{"start":99,"end":108,"username":"EMA_News","id":"116716199"}],"urls":[{"start":76,"end":98,"url":"http://t.co/aTZbFHHVLS","expanded_url":"http://shar.es/ZTrve","display_url":"shar.es/ZTrve"}],"hashtags":[{"start":57,"end":65,"tag":"dimetil"},{"start":66,"end":75,"tag":"fumarato"},{"start":109,"end":114,"tag":"RRMS"},{"start":115,"end":120,"tag":"CHMP"},{"start":121,"end":137,"tag":"dimetilfumarato"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-26T22:41:54.000Z","conversation_id":"338787101531312129","possibly_sensitive":false,"lang":"it","referenced_tweets":{},"id":"338787101531312129","author_id":"142310101","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"Where are proposals re medtech for better compliance? “@EMA_News: #medicationerrors in EU, 6 key recommendations: http://t.co/8jsOKXXtC3”","entities":{"mentions":[{"start":55,"end":64,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/8jsOKXXtC3","expanded_url":"http://bit.ly/16Q91kA","display_url":"bit.ly/16Q91kA"}],"hashtags":[{"start":66,"end":83,"tag":"medicationerrors"}],"annotations":[{"start":87,"end":88,"probability":0.5066,"type":"Place","normalized_text":"EU"}],"cashtags":{}},"created_at":"2013-05-23T11:38:32.000Z","conversation_id":"337524821703397377","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"337524821703397377"}],"id":"337532998318702593","author_id":"183177433","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: From March all applications for human medicines will need to use the #eSubmission Gateway or web client: http://t.co/rbdvPA75SX”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/rbdvPA75SX","expanded_url":"http://bit.ly/10LXhHt","display_url":"bit.ly/10LXhHt"}],"hashtags":[{"start":81,"end":93,"tag":"eSubmission"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-22T16:20:27.000Z","conversation_id":"337230023750737920","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"337230023750737920"}],"id":"337241558384508929","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News #veterinary committee recommended the first vaccine for #footandmouth disease for authorisation last week: http://t.co/EZnGvqXhrG","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/EZnGvqXhrG","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":[{"start":11,"end":22,"tag":"veterinary"},{"start":67,"end":80,"tag":"footandmouth"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-21T17:00:20.000Z","conversation_id":"336756522304561152","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"336756522304561152"}],"id":"336889207354171393","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We published the full highlights from our #pharmacovigilance committee last Friday: http://t.co/4bQYW6lVcy”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/4bQYW6lVcy","expanded_url":"http://bit.ly/16pwHMT","display_url":"bit.ly/16pwHMT"}],"hashtags":[{"start":54,"end":72,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-21T17:00:06.000Z","conversation_id":"336756326862577664","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"336756326862577664"}],"id":"336889145697918976","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"@EMA_News recommends #EU authorisation of #Aftovaxpur DOE, first multi-strain #vaccine for foot and mouth disease #Merial","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":21,"end":24,"tag":"EU"},{"start":42,"end":53,"tag":"Aftovaxpur"},{"start":78,"end":86,"tag":"vaccine"},{"start":114,"end":121,"tag":"Merial"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-20T10:32:26.000Z","conversation_id":"336429202003861505","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"336429202003861505","author_id":"243228907","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @jdflaysakier . L'agence française ne reconnaît pas l'Europe et protégé sa seule responsabilité","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"jdflaysakier","id":"117459814"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-18T20:42:27.000Z","conversation_id":"335488046277484544","possibly_sensitive":false,"lang":"fr","referenced_tweets":[{"type":"replied_to","id":"335488046277484544"}],"id":"335857939770380288","author_id":"120702168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: We've reiterated the PRAC's earlier recommendation on #Diane35 and its generics: http://t.co/ijjNSTjUh7”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/ijjNSTjUh7","expanded_url":"http://bit.ly/Z1MGOc","display_url":"bit.ly/Z1MGOc"}],"hashtags":[{"start":66,"end":74,"tag":"Diane35"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-17T20:13:58.000Z","conversation_id":"335488046277484544","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"335488046277484544"}],"id":"335488384392916992","author_id":"264291314","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: EMA recommends first vaccine for foot-and-mouth disease for authorisation at EU level: http://t.co/EZnGvqXhrG”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/EZnGvqXhrG","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-17T18:00:44.000Z","conversation_id":"335392584480468992","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"335392584480468992"}],"id":"335454856024313856","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: PRAC recommends positive benefit/risk balance of #Diane 35 and generics in specific patient group http://t.co/OCIHDQns4m”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/OCIHDQns4m","expanded_url":"http://bit.ly/10CxqBy","display_url":"bit.ly/10CxqBy"}],"hashtags":[{"start":61,"end":67,"tag":"Diane"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-17T17:10:15.000Z","conversation_id":"335357753885331457","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"335357753885331457"}],"id":"335442149539717121","author_id":"216527950","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"International #ClinicalTrials Day on Monday: http://t.co/Q7GuT1xwaO vía @EMA_News","entities":{"mentions":[{"start":72,"end":81,"username":"EMA_News","id":"116716199"}],"urls":[{"start":45,"end":67,"url":"http://t.co/Q7GuT1xwaO","expanded_url":"http://bit.ly/10KaUYE","display_url":"bit.ly/10KaUYE"}],"hashtags":[{"start":14,"end":29,"tag":"ClinicalTrials"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-17T16:36:06.000Z","conversation_id":"335432413335416832","possibly_sensitive":false,"lang":"eu","referenced_tweets":[{"type":"replied_to","id":"335432413335416832"}],"id":"335433556845289473","author_id":"109792171","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News published inventory of #paediatric medicine needs in #infectious diseases for consultation until 15/07/2013 http://t.co/jjf4NBPzkP","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/jjf4NBPzkP","expanded_url":"http://bit.ly/12DkBdd","display_url":"bit.ly/12DkBdd"}],"hashtags":[{"start":33,"end":44,"tag":"paediatric"},{"start":63,"end":74,"tag":"infectious"}],"annotations":{},"cashtags":{}},"created_at":"2013-05-16T11:06:07.000Z","conversation_id":"334988123169759233","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"334988123169759233","author_id":"606325697","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Windows","text":"@EMA_News and when will this be?","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-15T20:26:22.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"334226243912359936"}],"id":"334766728758308864","author_id":"1367162942","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPad","text":"“@EMA_News: RT @URPLWMiPB: Cases of necrotising fasciitis due to the use of Avastin (bevacizumab): http://t.co/YNIGh3R7l3 …”","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":25,"username":"URPLWMiPB","id":"556679074"}],"urls":[{"start":99,"end":121,"url":"http://t.co/YNIGh3R7l3","expanded_url":"http://urpl.gov.pl/pl-komunikaty-bezp/przypadki-martwiczego-zapalenia-powiezi-w-zwiazku-z-zastosowaniem-produktu-avastin-bewacyzumab","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-15T16:47:06.000Z","conversation_id":"334623043517304832","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"334623043517304832"}],"id":"334711549908365312","author_id":"514255564","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for Windows","text":"@EMA_News i know it is still pending but I am already waiting for two years","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-14T10:43:55.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"334226243912359936"}],"id":"334257762433368065","author_id":"1367162942","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter for iPhone","text":"@EMA_News @FrancoisMaignen http://t.co/cElR3kSBYb","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"FrancoisMaignen","id":"769373400"}],"urls":[{"start":27,"end":49,"url":"http://t.co/cElR3kSBYb","expanded_url":"http://www.urpl.gov.pl/pl-komunikaty-bezp/protelos-osseor-dhcp-pdf","display_url":"urpl.gov.pl/pl-komunikaty-…"}],"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-14T10:20:10.000Z","conversation_id":"334216509482213377","possibly_sensitive":false,"lang":"und","referenced_tweets":[{"type":"replied_to","id":"334242906154098688"}],"id":"334251785982189570","author_id":"556679074","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Tweetbot for iOS","text":"@EMA_News J’ai vu ! Fr","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-14T09:46:14.000Z","conversation_id":"334223216191082496","possibly_sensitive":false,"lang":"fr","referenced_tweets":[{"type":"replied_to","id":"334243151164346369"}],"id":"334243244340817920","author_id":"769373400","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Tweetbot for iOS","text":"@EMA_News The link doesn’t work …","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-14T09:40:52.000Z","conversation_id":"334223216191082496","possibly_sensitive":false,"lang":"en","referenced_tweets":[{"type":"replied_to","id":"334223216191082496"}],"id":"334241896278941696","author_id":"769373400","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News i hope i will get an answer on my letter but be sure I will not stop with sending tweets till i get this medicine","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-12T10:40:09.000Z","conversation_id":"333532037954813953","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"333532037954813953","author_id":"1367162942","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News then you can tell to me and my little daughter of 4 years old that the medicine what will change my whole life is not availebale","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-12T10:39:25.000Z","conversation_id":"333531852465909760","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"333531852465909760","author_id":"1367162942","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"source":"Twitter Web Client","text":"@EMA_News \ni would like to invite members of the EMA to come to my house and sit for just one weekend in the dark with me!","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"created_at":"2013-05-12T10:38:15.000Z","conversation_id":"333531560567504897","possibly_sensitive":false,"lang":"en","referenced_tweets":{},"id":"333531560567504897","author_id":"1367162942","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}}]
